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ABSTRACT 
 
Binge alcohol (EtOH) exposure in adolescence is a fundamental health 
concern. In 2005, over 20% of teenagers between ages 15 and 17 reported 
binge drinking behavior within a one month period preceding the survey (Dept. of 
Health and Human Services: Substance Abuse and Mental Health Services 
Administration). Binge drinking is defined as consuming enough alcohol within a 
2.0 h period to bring blood alcohol concentration above 0.08%. In the adolescent 
population, this type of alcohol exposure tends to be repeated. In adults, alcohol 
abuse has been correlated with increased incidence of mood disorders and these 
disorders are characterized by dysregulation of the hypothalamo-pituitary-adrenal 
(HPA) axis, a three tiered biological system that mediates physiological stress 
response. Corticotrophin releasing hormone (CRH) and arginine vasopressin 
(AVP) localized in the paraventricular nucleus (PVN) of the hypothalamus are the 
major neuropeptides involved in modulating HPA axis responses to stress. 
Corticosterone (CORT) in rodents, and cortisol in humans, is a major 
glucocorticoid hormone released into the circulation upon activation of the HPA 
axis. Puberty is a period during which extensive maturation occurs, yet our 
knowledge of the neurobiological consequences of binge EtOH exposure during 
this time period is severely limited. I sought to investigate the neuroendocrine 
consequences of EtOH exposure during pubertal maturation and tested the
xvii 
 
 
hypothesis that EtOH exposure during puberty has long lasting detrimental 
consequences for a proper maturation of the HPA axis. My data revealed that 
repeated binge-pattern EtOH exposure resulted in a sex specific dysregulation of 
the HPA axis in pubertal rats. This was marked by an increase in the expression 
of CRH and AVP mRNA in the male, but not female, PVN. Notably, in both 
sexes, both single and repeated binge EtOH exposures resulted in increased 
circulating CORT levels and habituation effects. These results suggested that 
repeated binge-like EtOH exposure differentially dysregulated the HPA axis in 
males compared to females (Przybycien-Szymanska et al., AJP Endocrin. and 
Metabol., 2010). My data further showed that the sex steroid hormone, 17β-
estradiol, is required for the maintenance of steady state levels of CRH and AVP 
mRNA in the PVN of pubertal female rats and for the habituation effects 
observed in CORT responses after repeated binge-pattern EtOH exposure. Most 
striking, these results showed that in males, binge-pattern EtOH exposure during 
puberty resulted in the dysregulation of adult HPA axis. This was evidenced by 1) 
increased adult basal levels of CRH mRNA in the PVN and lower basal 
circulating CORT levels, 2) differential patterns of CRH and AVP mRNA 
expression in the PVN after subsequent EtOH exposures in adulthood, 3) 
enhanced circulating CORT increase after single or repeated binge-like 
exposures in adulthood, 4) lack of habituation in CORT response after adult 
repeated binge pattern EtOH exposure (Przybycien-Szymanska et al., PLoS 
One, 2011).
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In addition, I investigated the molecular mechanisms involved in the 
observed EtOH-induced increase in the CRH mRNA in the PVN. Increased gene 
expression correlates closely with increased gene promoter activity; therefore I 
tested whether EtOH affects CRH promoter activity and whether glucocorticoid 
negative feedback at the promoter was dysregulated by EtOH. My data showed 
that EtOH exerts a biphasic effects on the activity of the CRH promoter and these 
effects are blocked by glucocorticoid receptor (GR) antagonist and deletion of 
glucocorticoid response element site (a binding site for GR) on CRH promoter. 
These results indicated that EtOH dysregulates functioning of the HPA axis by 
interfering with normal negative glucocorticoid feedback mechanism exerted on 
CRH promoter. Moreover, I showed that 17β-estradiol prevented the EtOH-
induced increase in CRH promoter activity supporting a role of this hormone in 
the sexually dimorphic changes of CRH mRNA in the PVN after EtOH exposure. 
 In conclusion, my data showed that binge-pattern EtOH exposure during 
puberty has long lasting effects on the HPA axis. These effects are manifested 
by alterations in PVN expression of neuropeptides involved in modulating stress 
responses and glucocorticoid hormone signaling. These effects are caused by 
EtOH-induced dysregulation of glucocorticoid negative feedback normally 
exerted at the level of the gene promoter in the PVN and may lead to increased 
risk for mood disorders in adulthood.
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CHAPTER ONE 
INTRODUCTION 
 
Literature review 
 
Binge alcohol consumption in adolescents 
Alcohol abuse during adolescence is a fundamental health concern in the 
United States. According to the U.S. Department of Health and Human Services, 
boys on average have their first drink before age 11 and girls tend to have their 
first drink before age 13. Alarming overall statistics show that by age 14, 41% of 
teenagers have consumed their first drink.  
Underage drinkers do not chronically abuse alcohol, they  typically adopt a 
“binge” pattern of alcohol consumption, defined by the National Institute on 
Alcohol Abuse and Alcoholism (NIAAA) as heavy, episodic drinking in which 
enough alcohol (on average 4 or 5 drinks in adult females and males, 
respectively) is consumed to bring the blood alcohol concentration above 0.08 % 
limit within that 2.0 h time period (White, Kraus et al. 2006). According to the 
Department of Health and Human Services survey performed in 2005, 2.0% of 
12-13 year-old, 8.0% of 14-15 year-old, 19.7% of 16-17 year-old, and 51% of 18-
20 year-old adolescents reported this pattern of drinking within a month 
preceding the survey. Overall, these statistics indicate that a significant 
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percentage of the young population consumes heavy doses of alcohol during 
adolescence. 
 
Brain development during adolescence 
The onset of adult reproductive functions, also known as puberty, is 
marked by many endocrinological, neurological and anatomical changes in both 
males and females. During this time period, changes in hormone levels 
accompany gonad maturation and acquisition of secondary sex characteristics. 
In addition to sexual maturation, the late pubertal period, also known as 
adolescence, is a period during which extensive brain maturation continues to 
occur. Even though it is relatively vague, very often adolescence is a term 
describing a time period of maturation between puberty and adulthood. This 
phase is marked by emotional, cognitive and personality development and is 
characterized by increased associations with groups of peers, increased risk 
taking behavior, lack of behavioral inhibition, and mood swings. These 
personality changes are a result of extensive brain maturation occurring during 
this time and characterized by changes in cortical gray matter (Lenroot and 
Giedd 2006), increased neurogenesis in some brain areas (Rankin, Partlow et al. 
2003; Raymond, Kucherepa et al. 2006; Ahmed, Zehr et al. 2008), increased 
dendritic pruning in other brain regions (Woo, Pucak et al. 1997; Zehr, Todd et al. 
2006), changes in corpus collosum thickness (Luders, Thompson et al.; Luders, 
Thompson et al. 2010) and increased synaptic connectivity (Cunningham, 
Bhattacharyya et al. 2002). Adolescents may be extremely vulnerable to harmful 
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effects of drugs of abuse, including alcohol because of this extensive brain 
maturation occurring during this stage of development.   
 
Fetal brain development and some of the effects of in utero alcohol exposure 
 The embryonic stage of life is extremely vulnerable to any types of 
stressors because it is the time during which all critical systems in the fetus are 
being formed. Obviously, one of the organs that develop during this time period is 
the brain. Alcohol exposure during a critical developmental period, such as 
embryonic or pubertal development, may result in long lasting alteration of the 
systems that undergo development or maturation during these periods, Alcohol 
(EtOH) exposure during fetal development has been shown to cause neuronal 
dysfunction and cell death (Miki, Harris et al. 2003; Ramachandran, Watts et al. 
2003; Akbar, Baick et al. 2006; Aloe 2006; Camarillo and Miranda 2008) and it 
has been well described that in utero alcohol exposure can result in development 
of a spectrum of disorders called Fetal Alcohol Spectrum Disorder (FASD) in the 
offspring. Among other characteristics, FASD is marked by a mild or, in some 
cases, severe mental retardation. This mental retardation is indicative of alcohol 
exposure induced compromise in brain development that could be a result of 
EtOH induced neuronal dysfunction. Some of the brain systems that are affected 
by fetal EtOH exposure are cortical and striatal dopaminergic systems (Druse, 
Tajuddin et al. 1990), cortical and brain stem serotonergic systems (Druse, Kuo 
et al. 1991; Tajuddin and Druse 1993; Kim, Gillespie et al. 1997; Tajuddin and 
Druse 1999), brain stem adrenergic systems (Choi, Lee et al. 2008) and the 
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hypothalamo-pituitary-adrenal (HPA) axis (Taylor, Branch et al. 1981; Taylor, 
Nelson et al. 1984; Tajuddin and Druse 1999; Hofmann, Ellis et al. 2007; Lee, 
Choi et al. 2008). For example, in utero EtOH exposure decreased serotonin 
levels and the density of its receptors in the brain stem and in the motor and 
somatosensory cortices (Druse, Kuo et al. 1991; Tajuddin and Druse 1993). 
EtOH exposure also decreased dopamine levels, dopamine uptake sites and the 
number of dopamine receptors in the striatum (Druse, Tajuddin et al. 1990). 
Abnormal formation of either of these systems, dopaminergic, serotonergic or 
adrenergic, increases the risk for developing substance dependence, mental 
retardation, or mood disturbances in the offspring.  
Mood disturbances are the end result of the dysregulation of the 
homeostatic balance between different players of the HPA axis. Functioning of 
the HPA axis is severely compromised by fetal EtOH exposure. It has been 
shown that in utero EtOH exposure resulted in the hyperactivity of the HPA axis 
responses in the young and adult offspring (Ogilvie and Rivier 1997; Kim, 
Giberson et al. 1999). In post natal day (PND) 21 offspring, for example, this 
hypersensitivity was marked by an enhanced increase in foot shock induced 
elevation in plasma adrenocorticotrophic hormone (ACTH) levels and an 
increase in basal (non-stress) corticotrophin releasing hormone (CRH) 
messenger ribonucleic acid (mRNA) levels (Lee, Imaki et al. 1990; Ogilvie and 
Rivier 1997). Interestingly, the effects of in utero EtOH exposure were observed 
specifically if EtOH exposure occurred during the second week of gestation (Lee, 
Imaki et al. 1990). The second week of rat pregnancy coincides with the 
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development of the rat hypothalamic CRH system (Altman and Bayer 1986), 
therefore, EtOH exposure in utero may result in permanent dysregulation of the 
system. Notably, the hyper-sensitivity of the HPA axis after fetal EtOH exposure 
was maintained until adulthood. In multiple studies, it has been shown that  in 
rats exposed to EtOH in utero, a stressor induced increase in ACTH release was 
enhanced in adulthood (Weinberg 1988; Kang, Cole et al. 2004; Lee, Choi et al. 
2008). In addition, CRH  hetero nuclear (hn) RNA was increased after stressor in  
adult rats pre-exposed to EtOH in utero as compared to control rats (Lee, Choi et 
al. 2008). Together, these data suggest that alcohol exposure during a critical 
developmental period, such as embryonic or pubertal development, may result in 
long lasting alteration of the systems that undergo development or maturation 
during these periods, however, long lasting effects of EtOH exposure during 
puberty have not been extensively investigated.      
 
The hypothalamo-pituitary-adrenal (HPA) axis 
The hypothalamo-pituitary adrenal (HPA) axis is a three part endocrine 
system responsible for coordinating stress responses. In a healthy system, upon 
stressful stimulus, parvocellular cells of the PVN (pPVN) located in the 
hypothalamus synthesize and secrete corticotrophin-releasing hormone (CRH) 
and arginine vasopressin (AVP). CRH and AVP then activate CRH 1 receptors 
(CRH-R1) and vasopressin 1B (V1B) receptors, respectively, in the anterior 
pituitary gland and act synergistically to stimulate the anterior pituitary gland to 
produce adrenocorticotrophic hormone (ACTH) (Aguilera, Harwood et al. 1983; 
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Rivier, Rivier et al. 1996; Papadimitriou and Priftis 2009) . CRH and AVP 
expressing neurons in the PVN that project to the median eminence and 
stimulate ACTH secretion from the anterior pituitary gland play a pivotal role in 
orchestrating central and endocrine signals reaching the brain during stressful 
events, therefore, proper functioning of these neurons is critical for maintaining 
homeostasis after stress. After CRH and AVP stimulation, corticotrope cells of 
the pituitary release ACTH into systemic circulation and then ACTH acts in 
endocrine fashion on the adrenal gland to produce and release glucocorticoids, 
cortisol in humans and corticosterone (CORT) in rodents (Papadimitriou and 
Priftis 2009) . Glucocorticoids can then exert negative feedback on both the 
hypothalamus and pituitary gland to decrease the neuropeptides and ACTH 
release, respectively, allowing for homeostatic state to be re-established (Erkut, 
Pool et al. 1998; Malkoski and Dorin 1999; Figueiredo, Bodie et al. 2003; 
Ostrander, Ulrich-Lai et al. 2006; Yamamori, Iwasaki et al. 2007; Papadimitriou 
and Priftis 2009; van der Laan, de Kloet et al. 2009).  
 
Paraventricular nucleus of the hypothalamus (PVN). Outputs and Inputs. 
 The paraventricular nucleus of the hypothalamus (PVN) is a diverse group 
of cell bodies localized in the hypothalamus adjacent to the third ventricle. In the 
adult rat brain it is localized between 0.8 mm and 2.12 mm posterior to Bregma, 
8.0 mm below the top of the brain (Smith, Gardiner et al. 2008) (Paxinos and 
Watson, Rat Brain Atlas, 5th edition). Among other neuropeptides and 
neurotransmitters, parvocellular cells of the PVN (pPVN) contain CRH and 
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arginine vasopressin (AVP) hormones and magnocellular cells of the PVN 
(mPVN) are known to produce AVP (Hou-Yu, Lamme et al. 1986; Ogilvie, Lee et 
al. 1998; Schulkin, Gold et al. 1998; Robertson 2001; Cole and Sawchenko 2002; 
Isgor, Shieh et al. 2003). Cells expressing CRH and AVP that are located in 
specific portions of the pPVN project to the median eminence where they secrete 
CRH and AVP into portal circulation by which these neuropeptides reach pituitary 
gland (Aguilera, Harwood et al. 1983; Rivier, Rivier et al. 1996; Hrabovszky, Deli 
et al. 2007). In addition to modulating stress reactivity, the PVN is involved in 
regulation of other critical body functions. For example, the PVN is known to 
send its glutamatergic projections to lateral hypothalamus (Hatton, Cobbett et al. 
1985), medial preoptic area (Kocsis, Kiss et al. 2003) and supraoptic nucleus 
(SON) (Csaki, Kocsis et al. 2002), therefore influencing reproduction and water 
homeostasis. It also sends projection to medial amygdala (MeA) (Meurisse, 
Chaillou et al. 2009) and ventral tegmental area (VTA) (Rodaros, Caruana et al. 
2007), therefore helps in coordinating emotional responses and appetitive 
behavior after stress. 
 The PVN does not function by itself. It receives a vast array of inputs from 
the central nervous system (CNS) therefore playing a pivotal role in coordinating 
homeostatic balance in the body. For example, PVN receives autonomic nervous 
system noradrenergic and adrenergic inputs from the brain stem, including such 
brain stem regions as  ventral medulla, vagal complex and locus coreleus 
(Sawchenko and Swanson 1982; Woulfe, Hrycyshyn et al. 1988; Sawchenko and 
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Bohn 1989), therefore coordinating functions of the autonomic nervous system 
and the HPA axis.  
The serotonergic system also extensively influences functions of the HPA 
axis. For example, it has been shown that long term (14 day) treatment with 
selective serotonin reuptake inhibitor, Fluoxetine, reversed conditioned stress 
response  procedure induced increase in anxiety-like behavior (Zhang, Raap et 
al. 2000)  The interaction between the serotonin system and the HPA axis may 
be occurring at the level of the PVN. Serotonergic axons terminate on CRH 
containing neurons within pPVN. Notably, serotonergic innervation to the pPVN 
has been shown to be greater than to other diencephalic regions and the 
innervation to the pPVN was more prominent than to the mPVN (Liposits, Phelix 
et al. 1987). Serotonin inputs have a stimulatory effect on the HPA axis as 
systemic administration of the serotonin precursor (5-hydroxytryptophan, 5-HTP) 
and serotonin reuptake inhibitor increased CRH mRNA expression in the PVN, 
increased ACTH precursor, pro-opiomelanocortin (POMC) mRNA in the anterior 
pituitary gland and increased plasma ACTH levels as compared to control 
animals (Jorgensen, Knigge et al. 2002). Also, activation of serotonin receptor 1A 
and 2A localized in the PVN  increased basal plasma CORT levels and increase 
c-Fos activity in the PVN (Mikkelsen, Hay-Schmidt et al. 2004).  
PVN is highly regulated by gamma amminobutiric acid (GABA) and 
glutamate projections of the limbic structures. For example, MeA sends 
GABAergic projections that terminate on the GABA receptor containing GABA 
inter-neurons located near the PVN indirectly stimulating the PVN activity 
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(Herman, Mueller et al. 2004). Infralimbic cortex can inhibit PVN activity, whereas 
hippocampus and anterior cingulate/prelimbic cortex projections to the PVN can 
stimulate the activity of the HPA axis (Herman, Tasker et al. 2002; Herman, 
Ostrander et al. 2005). Together, these data indicate that functioning of the HPA 
axis can be affected by various CNS systems including autonomic nervous 
system, serotonergic system, and limbic system. The HPA axis can in turn 
influence other functions in the body including reproduction; water balance, and 
memory therefore normal functioning of the HPA axis is critical for the health of 
the individual. 
 
Pituitary gland and its functions 
 The pituitary gland is a small endocrine organ protruding from the ventral 
side of the hypothalamus. It is connected to the hypothalamus via the median 
eminence from which the pituitary stalk originates. The pituitary gland plays a 
critical role in coordinating water balance, reproduction, energy metabolism, 
growth and stress responses, therefore it is called a “master endocrine gland”. 
The pituitary galnd consists of two major lobes, anterior (adenohypophysis) and 
posterior (neurohypophysis) lobe. The posterior pituitary gland stores and 
releases AVP (also called. antiduretic hormone or ADH) that is produced in the 
supraoptic nucleus (SON) and mPVN and oxytocin hormone produced in the 
mPVN and SON. The anterior pituitary gland, on the other hand, is under a tight 
regulation of parvocellular cells of the hypothalamus and releasing factors 
produced in these neurons. The releasing factors produced in various 
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hypothalamic nuclei include, thyroid releasing hormone (TRH) that stimulates 
production of thyroid stimulating hormone (TSH) from the pituitary gland, growth 
hormone releasing hormone (GHRH) stimulating production and release of 
growth hormone (GH), prolactin releasing hormone stimulating prolactin release 
from the gland, and CRH and AVP that stimulate the production and release of 
ACTH. In addition, anterior pituitary releases luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) that are under a tight regulation of gonadortophin 
releasing hormone (GnRH) (Gibo, Hokama et al. 1993; Dasen and Rosenfeld 
1999) tightly regulating reproductive functions of both males and females.  
 As mentioned previously, ACTH release from the anterior pituitary gland is 
under a tight regulation by CRH and AVP neuropeptides produced in the pPVN. 
CRH released from the pPVN acts on the anterior pituitary gland corticotropes 
via activating CRH 1 receptors (CRH R1) and stimulating ACTH production 
(Aguilera, Harwood et al. 1983; Makino, Schulkin et al. 1995; Rivier, Rivier et al. 
1996; Green, Figueroa et al. 2000; Rivier, Grigoriadis et al. 2003).  AVP, 
synergistically with CRH, stimulates the production of ACTH by acting at the 
pituitary gland corticotropes expressing AVP 1b receptors (AVP 1b) (Ostrowski, 
Lolait et al. 1992; Lolait, O'Carroll et al. 1995; Aguilera and Rabadan-Diehl 2000). 
Proper functioning of these hypothalamic neurons is critical for the normal 
functioning of the anterior pituitary gland corticotropes as they influence 
glucocorticoid release from the adrenal cortex and coordinate stress responses. 
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Adrenals and their functions 
 Adrenal glands are the two separate endocrine glands. Each adrenal 
gland is located on top of each kidney. Each gland contains two distinct divisions, 
adrenal cortex, and medulla, both responsible for producing different types of 
hormones. The core of the adrenal gland, medulla, surrounded by the cortex, 
contains chromaffin cells producing catecholamines, adrenaline (also called 
epinephrine) and noradrenalin (also called norepinephrine). Epinephrine and 
norepinephrine are major players in the ‘fight-or-flight” responses of the 
autonomic nervous system during extreme stress. The major inputs to the 
medulla are sympathetic nervous system inputs originating from the thoracic 
spinal cord (Bacon and Smith 1988; Cao and Morrison 2001). Upon release, 
epinephrine and norepinephrine act on the heart, gastrointestinal tract and the 
brain to prepare the body for immediate response to stress, “fight or flight” 
response.  
 The adrenal cortex, on the other hand, is devoted to slower endocrine 
responses exerted by production of steroid hormones such as major stress 
steroid hormones glucocorticoids (cortisol in primates and corticosterone (CORT) 
in rodents) and aldosterone. In primates, adrenal cortex is also a source of 
androgens such as testosterone (T) and dehydroepiandrosterone (DHEA). The 
adrenal cortex is subdivided into three zones, zona glomerulosa, zona fasciculata 
and zona reticularis, each responsible for production of different hormones 
(Kater, Biglieri et al. 1982; Nishikawa and Strott 1984; Kater, Irony et al. 1990; 
Rosol, Yarrington et al. 2001; Rainey, Carr et al. 2002; Young, Murphy et al. 
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2003). The outer-most layer, zona glomerulosa, contains cells that produce 
aldosterone which is responsible for maintaining blood pressure (Kater, Biglieri et 
al. 1982). The inner layer, zona fasciculata, contains cells that are responsible for 
producing glucocorticoids, in response to the ACTH stimulation during stress 
(Nishikawa and Strott 1984; Kater, Irony et al. 1990). Inner-most layer of the 
cortex, zona reticularis, produces androgens, such as DHEA (Rainey, Carr et al. 
2002).  
Glucocorticoids released from the adrenal glands act on variety of organs 
in the body in order to help to maintain homeostatic balance during and after 
stress. in the brain, glucocorticoids act on different brain regions, including 
amygdala, hippocampus, suprachiasmatic nucleus (SCN) and the PVN (Clark 
and Kemppainen 1994; Roy, Mittal et al. 2002; Sage, Maurel et al. 2002; Liu, 
Unmehopa et al. 2006; Morsink, Steenbergen et al. 2006; Little, Croft et al. 
2008). By modulating functions of these brain regions, glucocorticoids can affect 
emotion, memory, circadian rhythms, and their own release, therefore, chronic or 
extremely high elevation of these hormones may have detrimental consequences 
for the homeostatic balance in the body.  
 
Glucocorticoid mediated negative feedback in the PVN 
Glucocorticoid hormones released from the adrenals exert negative 
feedback at the level of the PVN and pituitary gland in order to bring itheir own 
release from the adrenals back to basal levels and return the HPA axis to its 
homeostatic state. They do that by decreasing the production and release of the 
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CRH and AVP from the PVN (Makino, Schulkin et al. 1995; Makino, Smith et al. 
1995; Erkut, Pool et al. 1998; Malkoski and Dorin 1999) and ACTH release from 
the anterior pituitary gland (Clark and Kemppainen 1994). This negative 
feedback allows for a homeostatic state to be maintained after stress and any 
dysregulation of this feedback may result in developing mood disorders.  
 In the PVN, glucocorticoids directly affect the transcriptional activity of the 
CRH gene. Glucocorticoids activate glucocorticoid receptors (GR) which belong 
to a classical steroid receptor superfamily (ligand activated transcription factors). 
Upon activation by glucocorticoid, GR undergo dimerization, translocate to the 
nucleus and directly affect gene transcription (Goujon, Laye et al. 1997; Schulkin, 
Gold et al. 1998; Sapolsky, Romero et al. 2000; Morsink, Steenbergen et al. 
2006). In the PVN, glucocorticoids acting through GR are known to decrease 
CRH gene transcription through signaling at the negative glucocorticoid response 
element (nGRE) located between -249 and -278 nucleotides upstream from the 
transcription initiation site of the CRH promoter and thorough interactions with 
cAMP response element (CRE) site of the CRH promoter located -224 upstream 
from the transcription initiation site. The CRE site binding of phosphorylated 
cAMP response element binding protein (pCREB) is required for an increase in 
CRH promoter activity and gene transcription (Van, Spengler et al. 1990; 
Malkoski and Dorin 1999; King, Smith et al. 2002; Yamamori, Iwasaki et al. 2007; 
Liu, Kamitakahara et al. 2008; van der Laan, de Kloet et al. 2009). Overall, 
glucocorticoids acting via GRs decrease CRH promoter activity in the PVN 
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therefore, they decrease transcriptional activity of the promoter and decrease 
CRH gene expression keeping the HPA axis in homeostatic state.  
 
Role of arginine vasopressin (AVP) in the regulation of the HPA axis 
In addition to CRH, arginine vasopressin (AVP) is another neuropeptide 
critical for mediating stress and anxiety responses. First discovered as antiduretic 
hormone (ADH), AVP is synthesized in the supraoptic nucleus (SON), PVN, bed 
nucleus of stria terminalis (BSTN), amygdala and suprachiasmatic nucleus 
(SCN). Neurons that synthesize AVP in the pPVN project to the median 
eminence and facilitate the synergistic actions of AVP and CRH following 
stressful stimuli through enhancing ACTH and glucocorticoid release (Aguilera, 
Harwood et al. 1983; Ogilvie, Lee et al. 1997; Ogilvie and Rivier 1997; Scott and 
Dinan 1998; Papadimitriou and Priftis 2009). The role of AVP in regulation of the 
HPA axis is substantiated by the following data 1) chronic social stress changes 
the expression of AVP mRNA in the amygdala of adult rats (Albeck, McKittrick et 
al. 1997); 2) rats bred for high anxiety traits exhibit high levels of AVP expression 
in the PVN and higher level of vasopressin release compared to rats bred for low 
anxiety traits (Wigger, Sanchez et al. 2004); 3) mice lacking the vasopressin 1a 
(V1a) receptor exhibit reduced anxiety responses (Bielsky, Hu et al. 2004). In 
addition to stress regulation of the AVP expression, it has been shown that the 
transcriptional activity in hypothalamic neurons expressing AVP can be 
stimulated by acute alcohol (EtOH) administration demonstrated by increased 
amount of AVP hetero nuclear ribonucleic acid (hnRNA) in this brain region 
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(Ogilvie, Lee et al. 1997). Together these studies indicate that, in addition to 
corticotrophin releasing hormone (CRH), AVP is an important modulator of 
normal HPA axis function and that these function can be disrupted by EtOH 
exposure. 
 
Pubertal maturation of the HPA axis 
The HPA axis is one of the systems that undergo extensive plasticity 
during pubertal development (Romeo, Lee et al. 2004; Romeo, Bellani et al. 
2006; Romeo and McEwen 2006; McCormick and Mathews 2007; Evuarherhe, 
Leggett et al. 2009; Evuarherhe, Leggett et al. 2009; Laroche, Gasbarro et al. 
2009). Corticosterone (CORT) and CRH and AVP levels, are markedly different 
in response to both acute and chronic stressors in pre-pubertal (juvenile) and 
pubertal animals as compared with adult animals (Jankord, Solomon et al.; 
Romeo, Lee et al. 2004; Romeo, Bellani et al. 2006; Romeo and McEwen 
2006{Laroche, 2009 #190; McCormick and Mathews 2007; Evuarherhe, Leggett 
et al. 2009; Evuarherhe, Leggett et al. 2009). Most striking is the observation that 
CORT and ACTH levels take much longer to return to baseline in juvenile 
compared to adult animals when subjected to a variety of stressful stimuli 
(Vazquez and Akil 1993; Romeo, Bellani et al. 2006).  Further, juveniles have 
higher overall stress reactivity (Romeo, Bellani et al. 2006) and chronic stress 
during puberty has been shown to result in an exaggerated stress-induced CORT 
response in adulthood  (Jankord, Solomon et al.; Isgor, Cecchi et al. 2003). In 
addition, even a very mild form of stress, such as shipping, during puberty 
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contributes to reduced sexual behaviors in adulthood as pubertal male and 
female mice shipped during their 6th week of age (puberty) exhibited suppressed 
sexual behaviors and lower plasma CORT levels at 12 weeks of age (adulthood) 
as compared to mice shipped during 12th week of age (Laroche, Gasbarro et al. 
2009).  
Changing gonadal steroid hormone levels differentially regulate the HPA 
axis during puberty vs. adulthood. It has been shown, for example, that 
ovariectomized pre-pubertal female rats (PND 28) replaced with estradiol (E2) 
have suppressed stress responses (as measured by lower plasma CORT levels) 
after 30 min restraint stress compared with ovariectomized adult female rats 
replaced with E2 and subjected to the same stressor (Evuarherhe, Leggett et al. 
2009), In males gonadectomized before puberty (PND 28), testosterone (T) 
treatment did not change adult circulating CORT levels but T decreased plasma 
CORT levels in animals that were gonadectomized in adulthood (11 week of 
age). Also, following 10 min noise stress in these same castrated during puberty 
males, testosterone (T) did not change the responsiveness of the HPA axis but T 
suppressed stress response in animals that were gonadectomized in adulthood 
(as measured by changes in CORT levels after stress) (Evuarherhe, Leggett et 
al. 2009). Further, Viau et al. have shown that 60 day old females had highest 
basal and stress induced plasma ACTH and CORT levels when compared to 30 
day old females, 60 day old and 30 day old males. 60 day old males, on the other 
hand, had the lowest basal and stress induced plasma ACTH and CORT levels 
when compared to 30 day old males, 60 day old and 30 day old females 
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indicating that changes in the responsiveness of the HPA axis that occur over 
pubertal maturation are correlated with changing sex steroid hormone levels   
(Viau, Bingham et al. 2005).  Together these data indicate that during pubertal 
maturation, the HPA axis undergoes extensive organization and is vulnerable to 
any types of stressors. Stress and EtOH exposure during puberty may have long 
lasting behavioral consequences in adulthood resulting from long lasting 
alterations of the HPA axis.  
 
Dysregulation of the HPA axis and mood disorders 
Dysregulation of the normal glucocorticoid negative feedback and 
functioning of the HPA axis is a hallmark of different types of mood disorders, 
including but not limited to post-traumatic stress disorder (PTSD), depression 
and anxiety (Ikin, Creamer et al.; Pervanidou and Chrousos; Wood, Walker et al.; 
Smith, Davidson et al. 1989; Scott and Dinan 1998; Newport, Heim et al. 2003; 
Steimer, Python et al. 2007). For example, in depressed patients, intravenous 
infusion of CRH resulted in blunted ACTH release but normal cortisol release 
(Holsboer, Lauer et al. 1995; Arborelius, Owens et al. 1999). Patients with PTSD 
tend to have elevated cerebrospinal fluid CRH levels and blunted ACTH 
responses to CRH challenge as compared to healthy individuals (Smith, 
Davidson et al. 1989; Arborelius, Owens et al. 1999). These data indicate 
dysregulation of the CRH-ACTH signaling in mood disorders. Various other 
human and animal studies indicated involvement of both the CRH and AVP 
systems in different types of mood disorders and individual differences in the 
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susceptibility towards developing  these types of disorders (Wood, Walker et al.; 
Jensen, Keller et al. 1997; Keck, Welt et al. 2003; Yamamoto, Morinobu et al. 
2009); however, other systems influencing functioning of the HPA axis also play 
a role in developing mood disorders 
Serotonergic and noradrenergic systems send their inputs to the PVN and 
have been implicated in major depressive and anxiety disorders (Eison 1990; 
Blier 2001). For example, enhanced serotonin transporter binding protein levels 
in the thalamus, insula and striatum were observed in patients with major 
depressive disorder or during the depressive stage of bipolar disorder (Cannon, 
Ichise et al. 2007). Serotonin 1A receptor function in patients with depression is 
reduced and this may be linked with reduction in the receptor binding potential in 
the cortex and raphe nucleus (Drevets, Thase et al. 2007). Selective serotonin 
reuptake inhibitors (SSRI) have been used in treatment of depression and 
generalized anxiety disorders as abnormality in serotonin receptor 1A, 1C and 2 
functions  have been implicated in these types of disorders (Baldwin and Rudge 
1995; Gorman and Kent 1999). Lastly, serotonin neurons are known to inhibit 
norepinephrine neurons, therefore SSRI can affect the noradrenergic system as 
well (Blier 2001) and both of these systems affect functioning of the HPA axis. 
These data show that other neurotransmitter systems that converge on the HPA 
axis may be involved in mood disorders, however, at the end, mood disorders 
are characterized by dysregulation of the proper negative feedback of the HPA 
axis.      
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Sex differences in the HPA axis reactivity to stressors 
There are gender differences in susceptibility of men and women to mood 
disorders with females being at a higher risk for these types of disorders 
(Zilberman, Tavares et al. 2003; Becker, Monteggia et al. 2007).  Multiple studies 
have show that in adult animals there are sex differences in the responsiveness 
of the HPA axis to stress and alcohol administration. For example, there are sex 
differences in 30 min restraint stress induced CORT release with young (PND 
20) females having lower plasma CORT levels and adult females (PND 80) 
having higher plasma CORT levels compared to males (Sencar-Cupovic and 
Milkovic 1976; Evuarherhe, Leggett et al. 2009). Also, after acute EtOH injection 
(3 g/kg) adult females had higher plasma ACTH and CORT increase compared 
to adult males (Rivier 1993; Ogilvie and Rivier 1996; Ogilvie and Rivier 1997), 
These data clearly show that there are sex differences in the responsiveness of 
the HPA axis to stressors at the levels of the ACTH and CORT. 
 There are also sex differences in adult basal CRH and AVP mRNA levels 
in the PVN as well as CRH and AVP mRNA levels in adult males and females 
after stress and EtOH exposure. For example, adult intact and adrenalectomized 
(PND 80) females have lower basal CRH and AVP mRNA in the PVN compared 
to age matched males (Patchev, Hayashi et al. 1999). In females, contrary to 
males, there are no changes in the expression of AVP mRNA 3.0 h after acute 
EtOH injection either in the pPVN or magnocellular (m) PVN (Ogilvie and Rivier 
1997) . Contrary to female data, in adult males, acute EtOH administration 
increases the expression of AVP mRNA in the pPVN after 3.0 h but fails to 
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change the expression of CRH heteronuclear (hn) RNA after 20 min in the same 
region (Rivier and Lee 1996). Together, these data clearly show that there are 
sex differences in the responsiveness of the HPA axis to stressors and to EtOH 
exposure at the level of the PVN, but the mechanisms involved in these 
differences are not well known.   
Steroid hormones have been shown to modulate the stress 
responsiveness of the HPA axis in males and in females. For example, in 
females, there was a greater plasma CORT increase after stress and alcohol 
administration as compared to males (Sencar-Cupovic and Milkovic 1976; Rivier 
1993; Ogilvie and Rivier 1997; Evuarherhe, Leggett et al. 2009; Weiser and 
Handa 2009). T is known to play inhibitory role on stress induced functions of the 
HPA axis marked by decreased ACTH and CORT increase when compared to 
females and increased basal plasma CORT levels in gonadectomized males as 
compared to intact males (Ogilvie and Rivier 1997; Viau, Chu et al. 1999; 
Williamson and Viau 2008; Evuarherhe, Leggett et al. 2009).  
T and its metabolites, such as 3β-diol and dihydrotestosterone (DHT), also 
differently modulate the HPA axis activity at the level of hypothalamus (De Vries, 
Wang et al. 1994; Viau and Meaney 1996; Viau, Chu et al. 1999; Viau, Lee et al. 
2003; Scordalakes and Rissman 2004; Lund, Hinds et al. 2006; Pak, Chung et al. 
2007; Williamson and Viau 2008; Handa, Weiser et al. 2009; Pak, Chung et al. 
2009). These effects can be mediated through estrogen receptor beta (ER β), 
main ER fond in the PVN (Isgor, Cecchi et al. 2003; Miller, Suzuki et al. 2004; 
Lund, Rovis et al. 2005; Suzuki and Handa 2005; Pak, Chung et al. 2007; Handa, 
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Weiser et al. 2009) and through androgen receptor (AR) present in the PVN and 
in other hypothalamic regions modulating PVN activity (Viau and Meaney 1996; 
Lund, Hinds et al. 2006). For example, in bed nucleus of stria terminalis (BST) of 
gonadectomized adult rats, DHT and E2 increase AVP mRNA as compared to 
gonadectomized rats not replaced with hormones. In juvenile rats, on the other 
hand, E2 and 3β-diol, but not DHT, increase AVP mRNA expression in BST but 
only E2 increased AVP mRNA expression in medial amygdala (MeA) (Pak, 
Chung et al. 2009). In addition, 3β-diol is known to activate the AVP promoter 
activity in a neuronal cell line (Pak, Chung et al. 2007; Pak, Chung et al. 2009). 
Together these data indicate that sex steroid hormones modulate the HPA axis 
activity at different levels of the HPA axis functioning.  
 
Chronic stress and hypo-activity of the HPA axis 
 Chronic stress induces habituation of the HPA axis. Several studies 
have shown that chronic stressor induced a lesser activation of the HPA axis as 
compared to acute stressor induced activation of the axis (Figueiredo, Bodie et 
al. 2003; Girotti, Pace et al. 2006; Ostrander, Ulrich-Lai et al. 2006; Ostrander, 
Ulrich-Lai et al. 2009). For example, acute cat exposure for 1.0 h (acute stress) 
resulted in a significant rise in plasma ACTH and CORT levels just after the 
cessation of the stressor as compared to no-stress control rats, however, daily 
1.0 h exposures for 7 or 14 days (chronic homotypic stress) resulted in ACTH 
and CORT levels that were not significantly different when compared to control, 
not stressed, animals. CRH mRNA in the PVN, on the other hand, was 
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significantly elevated after both acute and chronic stressors (Figueiredo, Bodie et 
al. 2003). In addition, chronic variable stress (twice daily exposure to various 
stressors (1.0 h restraint, 1.0 h restraint in cold temp, 1.0 h shaker stress, 20 min 
warm water forced swim, or 5.0 min cold water stress) plus occasional overnight 
stressor (overnight social isolation or overnight social crowding stress) for seven 
consecutive days) resulted in lower plasma ACTH responses to the new 
environment challenge 4.0 and 7.0 days after chronic variable stress paradigm. 
The same was true when plasma CORT levels were measured, however, the 
CRH mRNA in the PVN was elevated if novel environments challenge was 
administered 16.0 h after cessation of chronic variable stress and was not 
different after 4.0 or 7.0 days (Ostrander, Ulrich-Lai et al. 2006). These data 
suggest that chronic stress; either homo- or heterotypic, results in a habituation 
of the HPA axis responsiveness after cessation of the stressor or after exposure 
to a novel stressor. The mismatch between CRH mRNA levels and plasma 
hormone measurements further indicate that chronic stress in adulthood 
dysregulates normal functioning of the HPA axis and this may be linked to mood 
disturbances.    
 
Alcohol abuse and relationship to mood disorders 
Alcohol exposure is closely linked with a dysregulation of adult and 
adolescent stress system. For example, alcohol abuse in adulthood is correlated 
with a higher incidence of clinically diagnosed anxiety disorders and in 
adolescent and adult populations, alcohol consumption is correlated with 
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increased suicide risk  (Pompili, Serafini et al.; Zilberman, Tavares et al. 2003; 
Makhija and Sher 2007). Notably, women tend to be more sensitive to the effects 
of alcohol and have a higher incidence of clinically diagnosed anxiety disorders 
compared to men (Zilberman, Tavares et al. 2003; Becker, Monteggia et al. 
2007). In corroboration with human studies, it has been shown in experimental 
animals that EtOH exposure changes animal’s anxiety responses as well. In 
adolescent rats, for example, EtOH exposure increased anxiety-like behaviors 
without affecting performance in the retention based passive avoidance or novel 
object exploration tasks, performance which is indicative of memory retention 
abilities (Popovic, Caballero-Bleda et al. 2004). The link between increased risk 
of mood disorders in human population and increased anxiety-like behaviors in 
animals is substantiated by data showing EtOH induced alterations in 
neuropeptides involved in modulating HPA axis, CRH and AVP in the 
paraventricular nucleus of the hypothalamus (PVN), main brain region involved in 
coordinating stress responses in mammals (Allen, Rivier et al.; Rivier, Bruhn et 
al. 1984; Ogilvie and Rivier 1996; Rivier and Lee 1996; Ogilvie, Lee et al. 1997; 
Ogilvie, Lee et al. 1997; Ogilvie and Rivier 1997; Ogilvie, Lee et al. 1998; Ogilvie, 
Lee et al. 1998; Li, Kang et al. 2005). Together these data indicate that EtOH 
exposure dysregulates proper functions of the HPA axis which dysregulation is 
linked with developing mood disorders.  
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Alcohol exposure during puberty and its long lasting effects 
During puberty, EtOH exposure induces brain damage due to 
inflammation and has long lasting effects on a variety of CNS structures, 
including the mesolimbic dopaminergic and glutaminergic system (Pascual, Boix 
et al. 2009), hippocampus, and cerebellum (Pascual, Blanco et al. 2007). Such 
changes in the CNS are often manifested by altered adult behaviour patterns 
(Maldonado-Devincci, Badanich et al.; Slawecki, Thorsell et al. 2004; Pascual, 
Blanco et al. 2007; Pascual, Boix et al. 2009). For example, Pascual et al. 
showed that 2 weeks of  intermittent EtOH administration (single ip injection of 
3.0 g/kg EtOH for two consecutive days, followed by 2 day rest, then followed 
again by 2 days of EtOH injections) caused an increase in voluntary EtOH 
consumption in adult rats (Pascual, Boix et al. 2009). In a different study, they 
also showed that this intermittent pattern of EtOH administration induced long 
lasting deficits in learning ability, as discerned by a decreased number of correct 
choices in conditional discrimination learning task, and a reduced ability to adapt 
to a challenging environment in adulthood in a narrow beam task (Pascual, 
Blanco et al. 2007). These data indicate that the developing adolescent brain is 
extremely vulnerable to EtOH-induced toxicity and that effects of EtOH exposure 
during puberty can be observed in adulthood. 
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Summary 
Binge alcohol abuse during adolescence is a fundamental heath concern 
in the United States. Adolescence is a period during which extensive brain 
maturation continues to occur, therefore, this high dose EtOH exposure during 
this period can have detrimental effects on proper brain maturation. It has been 
shown that EtOH exposure during puberty can cause brain damage and that 
EtOH exposure during this phase of life has long lasting effects on a variety of 
CNS structures. These effects can be manifested by changes in adult 
behavioural responses.  
One of the systems that undergo extensive plasticity during pubertal 
development is the HPA axis responsible for coordinating stress responses. 
Dysregulation of the proper responses of this system, i.e. abnormal brain 
expression of neuropeptides involved in modulating stress responses, CRH and 
AVP and disrupted glucocorticoid signaling at the level of the PVN, results in 
development of different types of mood disorders including anxiety, depression 
and PTSD. In adulthood, alcohol abuse has been shown to be correlated with a 
higher incidence of clinically diagnosed anxiety disorders and increased suicide 
risk with women tending to be more sensitive to the effects of alcohol and have 
higher incidence of clinically diagnosed anxiety disorders compared to men. 
Even though the HPA axis changes during adolescence, consequences of binge 
pattern of EtOH exposure during this time period on the development of the HPA 
axis have not been investigated and have to be addressed in further research.  
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Next Step in Alcohol Research: Consequences of adolescent binge alcohol 
exposure and mechanisms involved. 
 It is well established that the HPA axis undergoes extensive maturation 
during adolescent period (Romeo and McEwen 2006; McCormick and Mathews 
2007; Evuarherhe, Leggett et al. 2009; Evuarherhe, Leggett et al. 2009). 
Previous reports have indicated that adult CRH and AVP expressing neurons in 
the PVN are modulated by EtOH exposure (Rivier, Bruhn et al. 1984; Ogilvie and 
Rivier 1996; Rivier and Lee 1996; Ogilvie, Lee et al. 1997; Ogilvie, Lee et al. 
1997; Ogilvie and Rivier 1997; Ogilvie, Lee et al. 1998; Ogilvie, Lee et al. 1998; 
Li, Kang et al. 2005) and that there are sex differences in the responsiveness of 
adult HPA axis to stress and EtOH exposure (Sencar-Cupovic and Milkovic 1976; 
Rivier 1993; Ogilvie and Rivier 1996; Ogilvie and Rivier 1997; Patchev, Hayashi 
et al. 1999), In addition, it has been shown that pubertal binge like EtOH 
exposure increased anxiety-like behaviors during this critical developmental time 
period (Popovic, Caballero-Bleda et al. 2004). The long lasting consequences of 
binge EtOH exposure on the development of the HPA axis have not been 
investigated. The overall goal of these studies was to extend previous findings 
performed in pubertal and adult animal models of EtOH exposure by elucidating 
1) short term effects of binge EtOH exposure during peri-pubertal period on the 
expression of CRH and AVP mRNA in the PVN and plasma CORT levels, 2) 
molecular mechanisms involved in EtOH effects and observed sex differences in 
the responsiveness of the HPA axis to EtOH exposure and 3) long lasting 
neuroendocrine consequences of binge EtOH exposure during this critical time 
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period on functioning of adult HPA axis as it has been shown that alcohol 
consumption during adolescence is a fundamental heath concern and can have 
detrimental effects on proper HPA axis maturation. 
 
Hypothesis and Aims 
One way to establish long lasting effects of binge EtOH exposure on 
functioning of adult HPA axis is to measure CRH and AVP mRNA expression in 
the PVN and circulating CORT levels in adult animals pre-exposed to binge 
EtOH paradigm during peri-pubertal development but before we can establish 
these long lasting effects of pubertal binge EtOH exposure, we have to verify if 
binge EtOH exposure during peri-puberty alters CRH and AVP mRNA expression 
in the PVN and what are possible mechanisms for these changes. In addition, 
based on the previous adult data, I also have to investigate whether there are 
sex differences in the responsiveness of adolescent HPA axis to EtOH exposure 
and if yes, what are possible mechanisms for these differences. If I see changes 
in pubertal HPA axis functioning after binge EtOH exposure, I can establish if 
these changes result in long lasting perturbations of the HPA axis. Based on 
previous data, I hypothesized that binge alcohol exposure during peri-pubertal 
development results in a long lasting dysregulation of adult HPA axis caused by 
permanent changes in the pubertal expression of the CRH and AVP mRNA 
expression in the PVN which results from EtOH induced dysregulation of the 
glucocorticoid negative feedback at the level of the hypothalamus (Fig. 1). 
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Fig 1. Schematic representation of the proposed hypothesis. A. Normal functioning of 
the HPA axis. Increased glucocorticoid (CORT) level exerts negative feedback to 
decrease production and release of CRH and AVP from the hypothalamus. I hypothesize 
that binge alcohol exposure during pubertal development results in a long lasting 
dysregulation of adult HPA axis caused by permanent changes in the pubertal 
expression of the CRH and AVP mRNA in the PVN which results from EtOH induced 
dysregulation of the glucocorticoid negative feedback at the level of the hypothalamus 
(B). 
 
 
  
29 
 
The following Specific Aims were established in other to test this hypothesis: 
Aim 1. Short term effects of binge EtOH exposure during peri-puberty. 
It is well established that adult EtOH exposure alters gene expression of 
CRH and AVP in the PVN and that there are sex differences in the 
responsiveness of adult HPA axis to EtOH exposures (Rivier 1993; Ogilvie and 
Rivier 1996; Rivier and Lee 1996; Ogilvie, Lee et al. 1997; Ogilvie and Rivier 
1997; Li, Kang et al. 2005). However, the effects of EtOH exposure during 
puberty on the central regulators of the HPA axis, CRH and AVP remain 
unknown. In this aim I answered following questions:  
1) Does binge EtOH exposure during peri-puberty change the PVN 
expression of stress regulated neuropeptides, CRH and AVP during this time 
period? 
  2) Are there sex differences in the responsiveness of peri-pubertal HPA 
axis to binge EtOH exposure?  
3) If there are sex differences in the responsiveness of pubertal HPA axis 
to binge EtOH exposure, is 17β-estradiol responsible for these sex differences? 
In order to answer these questions, peri-pubertal male and female rats 
were subjected to binge EtOH exposure paradigm 1.0 h after the last EtOH 
treatment, animals were sacrificed and blood and brains were collected. Plasma 
was isolated from the blood and used for measurements of blood EtOH 
concentrations (BAC) and hormone levels. Brains were rapidly frozen, specific 
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nuclei were microdisected and RNA was isolated. Quantitative real time reverse 
transcription-polymerase chain reaction (qRT-PCR) was used to measure 
changes in the mRNA expression in these brain nuclei. See Chapter 2 Results 
section and Chapter 7, General Methods section, for detailed description of 
experimental design and specific methods used for each specific experiment 
performed in this aim.  
In summary, my data showed that repeated binge, but not acute binge, 
EtOH exposure in peri-puberty increased the PVN expression of CRH and AVP 
mRNA but this effect was observed only in males. EtOH exposure had no effects 
on the CRH and AVP mRNA expression in peri-pubertal females indicating clear 
sex difference in the responsiveness of pubertal HPA axis to binge EtOH 
exposure. Further, the data showed that 17β-estradiol (E2) is partially responsible 
for observed sex differences but it is not the only factor involved. 
Aim 2. Molecular mechanism involved in EtOH effects in the PVN and 
observed sex differences in the CRH expression after EtOH exposure.  
Binge EtOH exposure increased CRH mRNA levels in the PVN and 
plasma CORT levels in peri-pubertal male rats (Przybycien-Szymanska, Rao et 
al. 2009) which is indicative of disrupted negative feedback that should be 
exerted by glucocorticoids at the level of the PVN in an undisturbed situation. In 
addition, in studies with ovariectomized females, I have shown that E2 is partially 
responsible for observed sex differences in the responsiveness of the HPA axis 
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to EtOH exposures (Chapter 4); however, the molecular mechanisms behind 
these EtOH effects remain unknown. In this aim I answered following questions:  
1) Does EtOH treatment directly regulate the activity of the CRH 
promoter?  
2) Does EtOH interfere with the glucocorticoid negative feedback that 
should be normally exerted at the CRH promoter?  
3) What specific sites on the CRH promoter are  involved in EtOH effects?  
4) Does 17β-estradiol (E2) treatment affect EtOH induced changes in the 
activity of the CRH promoter? 
    In order to answer these questions, cells derived from rat PVN (IVB cell 
line) were seeded and then transiently transfected with the wild type (WT) or 
mutated CRH promoter. 24.0 h after transient transfections, cells were treated 
with EtOH and after appropriate treatment time, dual luciferase reporter assay 
was performed in order to measure changes in the promoter-luciferase activity 
due to EtOH treatments. In addition, cells were treated with the same EtOH 
treatment paradigms in the presence of 10 nM E2 and this was done in order to 
investigate the role of E2 in sex specific effects of EtOH. See Chapters 3 and 4 
Results section and Chapter 7, General Methods section, for detailed description 
of experimental design and specific methods used for each specific experiment 
performed in this aim.  
  
32 
 
In summary, data presented in Chapter 3 showed that 12.5 and 100 mM 
EtOH treatment exerts biphasic effects on the activity of the CRH promoter with 
an initial decrease in the activity of the promoter at 0.5 h time point followed by 
an increase in the activity at 2.0 h. Interestingly, at the 2.0 h time point even dose 
as low as 12.5 mM induced an increase in CRH promoter activity. This effect was 
blocked when cells were treated with EtOH in the presence of glucocorticoid 
receptor (GR) antagonist and when portions of the negative glucocorticoid 
response element (nGRE) site and the cAMP response element (CRE) site of the 
CRH promoter were deleted. In addition, data presented in Chapter 4 showed 
that in the presence of E2, EtOH did not change CRH promoter activity 
supporting the role if E2 in mediating sexually dimorphic effects of EtOH. 
Together, these data indicated that EtOH exerts direct effects on the activity of 
the CRH promoter resulting in changes in CRH gene expression by interfering 
with GR signaling at the level of the CRH promoter and that EtOH interaction with 
E2 is partially responsible for observed sex differences.    
Aim 3. Long lasting consequences of binge EtOH exposure during peri-
pubertal development on functioning of adult HPA axis.  
Previous data showed that pubertal EtOH exposure has long lasting 
behavioral consequences marked by increased EtOH preference and impaired 
learning in adult animals (Pascual, Blanco et al. 2007; Pascual, Boix et al. 2009). 
I have shown that binge EtOH exposure in peri-pubertal male rats increased PVN 
expression of CRH and AVP mRNA (Przybycien-Szymanska, Rao et al. 2009) 
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and that EtOH induced dysregulation of normal negative GR feedback at the 
level of the CRH promoter in the PVN cells is involved in these effects (Chapter 
3). One main question that remains unanswered is whether these changes 
observed in peri-puberty are long lasting and result in dysregulation of 
functioning of adult HPA axis.  In this aim, I answered the following questions:  
1) Do changes observed during peri-puberty in the CRH and AVP mRNA 
persists into adulthood?  
2) Are adult animals prę-exposed to binge EtOH during peri-puberty more 
sensitive to subsequent single EtOH exposure in adulthood? 
 3) Do adult animals pre-exposed to binge EtOH during peri-puberty 
habituate to subsequent binge EtOH exposure in adulthood.  
 In order to answer these questions, peri-pubertal male rats were 
treated either with saline or binge EtOH exposure and then allowed to reach 
adulthood without any disturbances. In adulthood, these same animals were 
further subdivided into saline, acute EtOH and binge EtOH treatment groups (see 
Table 3 and General Methods of Chapter 7 for a detailed description) On the last 
day of adult treatments, 1.0 h after the last EtOH exposure, animals were 
sacrificed and blood and brains were collected. Plasma was isolated and used 
for BAC and hormone measurements. Brains were rapidly frozen, sectioned on a 
freezing microtome and PVN and SON were microdisected. Total mRNA was 
isolated and then qRT-PCR was performed to measure changes in the gene 
expression in these nuclei in all treatment groups. See Chapter 5 Results section 
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and Chapter 7, General Methods section, for detailed description of experimental 
design and specific methods used for each specific experiment performed in this 
aim.  
 Data collected in these experiments showed that binge EtOH exposure 
during peri-puberty resulted in long lasting changes in functioning of adult HPA 
axis marked by increased basal expression of CRH mRNA in the PVN and lower 
basal plasma CORT levels as compared to adult EtOH naïve rats. In addition, 
these data showed that binge EtOH exposure during peri-puberty increased 
sensitivity of adults to subsequent EtOH exposures as marked by enhanced 
increase in plasma CORT levels after adult acute and binge EtOH exposure as 
compared to adult EtOH naïve rats. In addition, at the level of the PVN, binge 
EtOH exposure during peri-puberty caused a different pattern of the CRH and 
AVP mRNA responses as compared to these animals that did not binge during 
puberty. Together, these data clearly show that binge EtOH exposure did not 
cause habituation of the HPA axis to subsequent binge EtOH exposure in 
adulthood but, on the contrary, it increased the sensitivity of the HPA axis to adult 
EtOH exposures. This indicates that binge EtOH exposure in adolescence may 
potentially  lead to increased risk for developing mood disorders in adulthood 
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CHAPTER TWO 
BINGE-PATTERN ALCOHOL EXPOSURE DURING PUBERTY INDUCES 
SEXUALLY DIMORPHIC CHANGES IN GENES REGULATING THE HPA AXIS 
(PRZYBYCIEN-SZYMANSKA ET AL, AM J PHYSIOL. ENDOCRINOL METAB 298; E-320-E328, 2010) 
 
Introduction 
Alcohol abuse during adolescence is a growing fundamental heath 
concern in the United States. According to the US Department of Health and 
Human Services, boys on average have had their first drink before age 11, and 
girls before age 13; with the overall statistics showing that 41% of teenagers 
have had their first drink by age 14. Underage drinkers typically adopt a “binge” 
pattern of alcohol consumption, defined by the National Institute on Alcohol 
Abuse and Alcoholism as heavy, episodic drinking in which enough alcohol is 
consumed in one sitting to bring the blood alcohol concentration (BAC) >0.08 
g/100 g (White, Kraus et al. 2006). During adolescence, significant neural 
remodeling occurs as evidenced by changes in cortical gray matter (Giedd, 
Blumenthal et al. 1999; Paus, Zijdenbos et al. 1999; Lenroot and Giedd 2006), 
neurogenesis (Raymond, Kucherepa et al. 2006), and increased synaptic 
connectivity (Cunningham, Bohn et al. 1990; Woo, Pucak et al. 1997; 
Cunningham, Bhattacharyya et al. 2002; Sisk and Zehr 2005), raising the 
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possibility that alcohol consumption during this critical period can lead to long-
term neurobiological and behavioral defects. 
One neurological system that undergoes extensive plasticity during 
pubertal development is the hypothalamo-pituitary-adrenal (HPA) axis (Romeo 
2003; Romeo, Lee et al. 2004; Romeo, Bellani et al. 2006; Romeo and McEwen 
2006). Under normal physiological conditions, an acute psychological or physical 
stressor activates the HPA axis. Hypothalamic corticotrophin-releasing hormone 
(CRH) stimulates adrenocorticotrophic hormone (ACTH) release from the 
anterior pituitary, which, in turn, causes the release of adrenal glucocorticoids. 
This sequence of events sets up a negative feedback system whereby increased 
circulating glucocorticoid levels serve to inhibit the additional release of 
hypothalamic CRH. Importantly, alcohol consumption can alter the expression of 
genes involved in mediating the stress response of the HPA axis. For instance, 
Rivier and Lee (Rivier and Lee 1996) demonstrated that acute ethanol (EtOH) 
administration to adult rats increased the transcriptional activity of hypothalamic 
CRH and arginine vasopressin (AVP) neurons, as measured by increased CRH 
and AVP heteronuclear (hn) RNA following a single dose of EtOH. In addition, 
the release of ACTH from the pituitary gland in response to EtOH was blocked 
when CRH and AVP antagonists were used concomitantly (Rivier and Lee 1996). 
These results show that acute EtOH exposure activates the HPA axis and the 
effects of EtOH are likely mediated by both CRH and AVP. 
AVP is a multifunctional neuropeptide critical for mediating both stress and 
anxiety responses (Wigger, Sanchez et al. 2004; Egashira, Tanoue et al. 2007). 
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First discovered as antidiuretic hormone, AVP is synthesized in the 
paraventricular nucleus (PVN), supraoptic nucleus (SON), bed nucleus of stria 
terminalis (BST), amygdala (AMY), and suprachiasmatic nucleus (SCN). 
Neurons that synthesize AVP in the parvocellular division PVN project to the 
median eminence and facilitate the synergistic actions of AVP and CRH following 
stressful stimuli by enhancing ACTH and glucocorticoid release 
(Dickstein, DeBold et al. 1996). Several lines of evidence suggest that acute or 
chronic alcohol exposure might lead to increased displays of anxiety behavior. 
Correlative studies have demonstrated that over 50% of patients with alcohol 
dependency also have anxiety-related or depression-related psychiatric 
disorders, and these types of disorders are often associated with an abnormal 
stress response. Interestingly, female alcoholics have a higher incidence of 
clinically diagnosed anxiety disorders compared with male alcoholics (Zilberman, 
Tavares et al. 2003; Epstein, Fischer-Elber et al. 2007), possibly because of the 
inherent sex differences in the stress responses of the HPA axis (Becker, 
Monteggia et al. 2007; Handa, Zoeller et al. 2007). Furthermore, repeated 
episodes of acute EtOH exposure increased anxiety behaviors in peri-pubertal 
animals, as measured by increased latency to explore a novel object in the 
retention-based passive avoidance task (Popovic, Caballero-Bleda et al. 2004). 
Direct effects of EtOH on AVP gene expression in the hypothalamus is one 
possible mechanism by which EtOH could alter anxiety behaviors, and, in fact, 
acute EtOH administration has been shown to increase the amount of AVP 
hnRNA in adult rats (Rivier and Lee 1996). Taken together, these studies show 
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that AVP is an important modulator of normal HPA axis function that can be 
disrupted by alcohol exposure. 
Our current understanding of how EtOH exposure, especially a binge 
pattern of EtOH exposure, affects the brain during pubertal development is very 
limited. In this study, we tested the hypothesis that a binge pattern of EtOH 
exposure during pubertal development stimulates the stress response by 
increasing circulating levels of corticosterone (CORT) and upregulating CRH and 
AVP mRNA levels in the PVN of the hypothalamus in male and female rats. Our 
results showed a striking sex difference in the response to binge EtOH exposure 
for most parameters measured. Overall, the results from our study confirm that a 
binge pattern of EtOH exposure during puberty significantly alters the expression 
of genes important or regulating the HPA axis and might lead to a higher risk of 
developing anxiety disorders in adulthood. 
 
Results 
 
General Approach 
 
 In order to investigate effects of EtOH exposure during puberty on 
stress responsiveness of the HPA axis during this time period, peri-pubertal male 
and female rats were treated either with saline, acute EtOH or binge EtOH 
exposure between PND 37 and 44 or remained untreated during the course of 
the experiment (see Fig 2). On the last day of treatments (PND 44), 1.0 h after 
the last EtOH administration, animals were sacrificed and brains and trunk blood 
were collected.  Plasma was isolated and used for further hormone and blood 
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alcohol concentration (BAC) measurements. Brains were rapidly frozen, 
sectioned on a freezing microtome and PVN and SON were microdissected for 
CRH and AVP mRNA measurements using qRT-PCR (see Chapter 7, General 
Methods section for detailed description). 
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Binge Exposure Paradigm During 
Puberty
PND 23
Arrival
30
Handling
37
Untreated   : Handled 8 days
Saline         : Saline 8 days
Acute EtOH: Saline (ip) 7 days + 3g/kgEtOH (ip) 1 day
Binge EtOH: 3g/kgEtOH (ip) 3 days + 
Saline (ip) 2 days +
3g/kgEtOH (ip) 3 days
40 42 44
 
Fig 2. Binge alcohol exposure paradigm employed in these studies.  
After 1 week of acclimation period and 1 week of daily handling, animals were divided 
into one of 4 groups and started following treatments: 1) UNTREATED 2) SALINE 
ONLY (intraperitoneal (ip) saline injection once/day for 8 days), 3) ACUTE EtOH (saline 
injection once/day for 7 days; one 3g/kg EtOH injection on day of sacrifice), 4) BINGE 
EtOH (EtOH injections once/day for 3 days (3g/kg), saline injection once/day for 2 days, 
EtOH injection once/day for 3 days). The same paradigm was used in all studies, 
regardless of the age.  
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Alcohol exposure had no effect on body weights 
 
Body weight measurements were obtained every other day during the 
duration of treatments in both males and females treated either with saline, acute 
EtOH or binge EtOH or that remained untreated during the course of the 
experiment (see Fig 2 and General Methods section in Chapter 7 for detailed 
description of binge EtOH exposure paradigm). 
 Repeated measured mix AVOVA revealed that neither EtOH exposure 
(acute or binge) nor saline injections caused males (Fig 3A) or females (Fig 3B) 
to lose weight during the duration of treatments indicating that neither EtOH nor 
stress inhibited growth of animals. 
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Fig 3. Effects of ethanol treatment on body weight during pubertal development (post 
natal day (PND) 37-44). Mean body weights of male (A) and female (B) animals 
untreated or treated with daily IP injections of saline, saline + one day EtOH (acute), or 
binge EtOH paradigm. 
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In these experiments, EtOH exposure paradigm resulted in average blood 
alcohol concentrations of 159.42 ± 14.38 and 143.92 ± 21.45 mg/dl in males and 
females (Fig 4), respectively. Acute (singe dose) EtOH exposure resulted in BAC 
of 146.91 ± 8.69 and 230.4 ± 36 mg/dl in males and females (Fig 4), respectively 
and in both cases the values were significantly different from BAC in untreated 
and saline groups (below the limit of detection, p<0.001). These values are 
consistent with the defined BAC threshold of binge drinking. 
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Fig 4. Effects of EtOH treatments on blood alcohol levels in male and female rats. Blood 
alcohol concentrations (BAC) 1.0 h post-injection in males (A) and females (B) treated 
with saline, acute EtOH or binge EtOH. Data expressed as mean EtOH mg/dl. * 
indicates statistically significant difference compared to untreated control (P < 0.05). 
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Binge alcohol exposure decreased testosterone levels in males but did not 
change estradiol levels in females. 
To determine the effects of binge EtOH exposure during puberty on 
gonadal steroid hormone levels, T and E2 were measured on the last day of 
treatments (see Chapter 7, General Methods section for detailed description of 
hormone measurements). In males, binge, but not acute, EtOH exposure 
significantly decreased T levels in the plasma (Fig 5A; p<0.001) compared to 
untreated and saline groups. T levels were 463.84 ± 43.54 pg/ml in untreated, 
435.35 ± 31.13 pg/ml in saline, 391.27 ± 55.42 pg/ml in acute EtOH and 264.88 ± 
58.59 pg/ml in binge EtOH groups. On the other hand, neither of the EtOH 
treatments changed the E2 levels in females (Fig 5B). The values were 22.91 ± 
3.74 pg/ml, 24.76 ± 4.84 pg/ml, 25.34 ± 7.11 pg/ml and 19.25 ± 2.95 pg/ml in 
untreated, saline, acute EtOH and binge EtOH groups, respectively. Even though 
there was no change in E2 level due to treatments, levels observed in females 
indicate that pubertal transition was initiated (Andrews, Advis et al. 1980; Sisk, 
Richardson et al. 2001). Since the E2 level did not increase beyond the level 
required for the occurrence of the first proestrus (Andrews, Advis et al. 1980) , 
females in our experiments did not start regular cycling.  
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Fig 5. Effects of EtOH treatment on gonadal steroid hormone levels. Plasma 
concentrations of (A) testosterone [T] and (B) estradiol [E2] 1.0 h after IP injection of 
saline, acute EtOH or binge EtOH treatments. Untreated animals received no injection. 
Data expressed as T or E2 pg/ml. * indicates statistically significant difference compared 
to untreated control (P < 0.05). 
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Effects of acute and binge alcohol exposure on circulating CORT levels. 
To determine circulating CORT levels on the last day of treatments, I 
measured plasma CORT levels using RIA (see Chapter 7, General Methods 
section for detailed description of hormone measurements). In males and 
females, acute and binge EtOH exposure significantly increased plasma CORT 
levels (Fig 6). In males, CORT levels in acute and binge EtOH groups were 
88.62 ± 12.65 pg/ml and 44.83 ± 11.66 ng/ml, respectively. Those values were 
significantly higher than values measured in untreated and saline groups (2.19 ± 
0.58 ng/ml and 5.82 ± 1.4 ng/ml, respectively; p<0.001) (Fig 6A). However, 
CORT levels between the two EtOH groups were also significantly different with 
the binge group having 50% lower CORT levels compared with acute EtOH 
group (P<0.05) (Fig 6A).  
As in males, both acute and binge EtOH exposures significantly increased 
plasma CORT levels in females (Fig 6B; p<0.001). In acute and binge EtOH 
exposure groups CORT levels were 469.67 ± 11.74 ng/ml and 365.04  ± 19.63 
ng/ml, respectively which were significantly different from values measured in 
untreated and saline groups (0.05 ± 0.05 ng/ml and 66.89 ± 29.64 ng/ml, 
respectively) (Fig 6B). As in males, binge EtOH exposure significantly decreased 
CORT level compared to acute EtOH exposure (p<0.001). in addition, females 
had significantly higher plasma CORT levels compared to males after EtOH 
exposure (Fig 6B, p<0.001).  
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Fig 6. Effects of EtOH treatments on blood corticosterone levels in male and female rats. 
Plasma corticosterone (CORT) levels in males (A) and females (B) 1.0 h after IP 
injection of saline, acute, or binge EtOH treatments. Untreated animals received no 
injection. Data expressed as mean CORT ng/ml of blood. * indicate statistically 
significant difference compared to untreated and saline controls; #  indicated significant 
difference compared to acute EtOH (P < 0.05).  
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Binge alcohol exposure changes the expression of CRH and AVP in the PVN in 
males but not in females. 
In order to investigate the effects of EtOH exposure during puberty on the 
expression of genes involved in stress and anxiety responses in males and 
females (see Chapter 7, General Methods section for detailed description), CRH 
and AVP mRNA expression was measured using qRT-PCR. No significant 
differences were observed between untreated and saline control groups in either 
of the sexes (Fig 7). Only binge, and not acute, EtOH exposure significantly 
increased the expression of CRH (Fig 7A, p < 0.05) and AVP mRNA (Fig 7B, p < 
0.05) in the male PVN. The expression of CRH and AVP mRNA in acute EtOH 
exposure group was the same as in the saline group indicating that the effect 
observed in the binge EtOH group is due to repeated EtOH exposure.  
On the other hand, there were no significant differences among treatment 
groups in the expression of CRH and AVP mRNA in the PVN of female rats (Fig 
7C, D) which indicates a sex difference in responsiveness of peri-pubertal HPA 
axis to EtOH exposures. 
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Fig 7. Effects of EtOH treatments on CRH and AVP gene expression in the PVN of male 
and female rats. CRH and AVP mRNA expression in the PVN of peri-pubertal male (A 
and B, respectively) and female (C and D, respectively) rats treated with saline, acute, or 
binge EtOH. Data expressed as mRNA copies/µg total RNA. * indicates statistically 
significant difference compared to untreated control (P < 0.05). 
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Alcohol exposure does not change the expression of AVP in the SON  
In order to confirm that the observed changes in the expression of AVP 
mRNA in PVN of male rats were not exclusively due to the reported diuretic 
effect of EtOH, I measured the expression of the AVP mRNA in the SON, region 
of the brain involved in controlling water balance. There were no differences in 
the expression of AVP mRNA in the SON either in males (Fig 8A, p = 0.319) or in 
females (Fig 8B, p = 0.652) suggesting that the change in the AVP mRNA 
observed in the PVN reflected change in the population of AVP-expressing cells 
responsible for mediating stress and anxiety. 
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Fig 8. Effects of EtOH treatments on AVP gene expression in the SON of male and 
female rats. AVP mRNA expression in SON of peri-pubertal male (A) and female (B) rats 
treated with saline, acute, or binge EtOH. Data expressed as AVP mRNA copies/µg total 
RNA. 
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Discussion 
Our current understanding of how alcohol consumption affects the 
developing postnatal brain is severely limited. To date, specific molecular and 
neuroendocrine markers that are activated by alcohol during puberty have not 
been identified. Elucidating the neurobiological targets of alcohol resulting from a 
binge pattern of consumption during adolescence is critical for understanding the 
long-term behavioral consequences and potential development of mental health 
disorders. Therefore, the goal of this study was to investigate the effects of 
binge-pattern EtOH exposure during puberty on the expression of specific 
neuroendocrine factors that mediate stress and anxiety, including CRH and AVP. 
My data reveal the novel findings that peri-pubertal binge-pattern, but not acute, 
EtOH exposure increased the expression of CRH and AVP mRNA in the PVN of 
peri-pubertal male rats, yet had no effect in peri-pubertal females (Fig 9). Data 
presented here indicate that the effects of alcohol on the HPA axis are sex-
specific and dependent on repeated high-dose exposures. Moreover, CORT 
levels were increased significantly in response to both acute and binge EtOH 
exposure paradigms (Fig 9), suggesting that EtOH is a potent activator of the 
HPA axis during pubertal development. Notably, there was no sex difference in 
the CORT response to EtOH, and, under binge-pattern exposure conditions, the 
animals appeared to habituate to the effects of the stressor. Last, we have shown 
that binge-pattern EtOH exposure decreased sex steroid hormone levels in male, 
but not female, rats and that the observed effects of EtOH on AVP gene 
expression were unlikely because of the diuretic effects of EtOH but, instead, 
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probably specific for the population of AVP-expressing neurons that regulate 
stress and anxiety.  
Acute and binge-pattern EtOH exposure increased plasma CORT levels in 
our study, confirming previous reports that EtOH is a potent activator of the 
stress response in adults. Ogilvie and Rivier (1997) showed that acute EtOH 
administration increased CORT levels which peaked at 15 min. post EtOH 
injection and were sustained until 1.0 h after the injection (Ogilvie and Rivier 
1997). However, I showed that plasma CORT levels in the binge EtOH groups 
were significantly lower compared to the acute EtOH exposure groups, 
suggesting that the HPA axis habituated to the stressful stimuli of multiple doses 
of EtOH. Also, females had higher plasma CORT levels after EtOH exposure 
compared with males, indicating that females were more sensitive to EtOH 
administration than males. These data are in agreement with multiple studies 
demonstrating that there are gender differences in responsiveness to alcohol, 
with females tending to achieve higher CORT levels compared with males given 
the same dose of EtOH (Rivier 1993; Ogilvie and Rivier 1996). 
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SUMMARY: Effects of binge alcohol exposure in puberty 
 Males (PND 37-44):  
- Repeated binge EtOH exposure INCREASED CRH and AVP mRNA in the PVN 
- Both acute and repeated binge EtOH exposures INCREASED plasma CORT 
levels, habituation effect after repeated binge EtOH exposure present  
Females (PND 37-44) 
- NO CHANGES in the CRH and AVP mRNA in the PVN dure to treatmnets 
- Both acute and repeated binge EtOH exposures INCREASED plasma CORT 
levels, habituation effect after repeated binge EtOH exposure present  
PVN
No change
CRH, AVP
Anterior pituitary gland
ACTH
Adrenal cortex
↑ CORT
_
EtOH
Body organs
PVN
↑ CRH, AVP
Anterior pituitary gland
ACTH
Adrenal cortex
↑ CORT
_
Body organs
A B EtOH
 
Fig 9. Summary of results described in Chapter 2. In males (A) binge EtOH exposure ↑ 
CRH and AVP mRNA in the PVN and ↑ plasma CORT levels. In females (B), binge 
EtOH exposure did not induce changes in the CRH and AVP mRNA in the PVN but ↑ 
plasma CORT levels. These data indicate that glucocorticoid (CORT) negative feedback 
is dysregulated in both males and females but mechanisms behind these effects are 
different. 
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  Acute EtOH consumption, chronic EtOH consumption, and withdrawal 
from EtOH dependency have all been associated with dysregulation of the HPA 
axis in adults at multiple levels including hypothalamic CRH and AVP systems. 
CRH and AVP neurons in the PVN are required for some of the effects of EtOH 
(Rivier, Bruhn et al. 1984; Hoffman and Dave 1991; Rivier 1993; Ogilvie and 
Rivier 1996; Rivier and Lee 1996; Rivier, Rivier et al. 1996; Ogilvie, Lee et al. 
1997; Ogilvie, Lee et al. 1997; Ogilvie and Rivier 1997; Ogilvie, Lee et al. 1998; 
Silva, Paula-Barbosa et al. 2002; Li, Kang et al. 2005). For instance, studies in 
adult rats have shown that acute alcohol administration increased circulating 
levels of ACTH (Rivier, Bruhn et al. 1984). This effect was dependent on the 
synergistic action of CRH and AVP, since pharmacological antagonism of the 
CRH and AVP receptors abolished the response (Rivier, Rivier et al. 1984; 
Rivier, Rivier et al. 1984; Ogilvie, Lee et al. 1997). Similarly, chronic alcohol 
treatment resulted in a 33% decrease in the number of AVP-expressing neurons 
in the SCN (Madeira, Andrade et al. 1997) and altered the diurnal rhythm in 
circulating glucocorticoids (Tabakoff, Jafee et al. 1978). AVP neurons in the SCN 
convey circadian information to the PVN and other extrahypothalamic brain 
nuclei. Moreover, the circadian expression of AVP in the SCN modulates the 
diurnal rhythm of circulating glucocorticoids (Isobe and Isobe 1998). Our data 
showing that EtOH administration alters CRH and AVP mRNA in peri-pubertal 
male rats are consistent with the observations in adult animals. Notably, in our 
study, a single dose of acute EtOH failed to increase CRH and AVP mRNA in the 
PVN despite inducing a dramatic increase in circulating CORT levels. These data 
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suggest that the EtOH-induced upregulation of these genes occurs as a result of 
repeated EtOH exposure, as would be achieved with a binge pattern of alcohol 
consumption. It remains to be determined whether there are long-lasting 
behavioral or physiological deficiencies associated with these changes in gene 
expression. Nevertheless, there is a growing body of evidence to suggest that 
neurite remodeling, neurogenesis, and synaptic connectivity are prominent 
developmental events during puberty (Sisk and Zehr 2005). Accordingly, it is 
logical to assume that repeated and excessive alcohol use during this critical 
stage of development could lead to permanent alterations in the morphological 
and/or neurochemical circuitry that might be organized during this time. These 
changes could, in turn, have negative consequences on normal adult behavior 
patterns, since brain morphology and neurochemistry are intimately linked with 
behavior. 
The neuropeptide AVP is a compelling candidate for mediating the 
underlying neuroendocrine basis of the sexually dimorphic effects of alcohol. 
First, central release of AVP from the PVN, BST, and AMY mediates a broad 
range of social behaviors and participates in modulation of the stress response. 
In both males and females, AVP augments the stress response by acting 
synergistically with CRH, which can be altered by a variety of factors, including 
gonadal steroid hormones and alcohol (Handa, Corbier et al. 1985; McCarthy, 
McDonald et al. 1996; Albeck, McKittrick et al. 1997; Erkut, Pool et al. 1998; 
Engelmann, Wotjak et al. 2000; Blanchard, Griebel et al. 2005; Ring, Malberg et 
al. 2006). Moreover, AVP and the AVP receptors are differentially regulated by 
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gonadal steroid hormones in a sex- and age-dependent manner (Sladek, 
Swenson et al. 2000; Bale, Davis et al. 2001; Quadros, Pfau et al. 2002; Yue, 
Mutsuga et al. 2006; Pak, Chung et al. 2009). For example, AVP expression in 
the BST is greater in males than females (Miller, Vician et al. 1989), and this sex 
difference is abolished by castration and restored with testosterone replacement, 
an effect that is accomplished mainly by testosterone-derived 17β-estradiol (Han 
and De Vries 2003). To date, little is known about the maturation of the central 
AVP system, including the temporal, sex-specific, and hormonal influences that 
occur during pubertal development. Previously, we showed that AVP mRNA 
expression in the BST and AMY was differentially regulated in pre- and post-
pubertal animals (Pak, Chung et al. 2009). Here, we have demonstrated 
prominent sex-dependent effects of binge-pattern EtOH administration on AVP 
mRNA levels during the pubertal transition. Our study showed that, in males, 
there was a significant increase in AVP mRNA following binge-pattern, but not 
acute, EtOH administration. Conversely, there were no effects on AVP in females 
using the same binge-pattern paradigm. It is important to note that, although the 
binge-pattern EtOH treatments significantly reduced testosterone levels, there 
was no effect on estradiol levels, suggesting that the EtOH effects on gonadal 
steroid hormones alone are not sufficient to explain these sex differences. 
Developmental changes in HPA axis reactivity have been well 
documented. Most striking is the observation that CORT and ACTH levels take 
much longer to return to baseline in juvenile compared with adult animals 
subjected to a variety of stressful stimuli (Vazquez and Akil 1993; Romeo, Bellani 
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et al. 2006). It is well known that males and females achieve sexual maturity at 
different rates with respect to reproductive function, but whether there are sex 
differences in the rate of HPA axis maturation during puberty is unknown. The 
majority of studies investigating the maturation of the HPA axis during pubertal 
development have focused strictly on comparisons between the pre- and post-
pubertal states, but not at time points in between (Romeo, Bellani et al. 2006). 
However, one study in human adolescents showed that there were sex 
differences in the cortisol response to a CRH challenge (Stroud, Papandonatos 
et al. 2004). In general, girls achieved peak cortisol levels later and had a slower 
return to baseline following a CRH challenge compared with boys (Stroud, 
Papandonatos et al. 2004), a difference that persisted throughout all Tanner 
stages of development. These data suggest that sex differences in HPA axis 
reactivity might not necessarily be because of a differential timing in HPA axis 
maturation between males and females but rather because of inherent 
differences that are perhaps organized before pubertal onset. Recent evidence 
from Evuarherhe and colleagues (Evuarherhe, Leggett et al. 2009; Evuarherhe, 
Leggett et al. 2009) support this possibility. In their study, 17β-estradiol inhibited 
the CORT-induced response to restraint stress in pre-pubertal female rats but 
enhanced the response post-pubertal. Importantly, the adult response to restraint 
stress in the presence of 17 β -estradiol was still enhanced regardless of whether 
the animals were ovariectomized before, or following, puberty. These data 
indicate that the maturation of the HPA axis in females might be programmed 
before pubertal onset and that it is independent of circulating gonadal steroid 
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hormones during pubertal development. At this time, there are no empirical data 
to suggest that the HPA axis matures at different rates in males compared with 
females, and, in fact, the evidence available from humans would predict that they 
likely mature at similar rates. However, we cannot rule out the possibility that the 
differences we observed might be because of discrepancies in the relative state 
of HPA axis maturation between males and females. Nevertheless, our data 
demonstrate a clear distinction between the effects of repeated EtOH exposure 
during the pubertal transition that might lend some insight into the time course for 
the development of the HPA axis between males and females. Furthermore, our 
data have demonstrated that repeated EtOH exposure during the pubertal 
transition results in a dysregulation of the HPA axis akin to that of a chronic 
stressor in adults.   
In this study, both males and females began receiving injection treatments 
on day 37, which were completed on day 44, falling within the defined peri-
pubertal period for both males and females (30–45 days of age; (Laviola, Adriani 
et al. 2002)). In general, female rats undergo pubertal onset (as measured by 
vaginal introitus) at 32–35 days of age, with regular estrous cyclicity and mature 
ova first occurring between 43 and 47 days of age (Sisk, Richardson et al. 2001; 
Sisk and Zehr 2005). Unlike females, in which puberty is defined as the 1st day 
of vaginal introitus, males do not have a reliable external benchmark that defines 
pubertal onset, since the commonly used external marker of preputial separation 
is dependent upon increased testosterone levels. The binge pattern alcohol 
exposure paradigm employed in our experiments did not inhibit feeding behavior 
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or normal growth patterns that occur during pubertal development. Moreover, it 
allowed us to distinguish the pharmacological effects of EtOH from the effects of 
other nonspecific stressors, such as handling and injections. This binge EtOH 
exposure paradigm has been previously shown to be reliable for testing the 
effects of alcohol using an exposure pattern that is typical for adolescents 
(Lauing, Himes et al. 2008). In addition, it has been show that the intraperitoneal 
injection of EtOH, employed in our paradigm, does not result in significantly 
different blood alcohol concentrations compared with oral gavage in adolescent 
Wistar rats (Walker and Ehlers 2009). 
Although it was not possible to separate the parvocellular and 
magnocellular divisions of the PVN in our tissue punch sample preparations, we 
are confident that the EtOH-induced changes in AVP expression accurately 
reflect changes in the AVP-expressing neurons associated with regulation of the 
HPA axis, and not in those responsible for osmoregulation for the following 
reasons. First, we showed that there were no changes in the expression of the 
AVP mRNA in the SON, a region where AVP is primarily responsible for 
regulating fluid homeostasis. Second, there was no effect of EtOH in the acute-
treated group, and, since fluid homeostasis is an immediate and not cumulative 
physiological response, any diuretic effect of EtOH would have been observed in 
the acutely treated groups. Third, if the effects of EtOH on AVP expression were 
because of an osmoregulatory effect, we would have expected to see a 
significant increase in the females, as well as the males. Finally, our data are in 
agreement with previous studies showing that there were no changes in AVP 
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expression in the magnocellular division of the PVN 3.0 h after an acute EtOH 
administration (Ogilvie, Lee et al. 1997).  
Alcohol is a potent neurotoxic agent that induces widespread cell death in 
the developing brain (Silva, Paula-Barbosa et al. 2002; Chu, Tong et al. 2007). 
Exciting new data have revealed that AVP has an important neuroprotective role 
in the PVN. Chen and colleagues (Chen, Volpi et al. 2008; Chen, Liu et al. 2009) 
have shown that AVP prevented apoptosis in H32 cells, a cell line derived from 
the PVN, following serum deprivation. These effects were mediated by mitogen-
activated protein kinase activated Bad phosphorylation and by protein kinase Cα 
and -β. These data raise the possibility that the physiological role of increased 
AVP following binge EtOH exposure in males is, in part, to provide cellular 
protection against repeated EtOH toxicity. In females, on the other hand, 17_-
estradiol is known to be neuroprotective in addition to playing roles in modulating 
reproductive functions and anxiety responses (Cardona-Gomez, Mendez et al. 
2001; Garcia-Segura, Azcoitia et al. 2001; Cunningham, Bhattacharyya et al. 
2002; Huppenbauer, Tanzer et al. 2005; Bodo and Rissman 2006; DonCarlos, 
Azcoitia et al. 2009). Our study showed that there was no increase in AVP mRNA 
after binge EtOH exposure in females, possibly because there are different 
mechanisms for neuroprotection in males compared with females.  
Taken together, we have identified specific neuroendocrine targets of 
EtOH in the adolescent hypothalamus following a binge pattern of EtOH 
exposure. Furthermore, we have demonstrated that the effects of EtOH 
administration on genes critical for the developing HPA axis are sex specific. 
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Sexually dimorphic patterns of addictive behavior emerge during adolescence 
and often persist in adulthood. Patterns of alcohol use during this developmental 
time period can also lead to permanent changes in brain function that often 
manifest in adulthood as psychological disorders, such as depression and 
anxiety. Overall, these data have identified potential genes involved in increased 
anxiety responses after EtOH exposure and might lead to a better understanding 
of the mechanisms involved in increased prevalence of anxiety disorders in 
females compared with males. 
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CHAPTER THREE 
 
ALCOHOL DYSREGULATES CORTICOTROPHIN-RELEASING-HORMONE 
(CRH) PROMOTER ACTIVITY BY INTERFERING WITH THE NEGATIVE 
GLUCOCORTICOID RESPONSE ELEMENT (NGRE) SITE OF THE 
PROMOTER 
 
Introduction 
Alcohol is a potent activator of the hypothalamo-pituitary adrenal (HPA) 
axis, as manifested by immediate increases in circulating glucocorticoids 
following exposure (Rivier, Bruhn et al. 1984; Rivier 1993; Ogilvie and Rivier 
1996; Ogilvie and Rivier 1997; Ogilvie, Lee et al. 1998; Przybycien-Szymanska, 
Rao et al. 2010). Moreover, alcoholics are significantly more likely to have 
diagnosed mood disorders implicating alcohol as a potential endocrine disrupter 
of the HPA axis (Pompili, Serafini et al.; Zilberman, Tavares et al. 2003). 
Although the effects of alcohol on HPA function have been well described, our 
understanding of the molecular mechanisms regulating alcohol effects on the 
HPA axis remain poorly defined. Corticotrophin-releasing hormone (CRH)-
expressing neurons located in the paraventricular nucleus of the hypothalamus 
(PVN) play a pivotal role in orchestrating the central stress response and proper 
functioning of these neurons is critical for maintaining a homeostatic state 
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following a stressful event. The HPA axis is a three-tiered biological system that 
begins at the highest level with CRH release from the PVN potentiating the 
release of adrenocorticotrophin hormone (ACTH) from the anterior pituitary 
gland. ACTH acts, in turn, on the adrenal glands to increase theproduction and 
release of glucocorticoid hormones (Papadimitriou and Priftis 2009). 
Glucocorticoids (CORT) can then exert negative feedback on both the 
hypothalamus and pituitary gland to decrease CRH and ACTH release, 
respectively, allowing for a homeostatic state to be re-established (Figueiredo, 
Bodie et al. 2003; Ostrander, Ulrich-Lai et al. 2006; Papadimitriou and Priftis 
2009).  
We previously demonstrated that binge-pattern alcohol exposure during 
pubertal development increased both circulating plasma CORT levels and CRH 
mRNA expression in the PVN (Przybycien-Szymanska, Rao et al. 2009), 
suggesting that alcohol exposure disrupted normal glucocorticoid negative 
feedback pathways.  Glucocorticoid negative feedback is mediated, in part, by 
the activation of glucocorticoid receptors (GR), which belong to the superfamily of 
nuclear steroid receptors. Upon activation by glucocorticoids, GRs undergo 
dimerization, translocate to the nucleus, and modulate gene transcription 
(Goujon, Laye et al. 1997; Schulkin, Gold et al. 1998; Sapolsky, Romero et al. 
2000; Morsink, Steenbergen et al. 2006). In the PVN, GRs are known to 
decrease CRH gene transcription through signaling at the negative glucocorticoid 
response element (nGRE), located between -249 and -278 nucleotides upstream 
from the transcription start site of the CRH promoter (Fig 10). Overall, 
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glucorticoids acting through GRs decrease CRH promoter activity thereby, 
decreasing transcriptional activity of the promoter and decreasing CRH gene 
expression. 
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Fig. 10 Schematic model describing normal CRH promoter regulatopn. In the absence of 
EtOH when activated GRs interact with nGRE to recruit specific coregulators (not 
depicted in this diagram), they also prevent signaling at the CRE site of the CRH 
promoter by CREB thereby decreasing the activity of this promoter and its gene 
transcription. These interactions between the nGRE and CRE sites are required for 
glucocorticoid mediated decrease in CRH promoter activity. 
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Based on our previous observations that binge-pattern EtOH exposure in 
pubertal rats increased CRH gene expression in the PVN (Przybycien-
Szymanska, Rao et al. 2009), we tested the hypothesis that ethanol (EtOH) 
increases CRH gene expression by directly interfering with glucocorticoid 
negative feedback at the level of the CRH promoter. The overall goals of this 
study were to determine if 1) EtOH directly modulates CRH promoter activity and 
2), to identify a putative site of action for EtOH on the CRH promoter. Overall, our 
results showed that EtOH differentially modulated CRH promoter activity in a 
time-dependent manner. Further, these effects were mediated, in part, through 
the nGRE site on the CRH promoter. Taken together, our data provide strong 
evidence that EtOH exposure directly disrupts GR:CRH signaling which, if occurs 
during adolescence, may be detrimental for proper maturation of the HPA axis.  
 
Results 
General approach 
 In order to investigate molecular mechanisms involved in EtOH effects in 
the PVN, CRH promoter activity was measured in PVN derived neuronal cell line 
(IVB) after various EtOH treatments. The CRH promoter-luciferase construct was 
transfected into the cells and 24.0 h after transfections cells were subjected to 
different EtOH treatments. First, time course experiments using 12.5 and 100 
mM dose of EtOH were performed in the wild type and mutated CRH promoter in 
order to investigate temporal regulation of CRH promoter activity by EtOH and 
direct sites on the CRH promoter involved in EtOH effects. Second, possible 
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EtOH interactions with GR signaling were investigated in cells pre-treated with 
GR antagonist and then treated with 100 mM EtOH for 0.5, 1.0, 2.0, or 4.0 h. 
After each specific EtOH treatment regiment, CRH promoter activity was 
measured using dual luciferase reporter assay. Also, GR expression in IVB cells 
after EtOH treatments was measured using qRT-PCR. 
 
100 mM EtOH treatment did not induce cell death. 
 
We used a MTT assay to determine whether our highest dose of EtOH 
treatment (100 mM) induced cell death in our IVB cell line. The results showed 
that EtOH treatment had a significant effect on cell viability (F(4,10) = 3.495, 
p=0.049, N = 3, Fig. 11). Contrary to what would be expected, EtOH did not 
decrease cell viability at any time point measured, rather, it increased 
mitochondrial activity at 4.0 h time point. 
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Fig 11. Effects of 100 mM EtOH treatment on cell viability in a neuronal cell line.  
Mitochondrial activity was measured in IVB cell line after 0.5, 1.0, 2.0 and 4.0 h of 100 
mM EtOH treatment. Data expressed as % change of mitochondrial activity relative to 
vehicle (10% FBS media) treated controls. Dissimilar letters indicate statistically 
significant difference. More specifically a is different from b but is not different from other 
a (P < 0.05) 
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EtOH treatment altered CRH promoter activity in a time- dependent manner.  
To determine whether EtOH alters CRH promoter activity, we used an in 
vitro reporter gene assay and added EtOH directly to the cell culture media (rat 
PVN-derived cell line (IVB). Our results showed that treatment with 100 mM 
EtOH had a biphasic effect on CRH promoter activity (F(4,28) = 15.331, p<0.001, 
N = 6, Fig 12A). Notably, EtOH significantly decreased CRH promoter activity 
after 0.5 h (p=0.002), whereas EtOH significantly increased the promoter activity 
after 2.0 h (p=0.043). We then treated the cells with EtOH in the presence of a 
glucocorticoid receptor antagonist (RU486) in order to ascertain whether EtOH 
interacted with glucorcorticoid negative feedback mechanisms that influences 
CRH promoter activity. Treatment with RU486 alone significantly decreased 
baseline promoter activity. Importantly however, RU486 completely abolished the 
EtOH-induced increase in CRH promoter activity observed after 2.0 h of EtOH 
treatment, suggesting that EtOH might interact with glucocorticoid receptors to 
alter CRH promoter activity. Interestingly, treatment with RU486 did not seem to 
affect the EtOH-induced decrease in CRH promoter activity observed after 0.5 h 
of EtOH treatment (Fig. 12B). 
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Fig 12. Effects of EtOH treatment (A) and RU486 pre-treatment (B) on CRH promoter 
activity in a neuronal cell line. CRH-luciferase activity was measured in IVB cell line after 
treatment with 100 mM EtOH for 0.5, 1.0, 2.0 or 4.0 h or media alone (A, n=6) and after 
16.0 h pretreatment with 100nM RU486 and 100 mM ETOH/100 nM RU486 co-
treatment for 0.5, 1.0, 2.0 or 4.0 h (B, n=3). Data expressed as % change in luciferase 
activity of vehicle treated WT control. Dissimilar letters indicate statistically significant 
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difference between groups. For example, a is significantly different from b, c, d and d b; 
b is different from a, c, ac, and so on (P < 0.05). 
 
EtOH treatment did not have an effect on GR mRNA expression in IVB cells 
 It is possible that EtOH directly affects GR expression, thereby altering 
CRH promoter activity. In order to test this we measured GR mRNA expression 
in IVB cells following treatment with 100 mM EtOH for 0.5 or 2.0 h using qRT-
PCR. Our data revealed that there were no changes in GR mRNA expression in 
IVB cells relative to baseline (F(4,47)=0.1.889, p=0.128) at any time point tested 
(p=0.435 and p=0.082 for 0.5 and 2.0 h, respectively) (Fig 13).  
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Fig 13. Effects of 0.5 h or 2.0 h EtOH treatment on the GR mRNA expression in IVB cell 
line. GR mRNA expression in IVB cell was measured after treatment with 100 mM EtOH 
for 0.5 or 2.0 h or vehicle. Data expressed as fold change in GR mRNA expression 
calculated according to the standard ∆∆ct method. 
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EtOH increased CRH promoter activity at 2.0 h time point at all concentrations 
tested 
 
The results obtained from initial experiments in Figure 12 demonstrated 
that EtOH alters CRH promoter activity. The concentration used in those 
experiments (100 mM) was based on previously published studies that used 
EtOH treatment in a cell culture model system however, the physiological 
relevance of this high concentration is questionable given that the blood alcohol 
level corresponding to the legal limit for driving (0.08%) is equivalent to about 25 
mM (Pickering, Wicher et al.; Blevins, Mirshahi et al. 1997; McAlhany, Miranda et 
al. 1999; Li, Kang et al. 2005; Druse, Tajuddin et al. 2006; Lee, Tajuddin et al. 
2009). Therefore, we tested CRH promoter activity in the presence of varying 
concentrations of EtOH in order to establish the minimal effective dose. The 
highest concentration of EtOH (100 mM) increased CRH promoter activity to the 
same degree following 2.0 h of EtOH treatment as observed in the previous time 
course experiments (Figs. 12A and 14). Surprisingly however, EtOH significantly 
increased CRH promoter activity at all of the lower concentrations we tested 
compared to vehicle treated control (F(4,45) = 2.665, p=0.044, N = 6, Fig 14). 
Also, there was no dose response observed, suggesting that lowest 12.5 mM 
concentration of EtOH is sufficient to elicit a maximal response of CRH promoter 
activity. Thus, for all subsequent studies the 12.5 mM concentration of EtOH was 
used in order to be consistent with concentrations that were more physiologically 
relevant.  
 
 
  
76 
 
 
0
50
100
150
200
250
CR
H 
Pr
o
m
o
te
r 
a
ct
ivi
ty
 
(%
 
Co
n
tro
l)
EtOH Dose (mM)
Vehicle             12.5              25.0                50.0  100.0 
a
b
b b b
 
Fig 14. Effects of 2.0 h EtOH treatment with different concentrations of EtOH on CRH 
promoter activity. CRH-luciferase activity was measured in IVB cell line after treatment 
with 12.5, 25.0, 50.0 and 100 mM EtOH for 2.0 h or media alone. Data expressed as % 
change in luciferase activity from vehicle treated control. Dissimilar letters indicate 
statistically significant difference between treatment groups. More specifically, a is 
significantly different from b (P < 0.05). 
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Validation of CRH promoter deletion mutants with forskolin treatment.    
To verify specific sites of EtOH action at the level of the CRH promoter, 
we sequentially deleted GR binding sites that are found within nGRE (see 
diagram in Fig 15 and Chapter 7 General Methods section for detailed 
description of methods used). In addition, we deleted a cAMP response element 
(CRE) site which is required for increasing CRH promoter activity (Liu, 
Kamitakahara et al. 2008). The CRE site has been implicated in EtOH effects at 
the CRH promoter in studies that showed that 25 mM EtOH treatment exerted a 
biphasic effect on the CRH promoter (a decrees at 0.5 h and an increase at 2.0 h 
) and that the forskolin induced increase in CRH promoter activity was decreased 
by EtOH treatment (Li, Kang et al. 2005).  
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Fig 15. Schematic representation of the CRH promoter deletions used in these 
experiments. Diagrams depict specific portions of the nGRE site deleted within this site 
that is located between -249 and -278 bp upstream from the transcription imitation site 
(arrow) on the CRH promoter and the CRE site deletion that is located -217 bp upstream 
from the transcription site. 
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Initially, in order to test validity of these mutants generated, cells 
transfected with the WT or mutated CRH promoter were treated with 25 mM 
forskolin for 6.0 h and the promoter activity was measured using dual luciferase 
assay (see Chapter 7 General Methods section for detailed description of 
methods used). Forskolin is a potent activator of the CRH promoter by increasing 
cAMP levels and affecting signaling at the CRE site. As expected, forskolin 
treatment significantly increased CRH promoter activity in all CRH promoter 
constructs used except for the construct in which the CRE regulatory site was 
deleted (N = 3, Fig. 16). These data indicate that the CRH promoter 
manipulations did not render the promoter inactive and the constructs were 
responding to forskolin stimulation as expected. 
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Fig 16. Effects of Forskolin treatment on WT and mutated CRH promoter activity. 
Luciferase activity was measured in IVB cell line after treatment with 25 µM Forskolin for 
6.0h (blue) or vehicle (black) in WT CRH promoter or in a promoter lacking above 
described regulatory sites. Data expressed as % change in luciferase activity of vehicle 
treated control. Dissimilar letters indicate statistically significant difference between 
groups. For example,  a is significantly different from b, c, d, and e and so on (P < 0.05). 
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Basal activity of the CRH promoter was changed after specific deletions.  
One-way ANOVA indicated that the mutations had a significant effect on 
basal (after vehicle treatment) CRH promoter activity (F(5, 39) = 28.118, p < 
0.001, N = 6, Fig 16 black bars). Deletion of GR binding site 1 and 2 (CRH∆GR1 
and CRH∆GR2) significantly increased basal CRH promoter activity (p<0.001, 
Fig 15 black bars) and CRE site deletion (CRH∆CRE) significantly decreased 
basal CRH promoter activity (Fig. 16 black bars, p = 0.023) as compared to 
vehicle treated promoter constructs.  
 
Deletion of GR binding sites within nGRE abolished alcohol induced increase in 
CRH promoter activity at 2.0 h time point but did not prevent EtOH-induced 
decrease at 0.5 h 
In order to investigate possible mechanisms involved in EtOH induced 
changes in CRH promoter activity, time course experiments with all the CRH 
deletion mutants described above were performed (see Chapter 7 General 
Methods section for detailed description of methods used). For the summary of 
results see Table 1.  
Similar to the 100 mM dose, 12.5 mM EtOH treatment induced biphasic 
effects on the WT CRH promoter activity. These effects were altered in various 
CRH promoter mutants. More specifically, one way AVOVA revealed an effect of 
this EtOH treatment on CRH promoter activity (F(4,36)=7.619, p<0.001) and post 
hoc tests showed that at 0.5 h there was a significant decrease (p<0.001) and at 
2.0 h there was a significant increase (p=0.023) in CRH promoter activity due to 
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12.5 mM EtOH treatment as compared to vehicle treated controls (Fig.17A). The 
same effects were evident with 100 mM EtOH treatment. These results indicate 
that regardless of the dose tested, EtOH exerted biphasic effects on CRH 
promoter activity. 
GR 1 and 2 deletions did not alter EtOH induced decreases in promoter 
activity but abolished an increase at 2.0 h. Notably, in these mutants EtOH 
treatment for 4.0 h increased the promoter activity. In the CRH∆GR1 mutant, one 
way ANOVA showed an effect of EtOH treatment (F(4,31)=8.144, p<0.001) and 
post hoc analysis showed that at 0.5 and 1.0 h time point there was a significant 
decrease in promoter activity (p=0.003 and 0.004, respectively, Fig 17B), an 
increase in CRH promoter activity was abolished at a 2.0 h time point but it was 
present at 4.0 h after 12.5 mM EtOH treatment (p=0.015). A similar trend was 
observed in the CRH∆GR2 mutant. One way ANOVA showed an effect of EtOH 
treatment (F(4,30)=4.826, p<0..001) and post hoc tests revealed that at 1.0 h 
post EtOH treatment there was a significant decrease in the promoter activity 
(Fig 17C, p=0.024). An increase was abolished at 2.0 h but present at 4.0 h time 
point (Fig 17C, p=0.002) as compared to vehicle treated control.  
A different pattern of responses was observed in the CRH∆GR3 mutant. 
Even though one way ANOVA showed an effect of EtOH treatment on the CRH 
promoter (F(4,37)=3.465, p=0.017), in this mutant, EtOH induced changes in 
CRH promoter activity relative to the vehicle treated group were abolished (Fig. 
17E). In this mutant, CRH promoter activity was significantly increased at the 4.0 
h time point as compare to the 0.5 and 2.0 h time point (p=0.018 and p=0.023, 
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respectively). These data indicate that even though the CRH∆GR3 mutant still 
exhibits dynamic changes after EtOH treatment, EtOH induced decrease and 
increase in CRH promoter activity relative to vehicle treatment were abolished. 
These data show that this site is important for EtOH modulation of the CRH 
promoter, especially for a decrease in the promoter activity.  
The time course data in a CRH∆GR1/2 mutant further supports the role of 
the GR binding site 3 in an EtOH induced decrease in CRH promoter activity. In 
this mutant, having only GR binding site 3 site of the nGRE intact, a decrease in 
CRH promoter activity was still present (Fig. 17D). One way ANOVA revealed 
that 12.5 mM EtOH treatment had a significant effect on CRH promoter activity in 
this mutant (F(4,29)=3.108, p=0.03). Post hoc analysis showed that at 0.5 h post 
EtOH treatment CRH promoter activity was significantly decreased as compared 
to vehicle treated control (p=0.01). An increase in the promoter activity in this 
mutant was completely abolished. 
 Interestingly, even though basal promoter activity was significantly 
decreased, in the CRH∆CRE mutant, a slight decrease in the promoter activity 
was still observed at the 0.5 h time point (Fig 17F). One way ANOVA showed 
that EtOH exerted a significant effect on CRH promoter activity in this mutant 
(F(4.19)=2.897, p=0.05). Post hoc analysis showed that EtOH significantly 
decreased the promoter activity at 0.5 h time point (p=0.046) but completely 
abolished an increase in the promoter activity at the later time points. 
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Fig 17. Effects of EtOH treatment on WT and mutated CRH promoter reactivity. 
Luciferase activity was measured in IVB cell line after treatment with 12.5 mM EtOH for 
0.5, 1.0, 2.0 or 4.0 h or vehicle in A) WT CRH promoter, B) promoter lacking GR binding 
site 1 (CRH∆GR1), C) GR binding site 2 (CRH∆GR2), D) GR binding site 1 and 2 
(CRH∆GR1/2); E) GR binding site 3 (CRH∆GR3), or F) CRE site (CRH∆CRE). Data 
expressed as % change in luciferase activity from vehicle treated control. Dissimilar 
letters indicate statistically significant difference between groups. More specifically a is 
significantly different from b and c; ab is the not different from a or b but is different from 
c and so on (P < 0.05). 
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SUMMARY: Effects of alcohol on CRH promoter activity in vitro 
- 12.5 and 100 mM EtOH ↓ CRH promoter activity at 0.5 h 
- 12.5 and 100 mM EtOH ↑ CRH promoter activity at 2.0 h 
- An increase in the promoter activity due to EtOH  is dependant on the nGRE and 
CRE sites 
CRH 
Promoter 
Construct 
Basal 
activity of 
the 
promoter 
(vehicle) 
relative to 
WT 
promoter 
activity 
(100%) 
Promoter 
activity at 
0.5 h 
relative to 
basal 
promoter 
activity 
Promoter 
activity at 
1.0 h 
relative to 
basal 
promoter 
activity 
Promoter 
activity at 
2.0 h 
relative to 
basal 
promoter 
activity 
Promoter 
activity at 
0.4 h 
relative to 
basal 
promoter 
activity 
      
WT CRH 100% ↓ - ↑ - 
 
   
 
 
CRH∆GR1 ↑ ↓ ↓ - ↑ 
CRH∆GR2 ↑ - ↓ - ↑ 
CRH∆GR3 - - - - - 
CRH∆GR1/2 - ↓ - - - 
CRH∆CRE ↓ ↓ - - - 
 
Table 1. Summary of EtOH induced effects in different CRH promoter constructs, 
Arrows indicate relative relationships in the promoter activity as compared to vehicle 
treated construct, red = increase and green = decrease. Basal activity of different 
mutants is compared to activity of the WT vehicle treated CRH promoter. 
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Discussion 
The goal of this study was to investigate in vitro the molecular 
mechanisms involved in alcohol induced increase in the CRH gene expression 
observed previously in the PVN of male rats. We tested the hypothesis that 
alcohol increases CRH mRNA expression in the PVN by directly interfering with 
negative glucocorticoid feedback at the level of the CRH promoter. Our data 
clearly show that in vitro EtOH treatment directly influences CRH promoter 
activity and that an increase in the promoter activity observed at 2.0 h is 
mediated via EtOH-GR signaling interaction at the nGRE site and its possible 
interactions with the signaling at the CRE site of the CRH promoter.  
When activated GRs interact with nGRE to recruit specific coregulators, 
they also prevent signaling at the CRE site of the CRH promoter by CREB, 
decreasing the activity of this promoter and its transcription. It has been shown 
that interaction between the nGRE and CRE sites is required for normal 
glucocorticoid mediated decrease in CRH promoter activity (King, Smith et al. 
2002), Fig 17A). Based on my data, I propose that in the presence of EtOH, GR-
CRH DNA interaction at the nGRE site is blocked allowing for free access of 
phosphorylated CREB (pCREB) to the CRE site and activation of CRH promoter 
(Fig 17B) which will then result in increased gene transcription and CRH mRNA 
expression that has been previously observed in vivo (Rivier and Lee 1996; 
Ogilvie, Lee et al. 1997; Ogilvie, Lee et al. 1998; Li, Kang et al. 2005; Przybycien-
Szymanska, Rao et al. 2009).  
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Fig. 18. Schematic model describing EtOH effects on the CRH promoter. A. In the 
absence of EtOH when activated GRs interact with nGRE to recruit specific coregulators 
(not depicted in this diagram), they also prevent signaling at the CRE site of the CRH 
promoter by CREB thereby decreasing the activity of this promoter and its gene 
transcription. These interactions between the nGRE and CRE sites are required for 
glucocorticoid mediated decrease in CRH promoter activity. It is possible that at 0.5 h 
EtOH treatment this mechanism is enhanced through yet un identypied mechanisms. B. 
If EtOH treatment is prolonged, GR-CRH DNA interaction at the nGRE site is blocked 
allowing for free access of phosphorylated CREB (pCREB) to the CRE site and 
activation of the CRH promoter witch will then result in increased gene transcription.  
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This conclusion is substantiated but the following data: 1) EtOH directly 
modulated CRH promoter activity in PVN derived neuronal cell line; 2) GR 
antagonist (RU486) abolished EtOH induced increase in CRH promoter activity 
observed at 2.0 h and 3) deletion of either of the specific GR binding sites within 
the nGRE site prevented EtOH induced increase in the promoter activity. These 
data support my hypothesis that alcohol modulates CRH mRNA expression in 
the PVN by directly interfering with negative glucocorticoid feedback exerted at 
the level of the CRH promoter. A direct effect of EtOH at the CRH promoter is 
further substantiated by data showing no changes in GR expression upon EtOH 
treatment in IVB cells. 
This conclusion is consistent with previous in vivo reports showing that 
chronic EtOH treatment and withdrawal modulated GRE-DNA binding in rat 
cortex and hippocampus. Chronic alcohol diet (15 days) decreased GRE- DNA 
binding in the cortex and hippocampus as measured by chromatin 
immunoprecipitation assay (ChIP) but 24.0 h withdrawal returned GRE-DNA 
binding levels back to basal levels only in hippocampus; in the cortex GRE-DNA 
binding levels remained decreased (Roy, Mittal et al. 2002). Our in vitro data 
show that deletion of portions of nGRE site on the CRH promoter and GR 
antagonist treatment abolished EtOH induced changes in the promoter activity. 
Based on these data, it is likely that alcohol affects GR protein binding at the 
GRE site of the CRH promoter but additional experiments verifying GRE-DNA 
binding of GR at the CRH promoter in the presence and absence of EtOH need 
to be performed in order to further verify this hypothesis.  
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Contrary to the results obtained by Roy, et al., we did not observe any 
EtOH-mediated changes in GR mRNA expression. One possibility is that GR 
protein levels change with chronic, as opposed to acute, EtOH treatment, 
although Spencer and McEwan (1990)  also noted that there were no changes in 
cytosolic fractions of mineralocorticoid receptor (MR) or GR following chronic 
EtOH treatment in the brains of adult rats (Spencer and McEwen 1990).  By 
contrast, Little at al., (2008) showed that chronic EtOH treatment (28 week, liquid 
diet) and 2 week withdrawal increased nuclear GR protein but did not change the 
cytosolic GR protein levels in the prefrontal cortex of male C57BL mice (Little, 
Croft et al. 2008).  In our study we measured GR mRNA and not protein due to 
the short time course of EtOH treatment, but the above cited studies raise the 
possibility that EtOH might directly target nuclear GR protein for degradation or 
alter translational processing of GR mRNA. 
There are several other possibilities that might explain our divergent 
results. First, it is possible that the reason why there were no changes in the GR 
is because we used an immortalized cell line instead of primary cells. Second, in 
previous reports investigators looked at the protein levels when we measured 
mRNA expression. Therefore, it is possible that EtOH could affect protein stability 
instead of transcriptional activity of the gene. Further experiments need to be 
performed in primary neurons or in neuronal cell lines to verify if changes in the 
GR expression in the PVN or in PVN derived cell lines play a role in EtOH 
induced increase in CRH promoter activity and increase in CRH mRNA after 
binge EtOH exposure. 
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Deletion of either GR binding site of the nGRE regulatory region of the 
CRH promoter abolished EtOH induced increase in CRH promoter activity at a 
2.0 h time point, Notably, in CRH∆GR1 and CRH∆GR2 mutants an increase in 
CRH promoter activity was present at 4.0 h time point post EtOH treatment 
indicating that when only one of the two GR binding sites is present, EtOH can 
still activate the promoter but it takes longer for it to do so. Deletion of both sites 
abolished the EtOH induced increase in the promoter activity completely 
indicating that these sites are important for EtOH effects. Deletion of the GR 
binding site 3 abolished EtOH induced increase in the promoter activity at 2.0 h 
as well and this effect was still not present at the 4.0 h time point. Together, 
these data indicate that at least two GR binding sites (GR 1 or 2 plus GR 3) are 
required for EtOH induced increase in promoter activity. Further studies need to 
be performed in order to elucidate more closely interactions between these GR 
binding sites on the CRH promoter that are involved in EtOH induced effects. 
Nevertheless, these data clearly show that EtOH disrupts normal glucocorticoid 
negative feedback exerted at the promoter level.  
Deletion of the CRE site eliminated EtOH induced increase in the 
promoter activity at 2.0 h time point but it also decreased basal CRH promoter 
activity and prevented forskolin induced activation of the promoter activity but did 
not abolish EtOH induced decrease in CRH promoter activity at 0.5 h.. Previous 
reports showed that in a rat glioma hybrid NG108-15 cell line, alcohol decreased 
forskolin induced increase in CRH promoter activity (Li, Kang et al. 2005) making 
it likely that the CRE site of the promoter is responsible for alcohol effects on the 
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CRH promoter. It is well known that cAMP signaling, CREB binding and 
coactivator recruitment to the CRH promoter is required for transcriptional 
activation of the CRH (Liu, Kamitakahara et al. 2008). Therefore, it is not 
surprising that when the CRE site is deleted, the CRH promoter cannot be 
activated, even in the presence of the potent cAMP stimulator, forskolin. 
Interaction of CRE site signaling with the effects exerted at the nGRE site were 
not investigated in the Li et al.,  study, but since nGRE and its interaction with the 
CRE site in the presence of glucocorticoids is required for inhibition of CRH 
promoter activity (Malkoski and Dorin 1999; King, Smith et al. 2002), it is likely 
that alcohol interferes with GR signaling at the level of the nGRE site of the CRH 
promoter and the interaction between nGRE site and the signaling at the CRE 
site is required for alcohol effects.   
These data suggest that the observed EtOH-induced decrease in CRH 
promoter activity does not involve the GR binding site 1 or 2 or the CRE site but 
requires GR binding site 3. This further supports my conclusion that EtOH 
interferes with GR signaling at the nGRE site to dysregulate the promoter activity. 
Based on my data, it appears that at an early time point (0.5 h), normal negative 
feedback exerted by glucocorticoids is still present and longer EtOH treatment 
time is required for EtOH induced dysregulation of this feedback and an increase 
in the promoter activity. Notably, these data indicate GR binding site 3 as being 
extremely important for this negative feedback. EtOH-induced decrease in the 
promoter activity was completely abolished only when this site was deleted. 
These data are consistent with our previous in vivo data showing that 
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longer/repeated EtOH exposure, i.e. binge EtOH exposure, is required for EtOH 
induced dysregulation of the HPA axis. Together, data presented herein clearly 
show that EtOH effects are mediated through nGRE site-EtOH interactions at the 
level of the CRH promoter and longer periods of EtOH treatments are required 
for dysregulation of normal glucocorticoid negative feedback. 
One may argue that an increase in CRH promoter activity at 2.0 h is a 
result of compensatory mechanisms being activated in the cells due to alcohol 
induced cell death at that may have occurred at 0.5 h when a decrease in 
promoter activity was observed. This explanation is highly unlikely due to 
following reasons: 1) there was no decrease in cell viability at 0.5 h as measured 
by MTT assay and 2) an increase in the promoter activity at 2.0 h time point 
exceeded basal levels of the activity of the promoter which would be highly 
unlikely to happen if cell death was occurring 
100 mM EtOH treatment did not induce cell death at any time point tested, 
instead, it increased mitochondrial activity at 4.0 h as measured by MTT 
toxicology assay in which increased absorbance indicates increased 
mitochondrial dehydrogenases activity. This result could be potentially an effect 
of increased mitochondrial activity due to EtOH-induced oxidative stress in cells. 
This conclusion is substantiated by previous reports showing a time course of 
events in primary cortical neurons after EtOH exposure (Ramachandran, Watts 
et al. 2003). In this report researchers showed that 5 min after 4.0 mg/ml EtOH 
treatment, there is an increase in the amount of reactive oxygen species, 
followed by an increase in mitochondrial 4-hydroxynonenal (HNE) at 1.0 h, 
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followed by an increase in cytochrome c release at 2.0 h and increase in caspase 
3 activation at 12.0 h. This sequence of events results in DNA fragmentation and 
decrease in cell number that starts at 12.0 h of EtOH exposure (Ramachandran, 
Watts et al. 2003). This proposed time line suggests that an increased 
mitochondrial activity at 4.0 h in our system could be a result of an initiation of 
oxidative stress induced cell death but it was too early for cell death to occur. If 
alcohol treatment was longer than 4.0 h, we could possibly observe a decrease 
in cell viability which would indicate cell death. Nevertheless, cell death was not 
observed at any time point in our studies and could not explain the observed 
decrease in CRH promoter activity at 0.5 h time point.  
Overall, results presented in this study show that in a neuronal cell line 
derived from the PVN, alcohol increases CRH promoter activity by interfering 
with GR signaling at the nGRE site of the promoter. This may explain a potential 
mechanism by which EtOH treatment in vivo increases the CRH mRNA levels in 
the PVN. Although further investigation is required to assess alcohol effects on 
upstream molecular targets that result in increased promoter activity. These data 
for the first time identify neuronal GR- CRH DNA system as a direct target for 
alcohol influence in the PVN. 
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CHAPTER FOUR 
 
ROLE OF ESTRADIOL IN THE HYPOTHALAMO-PITUITARY-ADRENAL (HPA) 
AXIS RESPONSIVENESS OF PERI-PUBERTAL FEMALE RATS TO BINGE 
ALCOHOL EXPOSURE 
 
Introduction 
Alcohol abuse during adolescence is a fundamental heath concern in the 
United States. According to the U.S. Department of Health and Human Services, 
41% of teenagers have had their first drink by the age of 14. Underage drinkers 
typically adopt a “binge” pattern of alcohol consumption, defined by the National 
Institute on Alcohol Abuse and Alcoholism (NIAAA) as heavy, episodic drinking in 
which enough alcohol is  consumed to bring the blood alcohol concentration 
above 0.08 % limit within that 2.0h period (White, Kraus et al. 2006). According to 
the Department of Health and Human Services survey performed in 2005, 2.0% 
of 12-13 year-old, 8.0% of 14-15 year-old, 19.7% of 16-17 year-old and 51% 18-
20 year-old adolescents reported this pattern of drinking within a month 
proceeding the survey. Overall, these statistics indicate that a significant 
percentage of the adolescent population consumes heavy doses of alcohol 
during this critical period of brain development which is called adolescence and is
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marked by dendrite pruning, prefrontal cortex development, increases in white 
matter and formation of new neuronal connections (Woo, Pucak et al. 1997; 
Giedd, Blumenthal et al. 1999; Paus, Zijdenbos et al. 1999; Cunningham, 
Bhattacharyya et al. 2002; Sisk and Zehr 2005; Lenroot and Giedd 2006; 
Raymond, Kucherepa et al. 2006) 
 One system that undergoes extensive maturation during adolescence is 
the hypothalamo-pituitary-adrenal (HPA) axis (Romeo, Lee et al. 2004; Romeo, 
Bellani et al. 2006; Romeo and McEwen 2006; McCormick and Mathews 2007; 
Evuarherhe, Leggett et al. 2009; Evuarherhe, Leggett et al. 2009). Under normal 
physiological conditions, an acute stressor activates the HPA axis. Hypothalamic 
corticotrophin-releasing hormone (CRH) stimulates adrenocorticotrophic 
hormone (ACTH) release from the anterior pituitary which in turn, causes the 
release of adrenal glucocorticoids, cortisol in humans and corticosterone (CORT) 
in rodents. Arginine vasopressin (AVP) released from the parvocellular portion of 
the paraventricular nucleus of the hypothalamus (PVN) and is known to act 
synergistically with CRH to augment the release of ACTH and CORT and 
mediate stress and anxiety responses (Dickstein, DeBold et al. 1996; Wigger, 
Sanchez et al. 2004; Egashira, Tanoue et al. 2007). This sequence of events 
sets up a negative feedback system whereby increased circulating glucocorticoid 
levels serve to inhibit the additional release of hypothalamic CRH and AVP by 
inhibiting the activity of the promoter (Van, Spengler et al. 1990; Iwasaki, Oiso et 
al. 1997; Malkoski and Dorin 1999; Kim, Summer et al. 2001).  
  
96 
 
Several lines of evidence suggest that acute or chronic alcohol exposure 
might lead to increased displays of anxiety behavior. Correlative studies have 
demonstrated that over 50% of patients with alcohol dependency also have 
anxiety-related or depression-related psychiatric disorders (Conway, Compton et 
al. 2006), and these types of disorders are often associated with an abnormal 
stress response. Interestingly, women alcoholics have a higher incidence of 
clinically diagnosed anxiety disorders compared to men alcoholics (Zilberman, 
Tavares et al. 2003; Epstein, Fischer-Elber et al. 2007), possibly due to the 
inherent sex differences in the stress responses of the HPA axis (Becker, 
Monteggia et al. 2007; Handa, Zoeller et al. 2007).  
Pubertal binge-alcohol exposure can alter the expression of both the CRH 
and the AVP mRNA in the PVN, a main region involved in modulating stress 
reposes.  We have shown previously that in peri-pubertal male rats, binge, but 
not acute EtOH exposure increased the expression of the CRH and AVP mRNA 
in the PVN but this effect was not observed in female peri-pubertal rats 
(Przybycien-Szymanska, Rao et al. 2009). In addition, in adult rats, even single 
exposure to alcohol at the dose of 3g/kg, significantly increased PVN expression 
of CRH and AVP mRNA but as observed in peri-pubertal rats, this effects was 
evident only in males. Together, these data clearly indicate that there is a sex 
difference in the responsiveness of the HPA axis to alcohol exposures and this 
sex difference becomes apparent during peri-pubertal development but the 
mechanisms behind these inherent sex differences in the responsive of female 
HPA axis to alcohol exposure remain unknown. 
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In this study,  the role of 17β-estradiol (E2) in the responsiveness of peri-
pubertal females to binge pattern EtOH exposure as well as the role of E2 to 
alcohol effects in vitro were investigated. I hypothesized that 1) in ovariectomized 
females E2 replacement will prevent alcohol induced changes in the CRH and 
AVP mRNA levels in the PVN that will be evident in Ch-treated group and 2) that 
in a cell culture, E2 treatment will prevent an increase in the CRH promoter 
activity observed previously in the CRH promoter after alcohol treatment. We 
showed here that 1) in E2–treated females, binge EtOH exposure did not cause 
changes in the CRH and AVP mRNA in the PVN and that the increase in 
circulating CORT level after binge EtOH exposure was lower compared to an 
increase in plasma CORT levels after acute EtOH exposure (habituation effects), 
2) in Ch-treated females, binge EtOH exposure decreased the CRH and AVP 
mRNA levels in the PVN and prevented habituation effect after binge EtOH 
exposure and 3) that in a neuronal cell line E2 treatment prevented EtOH induced 
increase in CRH promoter activity.   
 
Results 
General Approach 
In order to investigate a role of estradiol (E2) in sex differences observed 
after EtOH exposure during puberty on stress responsiveness of the HPA axis 
during this time period, peri-pubertal ovariectomized on PND 26 female rats that 
were replaced either with Cholesterol (Ch) or 17β-estradiol (E2) were treated 
either with saline, acute EtOH or binge EtOH exposure between PND 37 and 44 
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(see Fig 2 and Table 2 for binge EtOH exposure paradigm Fig 2 and 
experimental design Table 2). On the last day of treatments (PND 44), 1.0 h after 
the last EtOH administration, animals were sacrificed and brains and trunk blood 
were collected. Plasma was isolated and used for further hormone and BAC 
measurements. Brains were rapidly frozen, sectioned on a freezing microtome 
and PVN and SON were microdissected for CRH and AVP mRNA 
measurements using qRT-PCR.  
In addition, the effect of E2 on EtOH induced changes in CRH promoter 
activity was investigated in a neuronal cell line (IVB) derived from the PVN. Cells 
were transfected with CRH promoter-luciferase construct and 8.0 h after 
transfections, cells were pre-treated with 10 nM E2 for 16.0 h. After 16.0 h pre-
treatment period, cells were incubated with 10 nM E2 and 100 mM EtOH for 2.0 h 
and then CRH promoter activity was measured using dual luciferase assay (see 
Chapter 7, General Methods section for detailed description of methods used in 
this chapter). 
 
Body weight differences and E2 levels after alcohol treatments in ovariectomized 
Ch- or E2 – treated female rats 
On PND 26, females were bilaterally ovariectomized and replaced with 
silastic capsules containing either 17β-estradiol (E2) or cholesterol (Ch). On PND 
37, both E2-treated and Ch-treated animals were randomly assigned to either 1) 
saline-treated (N = 8/group), 2) acute EtOH treated (N=8/group) or 3) binge EtOH 
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treated (N = 8/group, 3g/kg/day) groups (see Table 2 and Chapter 7 General 
Methods section for detailed description). 
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Experimental design 1
PND 26                          PND 37-44
OVX + 17β-
Estradiol (n=24)
Saline (n=8)
OVX + Chol (n=24)
Saline (n=8)
Acute EtOH (n=8)
Acute EtOH (n=8)
Binge EtOH (n=8)
Binge EtOH (n=8)
Saline = 8 days ip 0.9% saline
Acute EtOH = 7 days ip saline + 1 day 3g/kg EtOH
Binge EtOH = 3 days ip 3g/kg EtOH + 2 days saline + 3 days ip 3g/kg EtOH
 
Table 2. Schematic representation of treatment groups used. Pre-pubertal females 
(PND 26) were bilaterally ovariectomized and replaced with 1.0 mm silastic capsules 
containing cholesterol (Ch) or 17β-estradiol (E2). Starting on PND 37, animals received 
one of the three treatments; saline, acute EtOH or binge EtOH.     
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Body weight measurements were obtained every other day during the 
duration of treatments. Repeated measures mixed ANOVA revealed that there 
was no main effect of EtOH treatment on body weight gain (F(2,44) = 0.252; 
p=0.388) but that there was a main effect of age (F(1,44)= 9.9. p = 0.003). In 
addition, there were no between subject interactions on weight gain in these 
groups (F(2,44)=0.267, p=0.767). On the other hand, there was hormone by age 
interaction on weight gain between groups (F(1,45)=33.362, p<0.001).  These 
data show that within E2–treated group, animals gained weight slower compared 
to animals within Ch-treated group (Fig. 19), Even though E2 treatment had an 
effect on body weight gain, EtOH did not cause animals to lose weight. As 
expected, in Ch-treated females lack of E2 in the system resulted in increased 
body mass as compared to E2–treated females (Fig 19B) indicating that 
implantation of E2 containing capsules was effective in our animals and raised 
plasma E2 levels.  
As reported by Dr. Pau from Oregon National Primate Research 
Center/Oregon Health Science University Endocrine Technology and Support 
Laboratory, E2 levels in E2–replaced ovariectomized females were 65 ± 7.3 pg/ml 
and there were no differences in plasma E2 levels between different EtOH 
treatment groups (F(2.20)=2.929, p=0.077). These data, together with body 
weight data, indicate that E2 replacement via silastic capsules was effective in 
these experiments and raised plasma E2 levels to expected values.  
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Fig 19. Effects of ethanol treatment on body weight of ovariectomized females replaced 
either with Ch or E2 during pubertal development. Representative mean body weights of 
animals in all treatments groups (A) and combined treatments groups within Ch and E2   
females (B) treated with daily IP injections of saline, saline + one day EtOH (acute), or 
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binge EtOH paradigm. Dissimilar letter indicate statistically significant difference. More 
specifically a is different from b, c, d, e, f, fg, and g; ef is different from a, b, c, d, and g 
(p<0.05). 
 
 
Blood alcohol concentrations (BAC) in Ch- or E2 – treated ovariectomized 
females.  
 1.0 h after the last EtOH treatment, BAC were measured using commercially 
available kit (Pointe Scientific) (see Chapter 7 General Methods section for 
details). Two-way ANOVA showed that there was no main effect of hormone 
treatment (F(2,38) = 1.595; p=0.516) and that there was a main effect of EtOH 
treatment (F(2,38) = 60.368, p <0.001) on BAC in these experiments. There was 
no interaction between these two factors (F(4,38 = 1.678; p = 0.175). On 
average, EtOH exposure resulted in BAC of 257.09 ± 19.97 mg/dl and 275.77 ± 
22.94 (Fig 20) in E2–treated and Ch-treated females, respectively. More 
specifically, acute (singe dose) EtOH exposure resulted in BAC of 252.25 ± 
36.57 and 244.65 ± 28.85 in E2– and Ch-treated females, respectively and in 
both cases the values were significantly different from BAC in saline group 
(below the limit of detection, p<0.001). Binge EtOH exposure resulted in BAC of 
221.94 ± 17.52 and 306.89 ± 33.84 in E2– and Ch-treated females, respectively 
and they both were significantly higher compared to BAC in saline treaded 
controls (below the limit of detection, p<0.001, Fig 20). These values are 
consistent with the defined BAC threshold of binge drinking. 
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Fig 20. Effects of EtOH treatments on blood alcohol levels in ovariectomized female 
rats. Blood alcohol concentrations (BAC) 1.0 h post-injection in ovariectomized females 
replaced either with Ch or E2 and then treated with saline, acute EtOH or binge EtOH. 
Data expressed as mean alcohol mg/dl.  Dissimilar letter indicate statistically significant 
difference between groups. More specifically a is significantly different from b (P < 0.05).  
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Plasma ACTH and CORT levels after alcohol exposure in Ch- or E2 – treated 
ovariectomized (OVX) females rats 
 In order to investigate the effects of E2 replacement on the effects of EtOH 
exposure during peri-puberty on circulating ACTH and CORT levels in OVX 
females, both plasma ACTH and CORT levels were measured using RIA (see 
Chapter 7 General Methods section for details). Overall two-way ANOVA 
revealed that there was a main effect of hormone treatment (F(1,35) = 10.563; 
p=0.003) and a main effect of EtOH treatment (F(2,35) = 24.219; p<0.001) on the 
plasma ACTH levels and that there was no interaction between the two factors 
(Fig 21A; F(2,35) = 3.154, p = 0.055). In Ch-treated females, both acute 
(p<0.001) and binge (p=0.002) EtOH exposures significantly increased plasma 
ACTH levels as compared to saline treated controls and there was no difference 
between plasma ACTH levels in acute EtOH group as compared to binge EtOH 
group (Fig 21A, p=0.735). Plasma ACTH levels in E2–treated group showed a 
different pattern of responses to EtOH exposure. Notably, there was a significant 
increase in plasma ACTH levels after acute EtOH exposure (p<0.001) and no 
changes after binge EtOH exposure (Fig 21A, p=0.15) as compared to saline 
treated controls (Fig 21A). These data indicate a habituation effect that is absent 
in Ch-treated group. Plasma ACTH levels in binge EtOH group were not different 
as compared to saline treated group within this hormone treatment (p=0.159).  
 Analysis of plasma CORT levels revealed that there was no main effect of 
hormone treatment (F(2,36) = 0.318; p=0.73) and that there was a main effect of 
EtOH treatment (F(2,36) = 27.834; p<0.001) on the plasma CORT levels. There 
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was no interaction between the two factors (Fig 21B; F(4, 36) = 2.235, p = 0.084) 
(Fig 21B). In Ch-treated females, both acute (p<0.001) and binge (p<0.001) 
EtOH  exposures significantly increased plasma CORT levels as compared to 
saline treated controls and there was no difference between plasma CORT levels 
in acute EtOH group as compared to binge EtOH group (p=547). Plasma CORT 
levels in E2–treated group showed a different pattern of responses to EtOH 
exposure. There was a significant increase in plasma CORT levels after acute 
EtOH exposure (p=0.007) and no changes after binge EtOH exposure (p=0.567) 
as compared to saline treated controls (Fig 21B). These data further indicate that 
the habituation effect that is absent in Ch-treated group is present in E2–treated 
females. Lastly, as expected, based on studies performed in intact animals and 
based on known influence of E2  on stress axis in females (Sencar-Cupovic and 
Milkovic 1976; Rivier 1993; Weiser and Handa 2009; Przybycien-Szymanska, 
Rao et al. 2010), basal (saline induced) plasma CORT levels were higher in E2 -
treated females as compared to Ch-treated females (Fig 21B, p=0.032). 
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Fig 21. Effects of EtOH treatments on blood ACTH and CORT levels in ovariectomized 
female rats replaced with Ch or E2. Plasma ACTH (A) and CORT (B) levels in 
ovariectomized females replaced either with Ch or E2 1.0 h after IP injection of saline, 
acute, or binge EtOH treatments.. Data expressed as mean ACTH and CORT ng/ml of 
blood. Dissimilar letters indicate statistically significant difference among groups. More 
specifically a is significantly different from b and c  but nor from a, and b is different from 
a and c but not b and so on (P < 0.05). 
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CRH and AVP mRNA expression in the PVN after alcohol treatments in CH- or 
E2–treated ovariectomized (OVX) females. 
In order to investigate the effects of E2 replacement on the effects of EtOH 
exposure during peri-puberty on the expression of genes involved in stress and 
anxiety responses in OVX females, CRH and AVP mRNA were measured using 
qRT-PCR (see Chapter 7 General Methods section for details). Two-way ANOVA 
revealed that there was no main effect of hormone treatment on the expression 
of CRH mRNA (F(1,40) = 0.0575; p=0.812) (Fig 22A) or AVP mRNA 
(F(1,40)=1.008; p=0.321) (Fig 22B) in the PVN and that there was a main effect 
of EtOH treatment on the CRH mRNA expression (F(2,40) = 5.397, p = 0.008). 
There was no interactions between these two factors on the CRH mRNA 
expression (F(2,40)=1.622; p=0.21) or on the AVP mRNA expression 
(F(2,40)=2.008; p=0.148) in the PVN in peri-pubertal females. Post hoc analysis 
of the CRH and AVP mRNA expression in the PVN of Ch-treated females 
showed that binge EtOH exposure significantly decrease the CRH mRNA (Fig 
22A, p=0.03) and AVP mRNA (Fig 22B, p=0.028) expression in these treatment 
groups but there were no differences within E2 -treated females.   
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Fig 22. Effects of EtOH treatments on CRH and AVP gene expression in the PVN of 
ovariectomized female rats replaced with Ch or E2. CRH (A) and AVP (B) mRNA 
expression in the PVN of peri-pubertal females replaced either with Ch or E2 1.0 h after 
treatment with either saline, acute, or binge EtOH. Data expressed as mRNA copies/µg 
total RNA. Dissimilar letters indicate statistically significant difference between groups. 
For example, a is significantly different from b but not ab and so on (P < 0.05). 
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CRH and AVP mRNA expression in the SON after alcohol treatments in Ch- or 
E2–traded ovariectomized (OVX) females. 
 We have shown previously that in peri-pubertal male and female rats 
(Przybycien-Szymanska, Rao et al. 2009), EtOH does not change the AVP 
mRNA expression in the SON, a main region responsible for osmoregelation 
which indicated that the effects observed in all previous studies in the PVN were 
not due to diuretic effects of EtOH on the AVP containing neurons. In this study I 
also measured the AVP mRNA expression in the SON in order to verify the HPA 
axis specificity of EtOH effects using qRT-PCR. Contrary to what we observed in 
intact animals, there were changes associated with EtOH treated in the AVP 
mRNA expression in the SON. Two-way ANOVA revealed that there was a main 
effect of EtOH treatment (F(2,39)=4.696, p=0.015) and no main effects of 
hormone replacement (F(1,39)=1.434, p=0.238) on the AVP mRNA expression in 
the SON and that there was an interaction between the two factors analyzed 
(F(2,39)=4.075, p=0.005) (Fig. 23). Post-hoc tests showed that in E2–treated 
females, there were no changes in the AVP mRNA expression (p=0.907); 
however, in the Ch-treated group binge EtOH treatment significantly decreased 
the AVP mRNA levels as compared to saline controls (p<0.001) and acute EtOH 
group (p = 0.003). There were no differences between saline and acute EtOH 
groups within Ch-treated females (Fig. 23, p=0.747). 
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Fig 23. Effects of ethanol treatments on AVP gene expression in the SON in 
ovariectomized female rats. AVP mRNA expression in SON of peri-pubertal Ch- or E2  - 
treated female rats treated with saline, acute, or binge EtOH. Data expressed as mRNA 
copies/µg total RNA. Dissimilar letters indicate statistically significant difference. More 
specifically a is significantly different from b and c but not from ca (P < 0.05). 
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17β-Estradiol treatment in vitro abolished EtOH induced changes in CRH 
promoter activity 
 In order to investigate possible interactions of EtOH with E2 on the activity 
of the CRH promoter, I treated IVB cells transfected with CRH promoter-
luciferase construct with 100 mM EtOH or 100 mM EtOH plus 10 nM E2 and 
measured luciferase activity (see Chapter 7 General Methods section for details).  
Statistical analysis revealed that EtOH significantly increased the CRH promoter 
activity as compared to vehicle treated controls (Fig 24, p=0.016) but in the 
presence of E2 this EtOH effect was abolished (Fig 24, p=0.539).  These data 
indicate that the presence of E2 moduulates EtOH induced effects exerted on 
CRH promoter. 
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Fig 24. Effects of EtOH treatment on CRH promoter activity in a neuronal cell line after 
E2 treatment. CRH promoter-luciferase activity was measured in IVB cell line in cells 
transfected with CRH promoter-luciferase construct after treatment with 100 mM EtOH 
for 2.0 h in media alone or in the presence of 10 nM E2. Data expressed as % change in 
luciferase activity of vehicle treated control. * indicates statistically significant different 
compared to vehicle treated control (P < 0.05) 
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Discussion 
We have shown previously that binge alcohol exposure during peri-
puberty induced sexually dimorphic changes in the PVN expression of CRH and 
AVP mRNA but the pattern of alcohol induced changes in plasma CORT levels 
was the same in females as in males (Przybycien-Szymanska, Rao et al. 2009). 
These data indicated sex specific dysregulation of peri-pubertal HPA axis. To 
date, mechanisms behind these effects have not been described. The goals of 
this study were to investigate 1) the effects of binge EtOH exposure in 
ovariectomized peri-pubertal females and a role of E2   replacement in modulating 
these effects and 2) effects of EtOH treatment in a presence of estradiol on the 
CRH promoter activity. These results showed for the first time that 1) in Ch-
treated ovariectomized females, binge EtOH exposure significantly decreased 
CRH and AVP mRNA in the PVN and both acute and binge EtOH exposures 
significantly increased circulating CORT levels, 2) that in E2 -treated 
ovariectomized females, alcohol did not induce changes in the CRH and AVP 
mRNA in the PVN and only acute EtOH exposure significantly increased plasma 
CORT levels in this group. In vitro data presented herein showed that estradiol 
treatment prevented EtOH induced increase in CRH promoter activity at the 2.0 h 
time. These data indicate that E2-EtOH interaction are potentially responsible for 
sex differences in responsiveness of the HPA axis to alcohol administration as in 
the presence of estradiol in vivo and in vitro these effects of alcohol were 
abolished (see Fig 25 for the summary of major findings) 
. 
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SUMMARY: Effetc of binge EtOH exposure in ovariectomized females 
Ch-treated females (PND 37-44) 
- BINGE EtOH ↓ CRH and AVP mRNA in the PVN 
- Both binge and acute EtOH ↑ plasma CORT levels, no habituation 
E2-treated females (PND 37-44) 
- NO CHANGES in the CRH and AVP mRNA after EtOH treatmnets 
- Both binge and acute EtOH treatments ↑ CORT levels, habituation effect present 
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Fig 25. Summary of results described in Chapter 4. In OVX Ch-treated females (A) 
binge EtOH exposure ↓ CRH and AVP mRNA in the PVN and ↑ plasma CORT levels. In 
OVX estradiol replaced females  (B), binge EtOH exposure did not induce changes in 
the CRH and AVP mRNA in the PVN but ↑ plasma CORT levels. These data indicate 
that the presence of estradiol is required for the maintenance of steady sate levels of the 
CRH and AVP mRNA in the PVN after EtOH exposures.  
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In this study, both acute and binge EtOH exposure increased circulating 
ACTH and CORT levels in Ch-treated ovariectomized females, however, in E2  -
treated females only acute EtOH exposure significantly increased plasma ACTH 
and CORT levels. Notably, in these females ACTH and CORT levels were similar 
between saline and binge alcohol treated groups indicating a clear habituation 
effects after repeated EtOH exposure. These data are consistent with our 
previous reports in intact peri-pubertal male and female rats in which we showed 
that there was a habituation effect after repeated EtOH administrations marked 
by lower increase in plasma CORT levels after binge EtOH treatment compared 
to plasma CORT levels after acute EtOH exposure (Przybycien-Szymanska, Rao 
et al. 2009). Data presented in this report indicate that the presence of estradiol 
is required for habituation effects because in Ch-treated females there was no 
difference between plasma ACTH and CORT levels between the two alcohol 
treated groups.  
In addition to the role of E2 in the habitation effect after binge EtOH 
exposure, these data support previous finding describing the role of E2 in 
increased sensitivity to stressful stimuli in female animals. Plasma CORT levels 
after saline administration were higher in E2 -treated  females compared to Ch-
treated females. This is consistent with previous reports showing greater plasma 
CORT increase after stress and alcohol administration in females compared to 
males (Sencar-Cupovic and Milkovic 1976; Rivier 1993; Ogilvie and Rivier 1997; 
Evuarherhe, Leggett et al. 2009; Weiser and Handa 2009). Our previous 
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experiments showed that CORT levels in intact peri-pubertal males and females 
were not different between saline treated groups as compared to untreated rats, 
however saline injection could be considered to be a mild stressor inducing a 
small increase in circulating CORT levels and these effects were significantly 
greater in females compared to males. These data indicate and further support 
findings showing increased sensitivity to stress in females and a role of E2 in this 
increased sensitivity. 
Contrary to what was observed in peri-pubertal (Przybycien-Szymanska, 
Rao et al. 2009) and adult animals (Rivier 1993; Ogilvie and Rivier 1996; Ogilvie 
and Rivier 1997), E2 failed to induce a greater increase in CORT levels after 
EtOH administration in E2 -treated  females as compared to Ch-treated group. 
This could be explained by lack of other sex steroid hormones that would inhibit 
the HPA axis. One such hormone, testosterone (T), is known to play inhibitory 
role on stress induced functions of the HPA axis marked by decreased ACTH 
and CORT increase when compared to females and increased basal CORT 
levels in gonadectomized males (Ogilvie and Rivier 1997; Viau, Chu et al. 1999; 
Williamson and Viau 2008; Evuarherhe, Leggett et al. 2009). The fact that 
plasma ACTH and CORT levels were not different after EtOH administration 
between CH- and E2 -treated females could be explained by the fact that there 
was no HPA axis inhibition. 
A most striking finding of these experiments is that E2  replacement 
abolished alcohol induced changes in the CRH and AVP mRNA in the PVN 
which is consistent with previous data showing no changes in the expression of 
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these neuropeptides in the PVN of peri-pubertal (Przybycien-Szymanska, Rao et 
al. 2009) and adult female rats (Ogilvie and Rivier 1997). These data indicate a 
role of E2 in lack of EtOH induced changes in the CRH and AVP mRNA 
expression in the PVN, however, it is not clear what is the role this lack of EtOH 
effects on the CRH and AVP mRNA in the PVN in females and what causes an 
increase in these genes in the PVN of intact males observed in previous studies 
(Rivier, Bruhn et al. 1984; Ogilvie and Rivier 1996; Rivier and Lee 1996; Ogilvie, 
Lee et al. 1997; Ogilvie and Rivier 1997; Przybycien-Szymanska, Rao et al. 
2009). Notably, in Ch-treated females lack of E2 alone did not increase CRH and 
AVP mRNA in the PVN, therefore E2 cannot be the only factor involved in 
sexually dimorphic effects of EtOH. Notably, in Ch-treated females, I observed a 
decrease in the CRH and AVP mRNA in the PVN which indicates that some 
other factor, not present in gonadectomized females, is responsible for EtOH 
induced increase in the CRH and AVP mRNA in male PVN.  
It has been shown that in addition to E2,  T and its metabolites such as 3β-
diol and dihydrotestosterone (DHT), differently modulate the HPA axis activity 
(De Vries, Wang et al. 1994; Viau and Meaney 1996; Viau, Chu et al. 1999; Viau, 
Lee et al. 2003; Scordalakes and Rissman 2004; Lund, Hinds et al. 2006; Pak, 
Chung et al. 2007; Williamson and Viau 2008; Handa, Weiser et al. 2009; Pak, 
Chung et al. 2009) and that this effect can be mediated through estrogen 
receptor beta (ER β), the main ER found in the PVN (Isgor, Cecchi et al. 2003; 
Miller, Suzuki et al. 2004; Lund, Rovis et al. 2005; Suzuki and Handa 2005; Pak, 
Chung et al. 2007; Handa, Weiser et al. 2009) or through androgen receptor 
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signaling present in the PVN and in other hypothalamic regions (Viau and 
Meaney 1996; Lund, Hinds et al. 2006). For example, in bed nucleus of stria 
terminalis (BST) of gonadectomized adult rats, DHT and E2 increased AVP 
mRNA as compared to gonadectomized rats not replaced with any hormones. 
The same is true in medial nucleus of amygdala (MeA) (De Vries, Wang et al. 
1994; Pak, Chung et al. 2009). In juvenile rats, on the other hand, E2 and 3β-diol, 
but not DHT, increase AVP mRNA expression in BST but only E2 increased AVP 
mRNA expression in MeA (Pak, Chung et al. 2009).  3β-diol is known to activate 
the AVP promoter activity in a neuronal cell line (Pak, Chung et al. 2007; Pak, 
Chung et al. 2009). In addition to inhibiting ACTH and CORT release, T can also 
inhibit the HPA axis at the level of the hypothalamus were it has been found to 
decrease restraint induced changes in the CRH expression (Patchev and 
Almeida 1996; Viau and Meaney 1996; Viau, Chu et al. 1999; Viau, Lee et al. 
2003; Williamson and Viau 2008). In our Ch-treated animals, lack of any sex 
steroid hormones could be partially responsible for a decrease in the CRH and 
AVP mRNA in the PVN due to EtOH but more studies need to be performed in 
order to elucidate exactly what factors are required for EtOH induced increase in 
the CRH and AVP mRNA in the PVN.  
Another possibility behind EtOH induced decrease in the CRH and AVP 
mRNA in the PVN of ovariectomized Ch-treated females, further supporting the 
role of E2, is that these females lack E2 mediated neuroprotection. E2 has been 
shown in multiple studies to exert neuroprotective effects after a neuronal insult 
(Li, Siegel et al.; Pietranera, Bellini et al.; Garcia-Segura, Wozniak et al. 1999; 
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Azcoitia, Sierra et al. 2001; McCullough, Blizzard et al. 2003; Sierra, Azcoitia et 
al. 2003; Saleh, Connell et al. 2005; Veiga, Azcoitia et al. 2005). There is an 
increase in aromatase, an enzyme involved in conversion of T to E2, activity after 
ischemic stroke and other brain insults (Garcia-Segura, Wozniak et al. 1999; 
Saleh, Connell et al. 2005; Veiga, Azcoitia et al. 2005) . These findings indicate 
that a decrease in the CRH and AVP mRNA in the PVN could be explained by 
lack of neuroprotection against neurotoxic effects of EtOH; however, this still 
does not explain the reason why we see an increase in the expression of these 
neuropeptides in the PVN of intact males. It is possible that in peri-pubertal 
males an AVP increase in the PVN plays a neuroprotective role as these binge-
EtOH exposed pubertal males have low levels of circulating E2. AVP has been 
shown to be protective against apoptotic cell death in a neuronal cell line (Chen, 
Volpi et al. 2008; Chen, Liu et al. 2009) therefore it is likely to speculate that in 
males an upregulation of AVP plays a neuroprotective role. This explanation, 
however, still does not explain an increase in the CRH mRNA. 
 The role of E2 in modulation of the HPA axis at the level of the 
hypothalamus is further supported by our in vitro data showing no EtOH induced 
increase in CRH promoter activity in the presence of E2. . These data are 
consistent with previous reports showing a close relationship between gonadal 
and adrenal hormones in regulation of the HPA and hypothalamo-pituitary-
gonadal (HPG) axis, respectively. For example, E2 and ERβ play a stimulatory 
role on the HPA axis activity. This enhancing effect is marked by increased CRH 
promoter activity after cotransfection of different ERβ isoforms and increased  
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AVP mRNA in the PVN, and enhanced increase in plasma ACTH and CORT 
after stress in the presence of E2 (De Vries, Wang et al. 1994; Ogilvie and Rivier 
1997; Miller, Suzuki et al. 2004; Weiser and Handa 2009). Adrenal hormones can 
in turn modulate the expression of ER β as adrenodectomy decreased ERβ 
mRNA expression in the PVN of adult rats and this effects was fully reversed with 
CORT replacement (Isgor, Cecchi et al. 2003). Consistent with in vivo data 
showing no EtOH induced changes in the CRH mRNA expression in the PVN in 
intact females or in ovariectomized females replaced with E2, in a neuronal cell 
line, E2 treatment prevented EtOH induced stimulation of CRH promoter activity. 
These data indicate that there is close cooperation between EtOH and E2 
signaling and this interaction is involved in sex specific effects of EtOH exposure.  
In this study binge EtOH exposure, did not change the AVP mRNA 
expression in the SON in E2 -treated group but it significantly decreased SON 
expression of this neuropeptides in Ch-treated group. Our data collected in E2 -
treated ovariectomized females are consistent with previous reports showing no 
effects of EtOH treatments in the SON of normal rats (Ogilvie, Lee et al. 1997), or 
in magnocellular division of the PVN (Ogilvie and Rivier 1997). Notably, in Ch-
treated group we observed a significant decrease in the AVP mRNA expression 
in the SON and this effect could be explained in two ways. First, data showing a 
decrease AVP in the SON is consistent with diuretic effects of alcohol on the 
AVP as the AVP is mostly known as antidiuretic hormone (ADH). This 
explanation is highly unlikely because we did not observe changes in the AVP 
mRNA expression in the SON in E2-treated females and in intact peri-pubertal 
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male and female rats (Przybycien-Szymanska, Rao et al. 2009). If this decrease 
was due to diuretic effects of EtOH, we would see it in other studies as well. 
Second, based on previous reports, I can speculate that EtOH could induce cell 
death in the PVN which would result in decreased expression of AVP mRNA in 
the SON. This explanation is consistent with previous reports showing that the 
AVP mRNA in the SON was decreased following alcohol exposure but only in 
rats bearing PVN lesions (Ogilvie, Lee et al. 1997) and AVP is neuroprotective in 
a PVN derived neuronal cell line (H32) (Chen, Volpi et al. 2008; Chen, Liu et al. 
2009). In these experiments, addition of the AVP into the media was found to 
protect against serum starvation induced cell death (Chen, Volpi et al. 2008; 
Chen, Liu et al. 2009). EtOH induced cell death in the PVN could be responsible 
for a decrease in the AVP mRNA in the PVN in Ch-treated females. If that was 
the case, the decrease in the AVP mRNA in the SON could be explained by the 
cooperation between these two nuclei. Functions of the PVN and SON and their 
responses to EtOH have been shown to be linked (Ogilvie, Lee et al. 1997) . The 
cooperation between both magnocellular and parvocellular AVP systems needs 
to be further investigated in order to support this hypothesis even though this 
explanation at this moment seems to be most likely.  
Lastly, we showed that E2 -treated females had significantly lower body 
weights and gained weight slower as compared to Ch-treated females but EtOH 
treatment had no effects on body weight. These findings are consistent with 
known anorexigenic effects of E2, as lack of this hormone in humans, for 
example during menopausal transition in women, tends to increase body weights 
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(Cagnacci, Zanin et al. 2007). In addition, body weight data in EtOH treated 
groups showed the binge alcohol exposure paradigm employed in our 
experiments did not inhibit the growth of animals. This is consistent with our 
previous data which showed no differences in body weights due to EtOH 
treatment (Przybycien-Szymanska, Rao et al. 2009). In addition this binge EtOH 
exposure paradigm has been shown to be reliable for testing the effects of EtOH 
using an exposure pattern that is typical for adolescents (Lauing, Himes et al. 
2008). Lastly, it has been show that the IP injection of EtOH, employed in our 
paradigm, does not seem to result in significantly different BAC compared to oral 
gavage in adolescent Wistar rats (Walker and Ehlers 2009). 
Taken together, our data show for the first time that E2 plays a critical role 
in mediating sexually dimorphic effects of EtOH and that these effects of E2 may 
be exerted at the level of the CRH promoter. Further studies need to be 
performed in order to investigate mechanisms involved in increase in the CRH 
and AVP mRNA in the PVN of intact peri-pubertal male rats after binge EtOH 
exposure as the absence of E2 does not explain this increase. In addition, we 
need to establish whether the presence of E2 in the system makes females 
protected or more sensitive to the effects of E2 as compared to males, If they are 
more sensitive, this increase in sensitivity to E2l effects may lead females who 
binged during adolescence to exhibit even grater risk for developing mood 
disorders in adulthood as compared to males. 
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CHAPTER FIVE 
 
BINGE-PATTERN ALCOHOL EXPOSURE DURING PUBERTY 
INDUCES LONG-TERM CHANGES IN HPA AXIS REACTIVITY. (PRZYBYCIEN-
SZYMANSKA MM ET AL., PLOS ONE APRIL 2011) 
 
Introduction 
Alcohol abuse, especially binge-pattern alcohol abuse, is highly prevalent 
among adolescents. According to the Substance Abuse and Mental Health 
Services Administration, 36% of youths ages 18 to 20 reported at least one 
binge-drinking episode during the past 30 days, defined by National Institute on 
Alcohol Abuse and Alcoholism (NIAAA) as consuming four or five drinks within a 
two hour period that causes a rapid increase in blood alcohol concentration 
(BAC) to the level of 0.08 g % or greater. Our previous studies demonstrated that 
binge-pattern EtOH exposure in adolescent rats negatively affected the HPA axis 
by dysregulating normal negative feedback pathways, however whether these 
neurobiological changes were transient or persistent remained unclear 
(Przybycien-Szymanska, Rao et al. 2009).  Thus, a central focus of this study 
was to determine the long-term neurobiological consequences of adolescent 
binge-pattern alcohol exposure on adult HPA axis reactivity. The HPA axis is 
xtremely plastic during pubertal development, suggesting that early alcohol
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abuse could permanently disrupt the normal maturational process of the 
HPAaxis. Alcohol is a physiological stressor and potent activator of the HPA axis 
(Rivier and Lee 1996; Ogilvie, Lee et al. 1997; Li, Kang et al. 2005; Przybycien-
Szymanska, Rao et al. 2009). Acute psychological or physical stressors activate 
parvocellular neurons in the hypothalamic paraventricular nucleus (pPVN) to 
release corticotrophin releasing hormone (CRH) and arginine vasopressin (AVP) 
into the portal system of the anterior pituitary gland, which, upon stimulation, 
releases adrenocorticotrophic hormone (ACTH). ACTH then acts on the adrenal 
cortex to release glucocorticoids, cortisol in humans and corticosterone (CORT) 
in rodents, into the systemic circulation setting up a negative feedback loop by 
which CORT acts on the hypothalamus and pituitary gland to decrease further 
release of CRH, AVP, and ACTH. During pubertal development, the brain and 
HPA axis undergo extensive maturational processing, characterized by altered 
HPA axis reactivity, increased synaptic connections, and differential 
responsiveness to the effects of gonadal steroid hormones (Sisk and Zehr 2005; 
Romeo, Bellani et al. 2006; McCormick and Mathews 2007; Evuarherhe, Leggett 
et al. 2009; Evuarherhe, Leggett et al. 2009). These studies indicate that the 
successful shaping of mature HPA function that occurs during pubertal 
development may be extremely vulnerable to the detrimental effects of alcohol.  
We have previously shown that binge-pattern EtOH exposure in peri-
pubertal male rats increased the expression of CRH and AVP mRNA in the PVN 
during this time period (Przybycien-Szymanska, Rao et al. 2009), however the 
long lasting effects of this pattern of EtOH exposure during puberty on the PVN 
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and the HPA axis as a whole remain unknown. In this study we tested the 
hypothesis that binge-pattern EtOH exposure during puberty has long lasting 
effects on the reactivity of the adult HPA axis. The overall goals of this study 
were to 1) determine how binge-pattern EtOH exposure during puberty affects 
central expression of adult CRH and AVP, as well as circulating CORT levels, 
and 2) determine whether adults pre-exposed to EtOH during puberty were more 
sensitive to subsequent EtOH exposures in adulthood.  Overall, our results 
showed that peri-pubertal binge-pattern EtOH exposure induced a striking long 
lasting alteration of many HPA axis parameters. Our data provide strong 
evidence that binge-pattern EtOH exposure during pubertal maturation has long-
term detrimental effects for the healthy development of the HPA axis.  
 
Results 
General Approach 
 In order to investigate the long lasting effects of binge EtOH exposure 
during puberty on functioning of adult HPA axis, peri-pubertal male rats (PND 37-
44) were exposed to saline (EtOH naïve) or binge EtOH exposure paradigm 
(EtOH pre-exposed) and then allowed to grow up undisturbed until adulthood. 
Starting on PND 68 (early adulthood), male rats were treated with following 
regiments 1) saline only, 2) acute EtOH exposure or 3) binge EtOH exposure for 
8 consecutive days (see Fig 2 and Table 3 for detailed description of binge EtOH 
exposure paradigm and experimental deign). On the last day of adult treatments 
(PND 75), 1.0 h after saline or EtOH administration, animals were sacrificed and 
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he brains and trunk blood were collected. Plasma was separated and used for 
further BAC and hormone measurement. Brains were rapidly frozen, then 
sectioned on a freezing microtome and the PVN and SON were microdissected 
to perform CRH and AVP mRNA measurements using qRT-PCR (see Chapter 7 
General Methods section for detailed description of methods used) 
   
Effects of binge EtOH exposure on body mass and growth rate.  
In order to investigate the long lasting effects of binge EtOH exposure 
during puberty, pubertal and then adult male rats were treated according to our 
binge EtOH exposure paradigm (Fig 2 and Table 3). Animals at PND 37 were 
randomly assigned to either 1) saline-treated (N = 30) or 2) binge EtOH treated 
(N = 30, 3g/kg/day) groups and then allowed to grow till adulthood. On PND 68 
(early adulthood) each group was divided into following treatment groups (Table 
3): 1) saline only control groups (N=10); 2) acute EtOH groups (N=10) and 3) 
binge EtOH groups (N=10).   
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              Experimental Design 2 
Binge EtOH (n=10)
Acute EtOH (n=10)
Saline (n=10)
Binge EtOH (n=10)
Acute EtOH (n=10)
Saline (n=10)
Adult (PND 68-75)Puberty (PND37-44)
EtOH pre-exposed
Binge EtOH (n = 30)
EtOH naïve
Saline (n = 30)
 
Table 3. Experimental design 2. During pubertal development animals were divided in 
two treatment groups, saline (ip injection of saline once a day for 8 days) or binge EtOH 
treatment (3 days of ip injections of 3g/kg EtOH, followed by 2 days of saline and again 
by 3 days of EtOH injections). After pubertal treatments animals were undisturbed for a 
month and then in adulthood each pubertal treatment group was divided into 3 
subsequent treatment groups; 1) saline, 2) acute EtOH (7 days of saline followed by 1 
day of 3g/kg EtOH injections), or 3) binge EtOH .  
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Body weights were measured every other day during the duration of both 
pubertal and adult treatments to determine whether pubertal binge pattern EtOH 
exposure altered normal growth patterns. Growth curves for each treatment 
group (Fig. 26A), and combined groups based on EtOH exposure during puberty 
(Fig. 26B), show that there was a significant weight difference between animals 
exposed to binge pattern EtOH starting from the fifth day of pubertal treatment 
(Fig 26B, p<0.01). The weight difference increased by the last day of treatment 
during puberty and persisted during the time when animals were undisturbed and 
throughout the adult treatment regiment (Fig 25B, p<0.001). Animals did not lose 
weight at any point, despite the fact that the animals that received binge EtOH 
treatment had significantly lower body weights compared to saline-treated 
controls. Interestingly, subsequent binge EtOH exposure in adulthood did not 
further alter the growth pattern of adult animals (Fig 26). 
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Fig 26. Effects of ethanol treatment on body weight during puberty and adulthood. Mean 
body weights of male animals untreated treated with daily IP injections of saline, saline + 
one day EtOH (acute), or binge EtOH paradigm. (A) represents body weights in all 
groups separately and (B) shown combined body weight based on pubertal treatment 
(saline or binge EtOH exposure). Data presented as mean body weight (g). * represents 
statistically significant difference as compared to saline treated group on a given 
treatment day (p<0.05).  
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BAC following adult acute and binge EtOH exposure.  
BACs were measured on the final day of adult treatment 60 min following 
the injections. There were no statistically significant differences in BAC between 
either acute (205.1±21.8; 221.8 ±19.1 for EtOH naïve and EtOH pre-exposed 
groups, respectively) or binge EtOH treated groups (172.9 ±27.0; 208.2 ±28.2 for 
EtOH naïve and EtOH pre-exposed groups, respectively) (Fig 27). BAC in 
animals treated with saline were below the limit of detection for the assay. 
Interestingly, prior EtOH exposure (i.e. EtOH pre-exposed binge group) had no 
effect on adult BAC after either acute or binge EtOH treatments. The values 
observed in EtOH-treated groups are consistent with the defined BAC threshold 
for binge drinking (80 mg/dl) and showed that all EtOH-treated groups were 
intoxicated to the same degree. 
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Fig 27. Adult blood alcohol concentrations (BAC) following EtOH treatment. BAC 1.0 h 
post-injection in adult animals pre-treated during peri-puberty with either saline (EtOH 
Naïve) or binge EtOH paradigm (ETOH pre-exposed) then treated with saline, acute 
EtOH or binge EtOH as adults. Data expressed as mean EtOH mg/dl. Dissimilar letters 
indicate statistically significant difference between groups. More specifically a is 
significantly different from b (P < 0.05).  
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Binge-pattern EtOH exposure during peri-puberty significantly altered adult 
CORT levels.   
Circulating CORT levels were measured by RIA to determine whether 
binge EtOH exposure during puberty affected responsiveness of the HPA axis to 
subsequent EtOH exposures in adulthood. All measurements were taken in adult 
animals and they were classified as either EtOH pre-exposed or EtOH naïve.  
Three different measures of adult HPA reactivity, as ascertained from plasma 
CORT levels, were compared: 1) basal pre-stress, 2) sensitivity to a single EtOH 
exposure (acute stress), and 3) sensitivity to repeated EtOH exposure (binge – 
repeated stress).  Two-factor ANOVA was used to assess main effects of 
pubertal and adult treatments and interactions between these two factors. Every 
parameter measured was significantly different between animals that were EtOH 
pre-exposed compared with those that only received saline during puberty (EtOH 
naïve). There was a statistically significant main effect of EtOH treatment during 
adulthood (F(2,51) = 71.218, p<0.001), no significant main effect of treatment 
during puberty (F(1,51 ) = 3.305, p = 0.075 and a there was a significant 
interaction between pubertal and adult treatment (F(2, 51) = 4.458, p = 0.016).   
Overall, our data revealed that the pattern of plasma CORT responses were 
significantly different depending on whether the animals were pre-exposed to 
EtOH (Fig. 28).  Notably, basal levels of plasma CORT were significantly lower in 
animals that had previously been exposed to EtOH during pubertal development 
compared with EtOH naïve animals (t(17) = 3.23, p = 0.005, Fig. 28, open bars).  
Second, plasma CORT levels in animals that were pre-exposed to EtOH during 
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puberty were significantly higher following adult treatment with a single (acute) 
(t(18) = -2.247, p = 0.037) or binge-pattern EtOH (t(15) = -2.218, p = 0.042) (Fig. 
28, hatched and solid bars), suggesting that the adult animals were more 
sensitive, or that the HPA axis was potentially more responsive, to the stressful 
effects of EtOH.  Animals that did not have prior EtOH exposure also had 
significantly elevated CORT levels following EtOH treatment in adulthood (F(2, 
27) = 34.105, p <0.001), but as mentioned above, it was significantly lower than 
the animals that were pre-exposed. Finally, animals that were pre-exposed to 
EtOH during puberty failed to habituate to the binge-treatment paradigm as 
indicated by their equivalently higher plasma CORT levels following a 
subsequent acute or binge EtOH treatment (p = 0.358, Fig. 28).  By stark 
contrast, animals that received saline during puberty (EtOH naïve) did show a 
habituation effect to the repeated binge EtOH treatment (p = 0.003), which is 
consistent with our previous reports in peri-pubertal animals.  
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Fig 28. Effects of pubertal binge EtOH pre-treatments on plasma CORT levels in EtOH 
exposed adult animals. Plasma corticosterone (CORT) levels 1.0 h post-injection in adult 
animals pre-treated with either saline (EtOH Naïve) or binge EtOH paradigm (EtOH pre-
exposed) during peri-puberty and then treated with saline, acute EtOH or binge EtOH 
paradigm in adulthood. Data expressed as mean CORT ng/ml of blood. Dissimilar letters 
indicate statistically significant difference. More specifically a is significantly different 
from b, c, d, e and be; e is different from a, b, c, d, but not from be and so on (P < 0.05).  
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Binge-pattern EtOH exposure during puberty significantly altered responsiveness 
of adult CRH and AVP mRNA in the PVN to subsequent EtOH exposure. 
Next, we measured CRH and AVP mRNA in the PVN using quantitative 
RT-PCR to determine the long-term effects of pubertal binge EtOH exposure on 
adult HPA axis reactivity. CRH and AVP mRNA were used as endpoints to 
ascertain three different measures of adult HPA axis status: 1) basal pre-stress, 
2) sensitivity to a single EtOH exposure (acute stress), and 3) sensitivity to 
repeated EtOH exposure (binge – repeated stress).  Two-way AVOVA showed 
that there was a main effect of EtOH treatment during puberty on adult CRH 
mRNA expression (F(1, 42) = 8.641, p = 0.005), as well as a main effect of 
pubertal treatment (F(1, 44) = 4.876, p = 0.032) and adult treatment (F(2, 44) = 
5.835, p = 0.006) for AVP mRNA expression in the PVN (Fig 29 and 30).  Similar 
to the results obtained with plasma CORT levels, the patterns of gene expression 
for CRH and AVP were significantly different depending on whether the animals 
were pre-exposed to EtOH or EtOH naïve. 
 Basal pre-stress levels of CRH mRNA was significantly higher in animals 
that were exposed to EtOH during puberty compared with those that received 
saline (EtOH naïve) (t(14) = -2.175, p = 0.047) (Fig. 29, open bars).  A single 
(acute) dose of EtOH significantly increased CRH mRNA levels (t(14) = -2.363, p 
= 0.033) in animals that were pre-exposed to EtOH during adolescence, yet had 
no effect in animals that were EtOH naïve (Fig. 29, hatched bars).  Conversely, 
binge-pattern EtOH exposure significantly increased CRH mRNA levels in EtOH 
pre-exposed animals compared to EtOH naive, however the levels were not 
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statistically different from the baseline levels of EtOH pre-exposed animals (Fig. 
29, solid bars).   
Pre-exposure to EtOH during puberty had no effect on baseline levels of 
adult AVP mRNA (t(15) = -1.342, p = 0.199, Fig. 30, open bars).  However 
compared to baseline, a single (acute) dose significantly decreased AVP mRNA 
levels in EtOH naïve animals (t(15) = -2.214, p = 0.043), but had no significant 
effect compared to baseline in animals pre-exposed to EtOH (Fig. 30, hatched 
bars).  Binge-pattern EtOH exposure significantly decreased AVP mRNA levels 
compared to baseline in both groups, however the levels were only different from 
acute EtOH treatment in the pre-exposed group (Fig. 30, solid bars).  
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Fig 29. Effects of pubertal binge EtOH pre-treatments on CRH gene expression in the 
PVN of EtOH exposed adult rats.  CRH mRNA expression in adult animals pre-treated 
with either saline (EtOH naïve) or binge EtOH paradigm (EtOH pre-exposed) during peri-
puberty and then treated with saline, acute EtOH or binge EtOH in adulthood. Data 
expressed as mRNA copies/µg total RNA. Dissimilar letters indicate statistically 
significant difference between groups. For example, a is significantly different from b and 
c but is not significantly different from ab, c is different from a, b and ab (P < 0.05). 
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Fig 30. Effects of pubertal binge EtOH pre-treatments on AVP gene expression in the 
PVN of EtOH exposed adult rats. AVP mRNA expression in adult animals pre-treated 
with either saline (EtOH naïve) or binge EtOH paradigm (EtOH pre-exposed) during peri-
puberty and then treated with saline, acute EtOH or binge EtOH in adulthood. Data 
expressed as mRNA copies/µg total RNA. Dissimilar letters indicate statistically 
significant difference. More specifically a is significantly different from b and bc; b is 
different from a but not bc (P < 0.05). 
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Binge EtOH exposure during puberty does not change the expression of the AVP 
mRNA in adult SON. 
To confirm that the observed changes in the expression of the AVP mRNA 
in PVN after EtOH treatments were not due to the reported diuretic effects of 
alcohol, we measured AVP mRNA expression in the supraoptic nucleus of the 
hypothalamus (SON), a region responsible for maintaining water homeostasis. 
Two way AVOVA showed no main effects of either pubertal (F(1, 48) = 0.65, p = 
0.424) or adult (F(2, 48) = 1.72, p = 0.19) treatment and no significant 
interactions between treatments during puberty and during adulthood (F(2,48) = 
1.359, p = 0.267) (Fig 31).  
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Fig 31. Effects of pubertal binge EtOH pre-treatments on AVP gene expression in the 
SON of EtOH exposed adult rats. AVP mRNA expression in adult animals pre-treated 
with either saline (EtOH naïve) or binge EtOH paradigm (EtOH pre-exposed) during peri-
puberty and then treated with saline, acute EtOH or binge EtOH in adulthood. Data 
expressed as AVP mRNA copies/µg total RNA. 
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Discussion 
The goals of this study were to 1) identify the long lasting effects of binge 
EtOH exposure during pubertal development on the maturation of the HPA axis 
by measuring circulating CORT, and hypothalamic neuropeptides (CRH and 
AVP), previously identified to be susceptible to EtOH effects and 2) determine 
whether binge-pattern EtOH exposure during puberty renders the adult HPA axis 
more sensitive, or responsive, to subsequent EtOH exposure. The most striking 
finding of our study was that exposure to binge-pattern EtOH during puberty 
resulted in a permanent dysregulation of the adult HPA axis, which is consistent 
with our hypothesis and is substantiated by the following data.  First, adult 
animals that were previously exposed to binge-pattern EtOH during puberty had 
significantly lower circulating basal CORT levels, yet increased basal CRH 
mRNA expression in the PVN. We previously showed that peri-pubertal animals 
exposed to binge-pattern EtOH had significantly elevated levels of CRH and AVP 
mRNA in the PVN (Przybycien-Szymanska, Rao et al. 2009) and the present 
data demonstrate that those observed elevated CRH levels are maintained well 
into adulthood.  Second, binge EtOH exposure during puberty sensitized the 
adult HPA axis to subsequent stressful stimuli (acute EtOH exposure), evident by 
a marked increase in adult levels of CRH mRNA in the PVN and higher 
circulating CORT levels compared to controls following a single exposure to 
EtOH.  Finally, the stress response to EtOH exposure was significantly 
exacerbated and there was no habituation effect following repeated doses of 
EtOH in adults that were previously exposed to binge-pattern EtOH during 
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pubertal development, which is contrary to the effects observed in adult EtOH 
naïve animals.  Collectively, present results underscore the heightened reactivity 
of the adult HPA axis in animals previously exposed to alcohol during 
adolescence and suggest that EtOH might interfere with the normal development 
of the HPA axis. See Fig 32 for summary of major finding in Chapter 5. 
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SUMMARY; The effects of pubertal; binge EtOH exposure on adult HPA axis reactivity 
 EtOH naïve males (PND 68-74) 
- NO CHANGES in CRH mRNA levels in the PVN after EtOH exposures 
- Acute and binge EtOH exposures ↑ plasma CORT levels, habituation effect 
present  
EtOH pre-exposed males (PND 68-74) 
- Acute EtOH ↑ CRH and AVP mRNA in the PVN (as compared to EtOH naïve) 
- In EtOH pre-exposed during puberty animals there was ↓ basal plasma CORT 
levels (as compared to EtOH naïve) 
- EtOH pre-exposed rats had ENHANCED ↑ in plasma CORT after subsequent 
acute and binge EtOH, No habituation  
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Fig 32. Summary of results described in Chapter 5. In EtOH-naive (A) binge EtOH 
exposure did not change CRH and AVP mRNA in the PVN and ↑ plasma CORT levels. 
In EtOH pre-exposed during puberty animals (B), binge EtOH exposure increased the 
CRH and AVP mRNA in the PVN and enhanced an increase in plasma CORT levels 
after acute and binge EtOH exposures. These data indicate that binge EtOH exposure 
during puberty induces long lasting changes in functioning of the HPA axis.  
 
 
EtOH is a potent activator of the stress response as indicated by 
increased plasma CORT levels after both acute and binge treatments, however 
repeated doses over several days (i.e. binge-pattern) leads to an habituation 
effect (Przybycien-Szymanska, Rao et al. 2009). This same pattern has been 
observed with other types of psychological and physiological stressor (acute vs. 
chronic stress) in adult animals. Adult animals exhibit a high increase in CORT 
levels after exposure to a single predator stress however, after chronic homotypic 
stress this response is diminished (Figueiredo, Bodie et al. 2003). Herein, we 
have shown that animals exposed to acute or binge EtOH only during adulthood 
had increased plasma CORT levels and, as observed in pubertal animals, this 
effect was diminished following a binge-pattern of EtOH exposure indicating 
habituation of the HPA axis to the repeated homotypic stressor. By contrast, 
adult animals that received prior EtOH exposure during puberty not only had 
higher plasma CORT levels, but the habituation effect was not observed. These 
data indicate that after binge EtOH exposure during puberty, the HPA axis is not 
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only more sensitive to subsequent EtOH exposures but also that its normal ability 
to habituate to repeated stressors is compromised.  
These data are consistent with other studies that show adult EtOH 
exposure alters the expression of CRH and AVP in the PVN (Rivier and Lee 
1996; Ogilvie, Lee et al. 1997; Silva, Madeira et al. 2002; Silva, Paula-Barbosa et 
al. 2002). For instance, adult rats treated with a single 3g/kg EtOH dose had 
increased CRH and AVP mRNA in the PVN, whereas chronic dietary EtOH 
treatment reduced the number of AVP immunoreactive neurons in that same 
brain region (Silva, Madeira et al. 2002). Notably, the decreased AVP 
immunoreactivity was maintained 4 months after EtOH withdrawal in animals that 
received chronic dietary EtOH treatment, highlighting the potential for EtOH to 
exert a permanent effect on specific regulatory parameters of the HPA axis. We 
have shown previously that binge-pattern, but not acute, EtOH exposure during 
puberty increased both CRH and AVP mRNA in the PVN (Przybycien-
Szymanska, Rao et al. 2009). Contrary to what has been observed in other 
studies in adult EtOH naïve animals, (Ogilvie, Lee et al. 1997; Ogilvie, Lee et al. 
1997; Ogilvie, Lee et al. 1998), we did not observe an increase in the CRH 
mRNA levels in adult animals treated with acute EtOH exposure. This 
discrepancy is possibly due to differences in mRNA detection methods, as well 
as timing.  In our study, we measured CRH and AVP mRNA levels one hour 
following the last EtOH injection.  To our knowledge there are no other reports 
that have measured CRH and AVP gene expression this early following EtOH 
exposure.  In this study, we show that this increased gene expression persists 
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into adulthood regardless of subsequent EtOH exposure, although the molecular 
mechanisms mediating these long-term changes remain to be elucidated.  
Recent evidence suggests that acute alcohol exposure can interfere 
directly with CRH promoter activity to alter CRH gene transcription (Li, Kang et 
al. 2005). For example, Li et al., showed that alcohol decreased forskolin-induced 
increase in CRH promoter activity possibly by interfering at the cAMP response 
element (CRE) site in the NO108-15 cell line (Li, Kang et al. 2005).  In addition, 
recent evidence also suggests that EtOH can alter the DNA status (Pandey, 
Ugale et al. 2008) or glucocorticoid response element (GRE):DNA binding in 
different brain regions, including cortex and hippocampus, due to chromatin 
remodelling (Roy, Mittal et al. 2002), raising the possibility that epigenetic 
mechanisms might underlie the EtOH-induced long-term changes in CRH and 
AVP gene expression. Histone deacetylases (HDAC) have the ability to remove 
acetyl groups off the chromatin making DNA more dense and unavailable for 
transcriptional machinery (Grunstein 1997). Interestingly, Pandey at al. showed 
that HDAC activity was decreased following acute EtOH exposure (single 1g/kg 
injection of EtOH), yet increased after chronic EtOH exposure (15 days of 9% 
EtOH liquid diet) in adult animals (Pandey, Ugale et al. 2008). One possibility is 
that binge-pattern EtOH exposure during puberty induces remodelling of the 
chromatin surrounding the CRH and/or AVP genes thereby permanently altering 
the access of transcriptional regulators for these gene promoters.  
To my knowledge this is the first study showing the effects of adolescent 
binge EtOH exposure on adult HPA axis reactivity, however other reports have 
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demonstrated that pubertal EtOH exposure has long lasting effects on a variety 
of other CNS systems and brain regions, including the mesolimbic dopaminergic 
and glutaminergic system (Pascual, Boix et al. 2009), hippocampus, and 
cerebellum (Pascual, Blanco et al. 2007). Such changes in the CNS are often 
manifested by altered adult behaviour patterns (Maldonado-Devincci, Badanich 
et al.; Pascual, Blanco et al. 2007; Pascual, Boix et al. 2009). For example, 
Pascual et al. showed that 2 weeks of  intermittent EtOH administration (single IP 
injection of 3g/kg EtOH for two consecutive days, followed by 2 day rest, then 
followed again by 2 days of EtOH injections) caused an increase in voluntary 
EtOH consumption in adult animals (Pascual, Boix et al. 2009). In a different 
study, they also showed that this intermittent pattern of EtOH administration 
induced long lasting deficits in learning ability, as discerned by a decreased 
number of correct choices in conditional discrimination learning task, and a 
reduced ability to adapt to a challenging environment in adulthood in a narrow 
beam task (Pascual, Blanco et al. 2007). Our data showing parallel effects of 
peri-pubertal binge EtOH exposure to the effects of juvenile stressors on the 
adult HPA axis (Avital and Richter-Levin 2005) or juvenile/early puberty EtOH 
exposure on EtOH abuse in adulthood (Pascual, Boix et al. 2009) indicate that 
during the peri-pubertal period the HPA axis is still immature and extremely 
vulnerable to EtOH-induced insults (Zilberman, Tavares et al. 2003; McEvoy and 
Shand 2008). 
Physiological parameters of HPA axis, such as CORT and neuropeptide 
levels, are markedly different in response to both acute and chronic stressors in 
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juvenile compared with adult animals, suggesting that an extensive maturational 
process occurs during the pubertal transition (Jankord, Solomon et al.; Romeo, 
Lee et al. 2004; Romeo, Bellani et al. 2006; Romeo and McEwen 2006{Laroche, 
2009 #190; McCormick and Mathews 2007; Evuarherhe, Leggett et al. 2009; 
Evuarherhe, Leggett et al. 2009; Laroche, Gasbarro et al. 2009). Most striking is 
the observation that corticosterone and ACTH levels take much longer to return 
to baseline in juvenile compared to adult animals when subjected to a variety of 
stressful stimuli (Vazquez and Akil 1993; Romeo, Bellani et al. 2006).  Further, 
juveniles have higher overall stress reactivity (Romeo, Bellani et al. 2006) and 
chronic stress during puberty has been shown to result in an exaggerated stress-
induced CORT response in adulthood  (Jankord, Solomon et al.; Isgor, Cecchi et 
al. 2003). My results are consistent with these observations, as our animals pre-
exposed to binge-pattern EtOH had a similarly exaggerated response to a 
subsequent EtOH stressor during adulthood. It is important to note that there are 
some inconsistencies between studies depending on the type of stressor and the 
specific paradigm (i.e. homotypic vs. heterotypic, chronic vs. acute).  
Consequently, the effects of EtOH on the HPA axis during adolescence may not 
necessarily be reflective of other types of stressors.  Nevertheless, these data 
contribute to the growing body of evidence that perturbations to the HPA axis 
during this critical period of pubertal development can potentially have long 
lasting consequences for the adult stress response.  
We are confident that the effects observed here on the expression of the 
AVP mRNA are specific to changes in the population of cells located in the 
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pPVN, and not to the magnocellular region.  First, our data are consistent with 
our previous report showing no changes in the AVP mRNA expression in SON, a 
region largely responsible for maintaining osmotic homeostasis (Przybycien-
Szymanska, Rao et al. 2009).  Second, our data are also consistent with other 
reports showing that EtOH induced changes only in AVP-expressing neurons 
located in the pPVN, and not mPVN (Silva, Paula-Barbosa et al. 2002). Finally, 
the diuretic effects of EtOH are rapid and transient, making it unlikely to 
contribute to long lasting changes in AVP expression in the PVN. 
 Binge alcohol consumption among adolescents is a fundamental problem 
and mood disorders among both young and adult populations are increasing, 
therefore elucidating the long lasting consequences of binge EtOH exposure 
during adolescence is critical for understanding the aetiology of certain mood 
disorders. In this study we have identified long lasting effects of binge pattern 
EtOH exposure during peri-puberty on the central regulators of the HPA axis, 
CRH and AVP, and on the adult stress response. We have shown that adults 
who were exposed to a binge-pattern of alcohol during pubertal development 
have increased stress responses after subsequent alcohol exposure.  
Dysregulation of the HPA axis has been shown to be predictive of developing 
mood disorders however more experiments, such as introducing a novel stressor 
and measuring behavioural outcomes, are needed to determine if there is a 
direct link between binge-pattern alcohol exposure and the development of mood 
disorders. Overall, these data have identified yet another system and additional 
molecular targets that are affected long term by adolescent alcohol exposure and 
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may lead to better understanding of factors that regulate HPA axis maturation 
during pubertal development.
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Chapter Six 
 
 
FINAL DISCUSSION 
 
 
Summary 
Our current understanding of how binge alcohol consumption affects the 
developing adolescent brain is severely limited. To date, specific molecular and 
neuroendocrine markers that are activated by alcohol during puberty and long 
lasting consequences of this pattern of alcohol exposure during this critical time 
period of development have not been identified. Elucidating the neurobiological 
targets of EtOH resulting from a binge pattern of EtOH consumption during 
adolescence is critical for understanding the long-term molecular and behavioral 
consequences of binge EtOH exposure and potential mechanisms that may be 
involved in development of mental health disorders. Therefore, the major goal of 
studies presented herein was to investigate the long lasting effects of binge EtOH 
exposure during puberty on the sensitivity of adult HPA axis to EtOH exposures 
in adulthood, as well as short term effects of this pattern of EtOH exposure and 
possible molecular mechanisms involved in these effects. In addition, in these 
studies I sought to investigate potential mechanisms responsible for observed 
sex differences in EtOH induced alteration of the HPA axis.  
Based on my data, I can conclude that my hypothesis, that in males, binge 
pattern EtOH exposure during pubertal development dysregulates functioning of
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adult HPA axis and that this effect is caused by long lasting changes in the PVN 
expression of CRH and AVP during adolescence mediated by direct actions of 
EtOH at the level of the CRH promoter, has been supported. (see Table 4 for 
summary of major findings).
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SUMMARY OF MAJOR FINDINGS 
Chapter 2. Effects of binge alcohol exposure in adolescence 
 Males (PND 37-44):  
- Binge EtOH INCREASED CRH and AVP mRNA in the PVN 
- Acute and Binge ETOH INCREASED plasma CORT levels, 
habituation effect after binge 
 
Females (PND 37-44) 
- NO CHANGES in the CRH and AVP mRNA in the PVN after EtOH 
treatmnet  
- Acute and Binge EtOH INCREASED plasma CORT levels, habituation 
effect after binge 
 
Chapter 3. Molecular mechanisms behind alcohol effects 
- 12.5 and 100 mM EtOH ↓ CRH promoter activity at 0.5 h 
- 12.5 and 100 mM EtOH EtOH ↑ CRH promoter activity at 2.0 h 
- An increase in the promoter activity at 2.0 h is dependant on the 
nGRE and CRE sites 
 
Chapter 4. Mechanisms behind sex differences 
 Ch-treated females (PND 37-44) 
- Binge EtOH ↓ CRH and AVP mRNA in the PVN 
- Acute and binge EtOH ↑ plasma CORT levels, no habituation after 
binge 
 
E2-treated females (PND 37-44) 
- NO CHANGES in the CRH and AVP mRNA after EtOH treatmnet 
- habituation effect after binge EtOH exposure  present 
 
Chapter 5. Long lasting consequences of binge alcohol exposure during puberty 
 EtOH naïve males (PND 68-74) 
- NO CHANGES in CRH mRNA levels in the PVN due to EtOH 
treatmnets 
- Acute and Binge EtOH ↑ plasma CORT levels, habituation effect after 
binge EtOH exposure present 
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SUMMARY OF MAJOR FINDINGS c.d. 
EtOH pre-exposed males (PND 68-74) 
- Acute EtOH in adulthood ↑ CRH and AVP mRNA in the PVN (as 
compared to EtOH naïve) 
- Pubertal binge EtOH exposure ↓ basal plasma CORT levels (as 
compared to EtOH naïve) 
- Pubertal binge EtOH exposure resulted in ENHANCED ↑ in plasma 
CORT after subsequent acute and binge EtOH exposures in adults 
- No habituation effect after subsequent binge EtOH in adults 
 
 
Table 4. Summary of major findings. Data compared to saline treated controls. In EtOH 
pre-exposed group data compared to EtOH naïve group.  
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Data presented in this report clearly show that binge pattern EtOH 
exposure during peri-pubertal development induces changes in CRH and AVP 
gene expression in the PVN, the main brain region responsible for coordinating 
stress responses, and circulating CORT levels. I showed that the effects of binge 
EtOH exposure are sexually dimorphic and that these sex differences are 
mediated by E2. In peri-pubertal females, E2 is responsible for maintaining basal 
levels of CRH and AVP mRNA in the PVN even after binge EtOH exposure and 
for the observed habituation effects after binge EtOH exposure. In addition, I 
showed that EtOH-nGRE-CRH DNA interaction disrupt normal glucocorticoid 
negative feedback exerted at the level of the CRH promoter in a PVN derived cell 
line. Lastly, I showed that the changes observed during peri-puberty are long 
lasting and result in dysregulation of functioning of adult HPA axis. Notably, in 
peri-pubertal male rats binge EtOH exposure increased CRH and AVP mRNA in 
the PVN in a permanent fashion and this permanent alteration in the HPA axis 
resulted in dysregulation of the HPA axis in adulthood.  Normal maturation of the 
HPA axis that should occur during pubertal development was compromised by 
binge EtOH exposure during peri-puberty because binge EtOH exposure during 
this time period resulted in more sensitive/dysregulated HPA axis in adulthood. 
Based on these data, I can speculate that this long lasting binge-EtOH-exposure-
induced HPA axis dysregulation may result in mood disturbances in adulthood 
and may lead to increased risk for developing mood disorders in adulthood.  
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Final considerations 
Binge alcohol exposure and magnocellular PVN and SON systems 
Although it was not possible to separate the parvocellular and 
magnocellular divisions of the PVN in my tissue microdissection sample 
preparations, I am confident that the EtOH-induced changes in the AVP 
expression in all experiments presented here, accurately reflect changes in the 
AVP-expressing neurons associated with regulation of the HPA axis, and not in 
those responsible for osmoregulation for the following reasons. First, I showed 
that there were no changes in the expression of the AVP mRNA in the SON, a 
region where AVP is primarily responsible for regulating fluid homeostasis, both 
in adolescent male and female rats as well as in adult male rats. Second, there 
was no effect of EtOH in either peri-pubertal or adult acute-treated groups and 
since fluid homeostasis is an immediate and not cumulative physiological 
response, any diuretic effect of EtOH would have been observed in the acutely 
treated groups. Third, if the effects of EtOH on the AVP expression were due to 
an osmoregulatory effect, I would have expected to see a significant increase in 
the AVP mRNA in the PVN of peri-pubertal females, as well as peri-pubertal and 
adult males. Fourth, the diuretic effects of EtOH are rapid and transient, making it 
unlikely to contribute to any long lasting changes in AVP expression in the PVN 
and finally, my data are in agreement with previous studies showing that there 
were no changes in AVP expression in the magnocellular division of the PVN 3.0 
h after an acute EtOH administration (Ogilvie, Lee et al. 1997).  
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The only time when I observed binge EtOH exposure induced changes in 
the AVP mRNA in the SON were in ovariectomized peri-pubertal females 
replaced with Ch. In these females, binge EtOH exposure decreased the AVP 
mRNA expression in the SON. This effect could be explained in two ways. First, 
data showing decreased AVP mRNA in the SON is consistent with diuretic 
effects of EtOH on the AVP as the AVP is mostly known as antiduretic hormone 
(ADH). This explanation is highly unlikely because of the reasons described in 
the previous paragraph. Second, based on previous reports, I can speculate that 
EtOH induced changes in the PVN could influence gene expression in the SON. 
EtOH could induce cell death in the PVN which would result in a decreased 
expression of AVP mRNA in the SON. This explanation is consistent with 
previous reports showing that the AVP mRNA in the SON is decreased following 
EtOH exposure but only in rats bearing PVN lesions (Ogilvie, Lee et al. 1997) 
and AVP is neuroprotective in a PVN derived neuronal cell line (H32) (Chen, 
Volpi et al. 2008; Chen, Liu et al. 2009).  Addition of the AVP to the media was 
found to protect against serum starvation induced apoptotic cell death in these 
neurons (Chen, Volpi et al. 2008; Chen, Liu et al. 2009). EtOH induced cell death 
in the PVN could be responsible for a decrease in the AVP mRNA in the PVN in 
Ch-treated females. It is likely that this decrease in the AVP mRNA in the PVN 
resulted in a decrease in the AVP mRNA in the SON as the functions of these 
two nuclei have been shown to be linked (Ogilvie, Lee et al. 1997). The 
cooperation between both magnocellular and parvocellular AVP systems needs 
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to be further investigated in order to support this hypothesis even though this 
explanation at this moment seems to be most likely.  
Overall, these data indicate that in intact peri-pubertal and adult animals 
EtOH induced changes in the PVN are not due to diuretic effects of EtOH on the 
magnocellular division of the PVN and are specific to regulation of the HPA axis. 
 
Body weight changes after EtOH treatments. 
In males treated with binge EtOH exposure during puberty and then again 
in adulthood, data showed that pubertal binge-pattern EtOH exposure retarded 
the rate of weight gain as compared to their saline treated counterparts.  This 
effect persisted into adulthood and resulted in adult animals that were 
significantly smaller than controls. It is important to note that these animals did 
not lose weight, but rather gained at a slower pace. Interestingly, this weight gap 
persisted throughout the period of one month during which animals were 
undisturbed and throughout adult EtOH treatments which had no further effects 
on the growth rate of animals. This growth rate retardation could be explained by 
following reasons. First, it is well known that both animals and humans undergo a 
growth spurt during pubertal development marked by an increase in muscle and 
bone mass (Gregory, Greene et al. 1992; Soliman, Khadir et al. 1995; Mauras, 
Rogol et al. 1996; Schoenau 2006; Venken, Moverare-Skrtic et al. 2007; 
Pradidarcheep and Showpittapornchai 2009) . In these experiments, binge EtOH 
treatment occurred during puberty and possibly during the critical period for 
weight gain. Alcohol is known to decrease bone and muscle mass (Callaci, 
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Himes et al.; Elmali, Ertem et al. 2002; Lauing, Himes et al. 2008; Alvisa-Negrin, 
Gonzalez-Reimers et al. 2009; Callaci, Himes et al. 2009), therefore it is possible 
that if EtOH exposure occurred during pubertal maturation, it hindered muscle 
mass and possibly bone gain and resulted in a permanent decrease in body 
weight. This critical period hypothesis is consistent with the fact that in adult 
animals, not undergoing growth spurt, binge EtOH exposure did not further cause 
growth retardation. Second, it is also possible that EtOH effects on sex steroid 
hormones were involved in the weight gain retardation observed. T levels 
increase markedly during puberty (Huhtaniemi, Nevo et al. 1986; Delemarre-van 
de Waal, van Coeverden et al. 2002; Evuarherhe, Leggett et al. 2009; 
Pradidarcheep and Showpittapornchai 2009) and T increased muscle tone 
contributes to the weight gain during pubertal development (Soliman, Khadir et 
al. 1995; Schoenau 2006; Pradidarcheep and Showpittapornchai 2009). I 
showed in peri-pubertal male rats that binge EtOH exposure decreased plasma T 
levels (Przybycien-Szymanska, Rao et al. 2010). This EtOH-induced decrease in 
plasma T levels could contribute to the slower weight gain in male rats that were 
exposed to binge EtOH during puberty. This weight difference was not observed 
in any of my previous studies most likely due to the shorter experimental time 
period and a smaller number of animals per treatment group. Lastly, it is also 
possible that in pubertal animals, binge-EtOH-exposure-induced elevated CORT 
levels inhibited feeding behavior. It is well established that during stress, elevated 
plasma CORT levels ingibit feeding behavior and cause muscle wasting (Tomas, 
Munro et al. 1979; Sapolsky, Romero et al. 2000). Binge EtOH exposure by 
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cousing elevation in plasma CORT levels could contribute to permanent 
decrease in body weight possible due to decreased food intake and increased 
muscle wasting during the growth spurt of animals. Together, these data support 
the notion that puberty is extremely vulnerable to alcohol abuse and effects of 
binge drinking during this developmental period can not only be manifested at the 
level of the central nervous system, but also can potentially disrupt normal 
homeostatic metabolic processes.  
 
Additional notes about the binge EtOH exposure paradigm 
This binge EtOH exposure paradigm employed in all of the studies 
presented herein was very useful because it allowed us to distinguish the 
pharmacological effects of EtOH from the effects of other nonspecific stressors, 
such as handling and injections. A similar binge EtOH exposure paradigm has 
been previously shown to be reliable for testing the effects of alcohol using an 
exposure pattern that is typical for adolescents (Lauing, Himes et al. 2008) . In 
addition, it has been show that the IP injection of EtOH, employed in my 
paradigm, does not appear to result in significantly different BAC compared to 
oral gavage in adolescent Wistar rats (Walker and Ehlers 2009), therefore the IP 
route of administration has been chosen as the least stressful method. 
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Future Directions 
Data presented herein add a substantial amount to our knowledge of 
consequences of alcohol exposure in adolescence, however, there are many 
more questions that remain unanswered.  
First, a direct link between binge EtOH exposure in adolescence, 
dysregulation of the HPA axis in adulthood, and the development of mood 
disorders in adulthood needs to be established. In studies presented herein, I 
have identified long lasting effects of binge pattern EtOH exposure during peri-
puberty on the central regulators of the HPA axis, CRH and AVP, and on adult 
stress response measured by plasma CORT levels. I have shown that adults 
who were exposed to a binge-pattern of EtOH during pubertal development have 
increased stress responses after subsequent EtOH exposure.  Dysregulation of 
the HPA axis has been shown to be predictive of developing mood disorders 
however more experiments, such as introducing a novel stressor and measuring 
behavioural outcomes, are needed to determine if there is this direct link between 
binge-pattern EtOH exposure during puberty and the development of mood 
disorders in adulthood. In the future, I would like to measure anxiety-like 
behaviors in adult animals exposed to “binging” during puberty using a variety of 
behavioral methods, including elevated plus maze, light-dark box and open field 
test. I would also like to test whether animals pre-exposed to binge EtOH during 
peri-puberty are more sensitive to other types of stressors, for example restraint 
stress, by measuring their CORT responses and changes in CRH and AVP 
mRNA expression after the stressor. These data would not only give me a direct 
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and clear link between binge alcohol consumption in adolescence and increased 
risk for developing mood disorders in adulthood, but would also strengthen my 
argument that binge drinking during adolescence has detrimental consequences 
for proper maturation of the HPA axis.  
Binge EtOH exposure has sex specific effects on the pubertal HPA axis. 
One very important question that still remains unanswered is whether females 
are protected from long lasting detrimental effects of binge EtOH exposure 
because they do not exhibit the same changes in gene expression as males or is 
EtOH exposure during puberty more detrimental for females. In the future, I 
would like to investigate the CRH and AVP mRNA expression in the PVN as well 
as changes in circulating CORT levels in adult females pre-exposed to binge 
EtOH during puberty and compare these changes with changes occurring in 
males. If binge EtOH exposure in peri-pubertal females also induces long lasting 
changes in functions of the HPA axis, the next step would be to investigate 
anxiety-like behaviors and responses to heterotypic stressors in these females. 
Results of these experiments would tell us if pubertal females are more 
susceptible to the detrimental effects of alcohol and they could lead us to a better 
understanding of the mechanisms behind these sex differences.  
17β-estradiol is partially responsible for sex differences in the 
responsiveness of pubertal HPA axis to binge EtOH exposure; however, it is not 
the only factor involved. In ovariectomized females replaced with Ch, there was a 
decrease in the CRH and AVP mRNA in the PVN and SON which is contrary to 
what was observed in intact peri-pubertal males. Further studies in 
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ovariectomized females replaced with other steroid hormones, for instance T or 
its metabolites need to be performed in order to better understand the 
mechanisms behind these sex differences. In these experiments, plasma CORT 
levels and PVN expression of CRH and AVP mRNA would be measured in 
ovariectomized females replaced with T or DHT and these effects would be 
compared to ovariectomized females replaced with E2 or cholesterol. In addition 
to these in vivo experiments, to better understand the interactions between EtOH 
and sex steroid hormones, CRH promoter activity would also be measured after 
EtOH treatment in the presence of androgen receptor agonists.  
I showed that EtOH-GR signaling is responsible for the EtOH-induced 
increase in CRH promoter activity and possibly CRH mRNA expression in the 
PVN, although it is still not clear what causes a decrease in the promoter activity 
at the 0.5 h time point, as GR antagonist treatment and deletion of specific GR 
binding sites within nGRE site did not abolish this decrease. I would like to 
investigate EtOH-induced changes in upstream signaling molecules and changes 
in early response genes as these may be involved in this initial decrease in the 
promoter activity. Some possible target molecules may be kinases that affect 
cAMP signaling (PKA) or small ubiqitin-related modifiers (SUMO) that may affect 
GR induced changes in the CRH promoter activity and gene transcription. For 
example, it has been shown that SUMO-1 can increase the GR stability and 
increase GR transcriptional activity (Le Drean, Mincheneau et al. 2002) therefore 
the effects of EtOH on SUMO need to be investigated. We also need to 
investigate the interaction of EtOH with GABA signaling using EtOH treatment in 
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the presence of GABA receptor agonists and antagonists as GABAergic inputs to 
the PVN are major inhibitory inputs to the PVN (Cole and Sawchenko 2002). It is 
possible that at the 0.5 h time point, EtOH strengthens this GABA inhibition and 
results in decreased CRH promoter activity. Another possibility is that AVP 
mediates the decrease in CRH promoter activity at the 0.5 h time point. It has 
been shown that a rapid and local release of AVP has an inhibitory tone on the 
HPA axis and this effect is mediated through AVP R1 (Wotjak, Kubota et al. 
1996). Therefore, it is possible that EtOH affects AVP receptors to inhibit CRH 
promoter activity. I would like to investigate the effects of EtOH in the presence of 
AVP, AVP receptors and AVP R agonist and antagonist to test for possible 
interactions between AVP and EtOH on the CRH promoter. 
To strengthen my hypothesis that EtOH interferes with GR:DNA binding, I 
would also like to investigate these interactions in the presence and absence of 
EtOH in vivo and in vitro  using chromatin immunoprecipitation assay (ChIP). 
Even though it has been shown in vivo, that EtOH decreases GR-DNA binding in 
the hippocampus (Roy, Mittal et al. 2002), this effect needs to be confirmed in the 
PVN derived cells. If there was a decrease in the GR-CRH DNA binding after 
EtOH treatment in both in vitro and in vivo, this would confirm my hypothesis that 
EtOH induced increase in CRH promoter activity is mediated by EtOH induced 
decrease in GR-CRH DNA binding. 
My in vitro data describe mechanisms involved in EtOH-induced changes 
in the CRH promoter activity and potentially CRH mRNA. In addition to CRH, my 
in vivo data identified yet another target of EtOH actions in the PVN, which is 
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AVP. It would be important in the future to investigate molecular mechanisms 
behind EtOH effects on this neuropeptide as they may be different from the 
mechanisms described for CRH. Time course experiments would need to be 
performed in order to investigate if EtOH can directly modulate AVP promoter 
activity and if yes, it would be important to investigate effects of EtOH on AVP 
promoter activity in AVP promoter lacking specific regulatory sites. It is possible 
that mechanisms behind EtOH-induced changes in the AVP mRNA are different 
from mechanisms responsible for changes in the CRH mRNA, however,  it is 
very likely that EtOH exerts similar effects on this promoter as the AVP promoter 
also contains GRE site and CRE site and is regulated at these sites in the same 
way as the CRH promoter (Iwasaki, Oiso et al. 1997; Kim, Summer et al. 2001; 
Yoshida, Iwasaki et al. 2006). 
     
Take Home Message 
My data clearly show that binge EtOH exposure has detrimental 
consequences for the adult HPA axis. Even though more experiments need to be 
performed in order to support this conclusion, binge alcohol consumption in 
adolescence may lead to increased risk for developing mood disorders in 
adulthood. 
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CHAPTER SEVEN 
GENERAL METHODS 
 Animals 
Male and female Wistar rats were purchased from Charles River 
Laboratories (Wilmington, MA) at weaning (post natal day (PND) 23) and allowed 
to acclimate to the new environment for several days after arrival. Pre-pubertal 
females on PND 26, were bilaterally ovariectomized and replaced with silastic 
capsules containing either 17β-estradiol (E2) or cholesterol (Ch). On PND 30, 
animals were handled 5 min/day for 7 days. EtOH treatments begun on PND 37. 
Animals were housed on a 12 h light 12 h dark cycle with lights on at 07.00h. 
Food and water were available ad libitum and all procedures were approved by 
the Loyola University Medical Center Institutional Animal Care and Use 
Committee (IACUC). 
 
Binge Exposure Paradigm. 
After one week of handling, animals were divided into one of 4 groups and 
begun the following treatments: 1) UNTREATED 2) SALINE ONLY 
(intraperitoneal (ip) saline injection once/day for 8 days), 3) ACUTE EtOH (saline 
injection once/day for 7 days; one 3g/kg EtOH injection on day of sacrifice), 4) 
BINGE EtOH (intraperitoneal (IP) 20% (v/v in saline) (Fig 2) EtOH injection every 
morning at 10:00 AM for 3 consecutive days, followed by 2 days of saline 
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injections, and then injected for additional 3 days with EtOH). A similar binge 
exposure paradigm has been used previously to mimic the pattern of binge EtOH 
consumption in adolescents (Lauing, Himes et al. 2008). It has been shown that 
this route of EtOH administration does not yield statistically different BAC 
compared to oral gavage (Walker and Ehlers 2009). 
 Importantly, the animals were given EtOH in the morning.  Previous 
studies showed that morning EtOH administration does not interfere with normal 
feeding behaviour and does not result in body weight differences between EtOH-
treated and control animals, thus eliminating the need for pair-fed controls 
(Lauing, Himes et al. 2008; Przybycien-Szymanska, Rao et al. 2009).  On the last 
day of pubertal or adult treatments, one hour after the injection, animals were 
sacrificed by decapitation under Halothane anesthesia and trunk blood and 
brains were collected.  
 
Blood alcohol concentration (BAC) measurements:  
Trunk blood samples were collected into heparinised tubes, centrifuged at 
3000 rpm for 10 min. at 4ºC; and plasma stored at -20ºC. Blood alcohol levels 
were determined by measuring the change in absorbance at 340 nm following 
enzymatic oxidation of EtOH to acetylaldehyde (Point Scientific Alcohol Reagent 
Kit). Assay range is 0 to 400 mg/dl and intra and interassay CV = 8.9% and 
7.86%, respectively.   
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Hormone measurements:  
Blood samples were collected into heparinized tubes, centrifuged at 3000 
rpm for 10 min at 4ºC and plasma stored at -20ºC. For the testosterone (T) EIA 
kit, the range of detection was between 3.9 – 500 pg/ml and for the estradiol (E2) 
kit the range of detection was 8.6 – 4000 pg/ml.  
In intact peri-pubertal males and females plasma levels of testosterone (T) 
and E2 were measured using commercially available EIA kit (Cayman Chemical 
Company, Ann Arbor, MI), respectively, according to manufacturer’s instructions. 
In ovariectomized females replaced either with Ch or E2, plasma E2 levels were 
measured by Endocrine Technology and Support Laboratory at the Oregon 
National Primate Center at the Oregon Health Science University (Protland, OR) 
where E2 Extraction-Chromatography-RIA was performed by Dr. K.-Y. Francis 
Pau and colleagues. For E2 RIA reported intraassay and interassay CVs were 
12% and 18%, respectively.  
To measure CORT, 3I-CORT (PerkinElmer, Waltham, MA) and rabbit 
CORT antiserum (MP Biomedicals, Solon, OH) were used to perform RIA. On 
the first day of the procedure, a standard curve was prepared using CORT-
standards (4-PREGNEN, 11b, 21-DIOL-3,20-DIONE-Steraloids, Inc). Appropriate 
sample tubes were filled with 100 µl of a sample, 100 µl of antibody solution (in 
0.1% gel PBS), and 100 µl diluted radioactive tracer (10-12000 cpm). Tubes 
were incubated overnight at 4ºC. On the second day, all tubes were filled with 
100 µl of 0.5% gel PBS, 1 ml Dextran-Coated Charcoal (DCC), and 1.0 ml 0.01 
M PBS. Samples were centrifuged at 3000 rpm at 4ºC for 15 min and the 
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supernatant was collected into scintillation vials. Radioactivity was measured in 
each vial for 3 min. using Packard liquid scintillation counter. Levels of CORT in 
unknown samples were interpolated based on the standard curve. Intra and 
interassay CV were 4.96% and 7.93%, respectively.  
To measure ACTH levels, 125I-ACTH (DIASORIN, Stillwater, MN), rabbit 
IgG-ACTH-I primary antibody (Ig Corp, Nashville, TN ) and goat anti-rabbit G-
globulin secondary antibody (CalBiochem, San Diego, CA) were used to perform 
RIA. On the first day of the procedure, a standard curve was prepared using 
ACTH stock-human (1-39) obtained from BACHEM (Torrance, CA). Appropriate 
sample tubes were filled with 90 or 50 µl of BSA Buffer (0.01M Phospate Buffer 
Saline (PBS), 0.15 M NaCl, 1% BSA, 0.15% Triton-X-100, 250 KIU/ml Aprotinin, 
pH7.6), 10 or 50 µl of sample for high and low hormone concentration 
measurements, respectively and 100 µl of primary antibody solution (20 µl IgG-
ACTH-I primary antibody in 100 ml of EDTA buffer (0.01 M PBS, 0.15 M NaCl, 
0.05 M EDTA, 1% normal rabbit serum, 2.6 ml Aprotinin, pH7.6)). Tubes were 
incubated for 24.0 h at 4ºC. On a second day, tubes were filled with 100 µl 
diluted radioactive tracer (2000 cpm ± 10%), gently vortexed and incubated for 
72.0 h at 4ºC. On the third day of the assay, 100 µl of goat anti-rabbit G-globulin 
secondary antibody solution (1:20 dilution in 0.01 M PBS buffer (0.15 M NaCl, pH 
7.6) was added to each tube, except for tubes containing tracer alone (total 
radioactivity tubes) and incubated at 4ºC for 16.0 h. On the fourth day, 1.5 ml of 
0.01 M PBS was added to each tube (except total radioactivity tubes) and tubes 
were centrifuged for 40 min at 3000 rpms at 4ºC. Supernatant was decanted and 
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radioactivity was counted for 5.0 min using gamma counter and levels of ACTH 
in unknown samples were interpolated based on the standard curve. Intra and 
interassay CV were 4.94% and.14.6 %, respectively. 
 
Tissue collection and qRT-PCR:  
After sacrifice, brains were rapidly collected and frozen using isopentane 
and stored at -80ºC until further processing. Tissue collection and qRT-PCR were 
performed as previously reported (Przybycien-Szymanska, Rao et al. 2009). 
Briefly, frozen brains were sectioned at 200 µm on a freezing microtome and the 
paraventricular (PVN) and supraoptic (SON) nuclei were microdissected using a 
0.75 mm Palkovit’s brainpunch tool (Stoelting Co., Wood Dale, IL). The specificity 
of the microdissected regions was confirmed using The Rat Bran in Stereotaxic 
Coordinates, Fourth Edition Atlas (G. Paxinos and C. Watson). The PVN was 
microdissected  taking an 0.75 mm area on each side of the third ventricle 
between 0.8 mm and 2.12 mm posterior to Bregma 8 mm below the top of the 
brain (Smith, Gardiner et al. 2008) (see Fig 33 for schematic localization of the 
PVN). The SON was microdissected taking a 0.4 mm area 9.5 mm below the top 
of the brain between 0.8 mm and 3.14 mm posterior to Bregma. Total RNA 
isolation was performed on sonicated tissue samples using Trizol reagent 
(Invitrogen Inc., Carlsbad, CA) according to the manufacture’s directions. 
Following RNA isolation, 0.5 µg total RNA was reverse transcribed using the First 
Strand Synthesis SuperMix for qRT-PCR (Invitrogen Inc., Carlsbad, CA). Roche 
FastStart SYBR Green Master Mix was added to intron-spanning AVP specific 
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upper and lower AVP primer (0.25 µM final concentration; 5-
GGGCAGGTAGTTCTCCTCCT; 5-CACCTCTGCCTGCTACTTCC) and intron-
spanning CRH primer (0.25 µM final concentration; 5-
GAGAAAGGGGAAAGGCAAAG; 5-ATCAGAATCGGCTGAGGTTG). Then, 2 µL 
cDNA templates were added to duplicate reactions performed in 96 well plates. 
Quantification of the target gene expression was achieved by extrapolating from 
standard curve of known concentrations of AVP or CRH run simultaneously in 
the same plate. All samples were normalized to the hypoxanthine guanine 
phosphoribosyl transferase 1 (HPRT) housekeeping gene, as it is not altered by 
EtOH treatment (Przybycien-Szymanska, Rao et al. 2009). 
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Fig 33. Representative diagram depicting the brain area microdissected (circle) for the 
PVN. Scale Bar = 1mm. Adjusted from The Rat Bran in Stereotaxic Coordinates, Fourth 
Edition Atlas (G. Paxinos and C. Watson).  
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qRT-PCR for GR expression in IVB cells 
 
GR gene expression levels were measured in IVB cells after EtOH 
treatment. Cells were plated at the density of 200, 000 cells/well in clear 6-well 
plate until they achieved final confluence of 90%. At that time (approximately 
72.0 h later) cells were treated with 100 mM EtOH or vehicle for 0.5 or 2.0 h. 
After appropriate treatment times, cells were washed 2 times with cold PBS and 
1 ml of Trizol was added to each well. Total RNA isolation was performed on 
sonicated samples using Trizol reagent (Invitrogen Inc., Carlsbad, CA) according 
to the manufacture’s directions. Following RNA isolation, 0.5 µg total RNA was 
reverse transcribed using the First Strand Synthesis SuperMix for qRT-PCR 
(Invitrogen Inc., Carlsbad, CA). Roche FastStart SYBR Green Master Mix was 
added to GR specific upper and lower primer (0.25 µM final concentration; 5-
AAACCTCAATAGGTCGACCAGCGT; 5-AGGTGCTTTGGTCTGTGGGATACA). 
Then, 2 µL cDNA templates were added to duplicate reactions performed in 96 
well plates. Quantification of the target gene expression was achieved by 
extrapolating from standard curve of known concentrations of the hypoxanthine 
guanine phosphoribosyl transferase 1 (HPRT) housekeeping gene ran 
simultaneously in the same plate. All samples were normalized to the HPRT 
housekeeping gene, as it is not altered by EtOH treatment (Przybycien-
Szymanska, Rao et al. 2009). 
 
Cell Culture 
 
 The IVB cell line, derived from the rat hypothalamic PVN, was used for all 
transient transfections (generously provided by Dr. John Kaskow, University of 
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Cincinnati) and was verified to be free of mycoplasma contamination (data not 
shown, MycoSensor QPCR, Stratagene/Agilent Technologies). Cells were 
maintained in DMEM containing 4.5% glucose and L-glutamine (HyClone 
Labolatories, Logan, UT) supplemented with 10% fetal bovine serum. Cells were 
grown to 90% confluence and all transient transfections were performed within 
10 passages. 
 
Reporter gene constructs and expression vectors 
 
The full-length CRH promoter was generously provided and validated by 
Dr. Audrey F. Seasholtz (University of Michigan, Ann Arbor, MI) and then 
modified as follows. The full- length promoter fragment (-2125/+94) was excised 
from the pUC18 vector by restriction enzyme digestion for EcoR1 (5’) and 
HINDIII (3’) and subsequently subcloned into the promoterless luciferase vector 
(pGL3 basic, Promega Corp., Madison, WI). The pRL-tk-luciferase reporter 
vector (Promega Corp., Madison, WI) was used as an internal control for 
calculating plasmid transfection efficiency.  
 
Transient Transfections and Dual Luciferase Assay:  
 
Cells were plated at the density of 20, 000 cells/well in opaque 96-well 
plate for 24 hours prior to transfection to achieve a final confluence of 70-90%. 
Transient transfections were performed in replicates of 6 wells/plate for each 
construct/treatment and each assay was repeated minimum of 6 times (N=6). 
Transfections were achieved using a lipid-mediated transfection reagent, 
  
176 
 
Fugene6 (Roche Molecular Biomedical, Indianapolis, IN) according to 
manufacturer’s instructions. Twenty-four hours following transfection, cells were 
treated (see below) and then processed for luciferase assays (Dual Luciferase 
Reporter (DLR) kit (Promega Inc., Madison, WI). Briefly, cells were lysed in 20 µl 
of lysis buffer, incubated on a shaker for 20 min at room temperature and then 
loaded into a multiple well plate reader (Synergy HT, Biotech). The plate reader 
is equipped with dual injectors and automatically dispensed 100 µl firefly 
luciferase substrate (LARII) followed by “stop-and glo” substrate for renilla 
luciferase. Results were analyzed using Gen5 software (Biotech Inc., Winooski, 
VT).  
 
EtOH and Hormone Treatments 
 
Twenty-four hours after transfection with the CRH promoter, cells were 
incubated with varying concentrations of EtOH (12.5, 25.0, 50.0 or 100 mM) 
diluted in 10% FBS media (vehicle) for 2.0 h (dose response), or  they were 
treated with 100 mM EtOH for either 0.5, 1.0, 2.0 or 4.0 h (time course). Cells 
transfected with the mutated CRH promoter that lacked specific GR regulatory 
regions were treated with 12.5 mM EtOH or vehicle for 2.0 h or, in control 
experiments, they were treated with 25 µM Forskolin for 6.0 h. In another set of 
experiments, 8.0 h after transfections with WT CRH promoter, cells were 
incubated in 10 nM E2 or vehicle. 16.0 h after hormone treatments, cells were 
treated with 10 nM E2 in the presence or absence of 100 mM EtOH for 2.0 h.  
The glucocorticoid receptor (GR) antagonist, RU486, was used in cell 
culture in the presence of EtOH in order to test if GRs are involved in EtOH 
  
177 
 
effects on the CRH promoter. RU486 antagonistic properties are achieved by 
corepressor recruitment to the GR-DNA complex and inhibition of gene 
transctiption. It has been shown that in the presence of RU486 DNA binding to 
GR still occurs but when RU486 is in a bound state, protein named nuclear 
corepressor (NCoR) is recruited to the N terminus of the GR and the DNA 
transcription is prevented. (Rajpert, Lemaigre et al. 1987; Schulz, Eggert et al. 
2002). 8.0 h after transfections with WT CRH promoter, cells were incubated in 
100nM RU
 
or vehicle. 16.0 h after hormone treatments, cells were treated with 
100nM RU486
 
in the presence or absence of 100 mM EtOH for 0.5, 1.0, 2.0 or 
4.0 h.  
 
Site-Directed Mutagenesis.  
 
Scanning mutagenesis deletions were performed on the CRH promoter 
using the QuickChange II XL kit according to manufacturer’s instructions 
(Stratagene, LaJolla, CA). Briefly, forward and reverse primer sequences were 
designed targeting the appropriate identified regions of the promoters (GR 1, (5’-
CTTGGATAATCTCATTCAAGAACAATGGACAAGTCATAAGAGC-3’; 5’-
GAACCTATTAGAGTAAGTTCTTGTTACCTGTTCAGTATTCTTCG-3’) GR 2 (5’-
CTCATTCAAGAATTTTTGTCAACAAGTCATAAGAAGCCCTTCCA-3’; 5’-
GAGTAAGTTCTTAAAAACAGTTGTTCAGTATTCTTCGGGAAGGR-3’), GR 3 
(5’-TTTGTCAATGGACAAGTCAGCCCTTCCATTTTAGGG-3’; 5’-
AAACAGTTACCTGTTCAGTCGGGAAGGTAAAATCCC-3’), GR1 and 2 double 
deletion (5’-GGATAATCTCATTCAAGAACAAAGTCATAAGAAGCCCTTCCA-3’; 
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5’TGGAAGGGCTTCTTATGACTTTGTTCTTGAATGAGATTATCC-3’ or CRE 
deletion (5’-CTTCCATTTTAGGGCTCGTTCCAAGGAGGCGATAA-3’; 5’-
TTATCGCCTCCTTGGAACGAGCCCTAAAATGGAAG-3’)). Sequences 
contained deletions of 7, 4, 6, 11 or 7 bp, respectively sequentially from 5’ to 3’ in 
these regions (Fig 12). A standard PCR reaction was performed on a thermal 
cycler using mutated CRH-luciferase construct as a template. Following the 
reaction, the parent plasmid was digested using the DpnI restriction enzyme and 
the daughter plasmid, containing the desired mutation was transformed into XL-
10 Ultragold competent cells and amplified. The mutation was confirmed by DNA 
sequencing using the in-house core sequencing facility (Loyola University 
Chicago, Stritch School of Medicine). 
 
In Vitro Toxicology Assay (MTT based) 
 
Cell viability was measured using in vitro 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) MTT based Toxicology assay (Sigma-Aldrich) 
according to manufacturer’s instructions. Briefly, following EtOH treatments cells 
were washed once with sterile PBS and media was replaced with 250 µl of a 0.25 
mg/ml solution of MTT in regular growth media without FBS and phenol red. 
Cells were incubated in the MTT solutions for 1.5 h at 37º C; then MTT solution 
was removed. MTT solubilization solution (200 µl of 0.04 M HCl in absolute 
isopropanol) was added to each sample and transferred to 96-well plate. 
Absorbance was read at 570 nm on a multimode multiplate reader (Biotech Inc., 
Wonooski, VT).  
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Statistical Analysis 
 
For most data, one-way ANOVA was used to test for differences between 
specific treatment groups followed by Tukey post-hoc test if one-way achieved 
significance. Student’s t-test was used in order to compare differences between 
vehicle and EtOH treatment within each deletion mutation.   
Two-way ANOVA was used to test for interactions between pubertal and 
adult treatments and for main effects of these treatments in regards to following 
dependent variables: plasma BAC, plasma CORT levels, CRH mRNA in the PVN 
and AVP mRNA in the PVN and in the SON. Tukeys post hoc test was used if 
ANOVA achieved significance. If ANOVA showed interactions between 
treatments, students t-tests were used to asses significance between EtOH and 
saline pre-exposed groups within specific adult EtOH treatments. 
Two-way ANOVA was also used to test for interactions between Ch and 
E2 treatments and for main effects of these treatments in regards to following 
dependent variables: plasma BAC, plasma ACRH and CORT levels, CRH mRNA 
in the PVN and AVP mRNA in the PVN and in the SON. Tukeys post hoc test 
was used if ANOVA achieved significance. If ANOVA showed interactions 
between treatments, students t-tests were used to asses significance between 
Ch and E2 treatments within specific saline or EtOH treatments. All tests were 
performed using SigmaStat Statistical Analysis Software. A p-value of less than 
0.05 was considered to be significant. 
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